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Abstract 
The recent development of biological therapies has revolutionized medical treatment 
for psoriatic arthritis. To date, research studies have focused on the treatment effects 
of biologics from a quantitative perspective using generic quality of life measures. An 
understanding of how treatment with biologics is experienced in the lives of psoriatic 
patients themselves therefore remains lacking. This study investigated the lived 
experience of psoriatic arthritis patients receiving biological therapy by employing 
Interpretative Phenomenological Analysis (IPA) to access this experience. Analysis of 
the data highlighted that receiving biologics for psoriatic arthritis was experienced as 
life-changing, but also required participants to make sense of the many unknowns 
surrounding treatment in regard to future effectiveness and long-term side effects of 
biologics. Participants experienced a biomedical focus on disease and treatment 
effects alone as not taking into account the significant psychological impact that 
having psoriatic arthritis and being treated with biologics can have on sufferers’ lives. 
Three master themes were identified: new lease of life, living with the fear of the 
unknown, and the importance of seeing the disease and the person. It is argued that 
this research extends the current knowledge base in counselling psychology on the 
psychological aspects of skin conditions such as psoriasis to what it is like to have 
both psoriasis and arthritis, whilst also being relevant to counselling psychologists 
working with psychological aspects of medical conditions, which is proposed to hold 
a promising future for the field.  
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Glossary of Terms 
Biological therapies (biologics): Biologics is the umbrella term given to a 
class of treatment drugs that are genetically engineered proteins derived from human 
cells. First licenced in the UK in 2004, biologics have revolutionised treatment of a 
number of inflammatory diseases. Biologics consist of highly selective agents that 
compromise the immune system by targeting specific internal events in the body that 
trigger the inflammatory response. Biologics are sometimes also referred to as anti-
TNF or anti-tumor necrosis factor therapies, because these work by targeting a 
substance in the blood called Tumor Necrosis Factor (TNF)- alpha, which is a 
cytokine (specialized protein that promotes inflammation). It is this overproduction of 
TNF-alpha that has been linked to inflammation, which target by blocking the TNF-
alpha activity by binding it to cell membranes and blood cells.  
Methotrexate: is a type of immunosuppressant drug known as disease-
modifying anti-rheumatic drugs (DMARDs). Methotrexate is prescribed to treat 
several auto-immune diseases including rheumatoid arthritis and psoriatic arthritis. 
Methotrexate works by blocking enzymes in the immune system but can cause serious 
side-effects to liver, lungs, and kidneys. Methotrexate is usually taken in tablet form.  
PUVA: PUVA stands for psoralen combined with ultraviolet A (UVA) light 
therapy that is used to treat psoriasis. Psolaren is usually taken orally 1 hour before 
UVA treatment, but can also be applied topically in some cases. PUVA is usually 
given 2-3 times per week for 12 weeks in a light box.  
Psychodermatology: Psychodermatology is a subspeciality of dermatology, 
which focuses on the interplay between dermatology (skin) and psychiatry/
psychology (mind). The field has emerged as a response to there being a high 
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prevalence of psychological and psychiatric comorbidity in people with visible skin 
conditions, but also to findings suggesting that emotional states, especially stress, are 
implicated in in the aetiology, maintenance, and exacerbation of several skin 
conditions. Psychodermatology is thus concerned with the interrelationship between 
the mind and skin and how treatment for skin conditions may include psychological 
interventions such as stress-reduction techniques, cognitive-behavioural therapy, 
mindfulness, etc. to reduce the psychosocial impact of disease and potentially 
physical symptoms of disease.  
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Illness is the night-side of life, a more onerous citizenship. Everyone who is 
born holds dual citizenship, in the kingdom of the well and in the kingdom of 
the sick. Although we all prefer to use only the good passport, sooner or later 
each of us is obligated, at least for a spell, to identify ourselves as citizens of 
that other place. 
—Susan Sontag (Illness as Metaphor, 1988, p. 3) 
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Reflexive Preamble 
The inspiration behind this thesis arose at a clinical placement at a National 
Health Service (NHS) trust, which pioneers the use of psychodermatology – an 
emerging field concerned with the interrelationship between psychology and the skin.  
For me, working with dermatology patients constituted the most formative 
experience as a counselling psychology trainee. It was one that led me to develop a 
profound interest in holistic patient care, the mind-body relationship, and how 
psychological therapy can be applied to patients with chronic medical conditions.  
The impact of having a skin condition is often trivialised. Dealing with this 
patient group, however, taught me what a stigmatising experience living with a skin 
condition can be. Many clients told harrowing tales of being asked to leave public 
places such as gyms and swimming pools, people moving away from them on public 
transport to people staring or asking intrusive questions about their condition. 
Feelings of shame about their appearance caused many to avoid social interaction 
with others for fear of negative evaluation with detrimental consequences for their 
relationships, lives, and self-esteem. It quickly became apparent that having a visibly 
disfiguring skin condition was anything but a superficial, cosmetic issue, but rather 
one that could have an all-encompassing effect on sufferers’ lives.  
However, I also experienced that there was seemingly no direct connection 
between the severity of disease and the psychological distress experienced by clients. 
How severe or widespread the physical manifestations of disease was had little 
bearing on how the client coped with his or her condition. Some clients would be 
crippled by shame and anxiety about their appearance despite barely visible or 
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minimum disease activity. Others were covered from head to toe in angry, red 
plaques, but seemingly took it in their stride.  
What I learnt was that how someone responded to having a medical condition 
had little to do with the illness and everything to do with the person behind the 
condition (Walker & Papadopoulos, 2005). The person’s social context, what 
learnings or beliefs they had formed about themselves, others, and the world at large 
were paramount in understanding a person’s illness-related distress. Consequently, 
psychological therapy would be most helpful when it centred not just on building 
adaptive coping responses, but on what lay behind that person’s emotional, 
behavioural, and cognitive response to having the condition in question. And treating 
the person ‘behind the condition’ would, in some cases, translate into astonishing 
physical improvements whereby the condition would visibly shrink or disappear. 
The specific research question of this study was the result of a meeting where 
consultant dermatologists and rheumatologists shared their observation that psoriasis 
patients, some with psoriatic arthritis, who had been offered a new and highly 
effective treatment drug called ‘biologics’ had mixed responses.  
While some patients reported significant physical and psychological 
improvement following treatment, others, it seemed, did not manage to make real 
changes in their lives despite significant symptom improvement. Quoting from 
memory, these were patients who one consultant suspected ‘might need rehabilitation 
or psychological help to move on with their lives’.  
I immediately found this interesting as it tapped right into what I found 
fascinating; namely research showing that symptom severity is often not as important 
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as psychological factors in understanding coping and adjustment to chronic illness 
(Leventhal, Diefenbach, & Leventhal, 1992).  
Furthermore, psoriatic arthritis patients were unique in that they suffered from 
both a skin and a joint condition. However, despite being affected by both psoriasis 
and arthritis, they had access to very little information about what it was like to have 
the condition and whether/how this was different from living with the well-
established burden of psoriasis or arthritis alone. 
Thus originating in a practice-based context, this thesis is the result of 
attempting to investigate further by attending to the experience of psoriatic arthritis 
patients treated with biologics.  
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Chapter I: Introduction 
Chronic Illness  
Recent years have seen an increased interest in the role of psychological 
factors in chronic illness management. A chronic illness can be defined as a disease 
that has a prolonged course, does not resolve spontaneously, and is rarely completely 
cured (WHO, 2005). Living with a chronic disease is therefore different from 
suffering from an acute condition, which, by definition, is characterised by a rapid 
onset, short duration, and, usually, identifiable and treatable origin of disease (Larsen, 
2013). 
Many chronic conditions are associated with physical symptoms that result in 
varying degrees of disability. Living with a chronic illness is therefore likely to 
introduce significant adaptive challenges and coping demands (Petrie & Reynolds, 
2007). Indeed, data suggest that 20–25 % of patients with chronic medical conditions 
experience significant negative psychological symptoms (White, 2001) with 
depression being especially prevalent  
Chronic Illness and the Biomedical and Biopsychosocial Model of Health 
The current healthcare delivery system is founded on the biomedical model of 
illness; the focus is on disease and ameliorating the pathophysiology by medical 
procedures and interventions to restore health and functioning (Larsen, 2013). The 
inadequacy of the biomedical model in chronic illness management has been 
repeatedly highlighted (Waisbond, 2007). While clearly relevant for acute and 
episodic types of diseases, its ‘fix and cure’ model is ill-suited to meet the demands of 
patients with chronic illnesses, where recovery is incomplete and disease incurable 
per se (Larsen, 2013).  
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However, it is also the biomedical model’s assumption of a linear 
correspondence between disease severity and degree of psychological distress that has 
been undermined. Whilst the prevalence of psychological disorders among people 
with chronic illness was initially assumed to be precipitated by the stress of having an 
incurable disease (Abram, Moore, & Westerfelt, 1971; Hong, Smith, Robson, & 
Wetzel, 1987), the correlation between disease severity and severity of psychosocial 
impact was found to be weak at best. Studies repeatedly found that the variability in 
coping, adjustment and psychological impact that came to the fore could not be 
explained by objective disease-specific factors alone (Rosenberg, Peterson, Hayes, 
Hatcher, & Headen, 1988; Hawley & Wolfe, 1988). 
Instead, psychological factors have been shown to be crucial in explaining this 
variability (Leventhal et al., 1992; Lazarus & Folkman, 1984; Maes & Gebhardt, 
2000; Devins, 2010). Indeed, a plethora of studies have demonstrated that it is how 
the individual perceives and experiences his or her illness and the meaning ascribed to 
having the specific illness that most significantly explain coping behaviours, 
psychological impact, and adherence to treatment across a wide range of medical 
conditions (Hagger & Orbell, 2003). 
Such findings have spurred on a widening of the scope to include 
consideration of the role of psychological factors and social processes alongside the 
biomedical in health and illness. Such developments can be conceptualised as a shift 
from the biomedical model’s focus on disease alone to a biopsychosocial model of 
health (Suls & Rothman, 2004), which holds that that biological, psychological, and 
social processes are integrally and interactively involved in health and illness (Engel, 
1977).  
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The Relevance to Counselling Psychology 
From a counselling psychology perspective, there appears to be a natural 
affinity between the biopsychosocial model and the values of counselling psychology. 
In a medical context, counselling psychology’s holistic and humanistic emphasis thus 
places the individual, subjective illness experience at the centre of inquiry. The 
subjective illness experience will thus inadvertently contain within it the biological, 
psychological, and social experience of having and living with the disease in question. 
For the counselling psychologist, it is the subjective, human experience of 
disease; how a disease is perceived, lived with, responded to and the meaning that is 
given to that experience that is in focus. This will mean paying attention to 
psychological factors that shape the individual response to disease, but also to the 
sociocultural context of that illness experience in recognition that “suffering, disease 
and illness are affected by multiple levels of organization, from the societal to the 
molecular” (Borrell-Carrio et al., 2004, p. 576).  
A commitment to a scientific research base that guides practice is often 
heralded as the hallmark of counselling psychology (Lorrie & Callahan, 2000; BPS, 
2005). Counselling psychology’s historical emphasis on the personal, subjective 
experience and the use of phenomenological methods has led to a body of research 
seeking to promote understanding of and giving voice to those marginalised or 
overlooked by existing research (Strawbridge & Woolfe, 2010; Hoyt & Bhati, 2007; 
Ponterotto, 2005).  
This has been reflected in the nascent body of research by counselling 
psychologists on the psychological impact of skin conditions like psoriasis 
(Papadopoulos & Bor, 1999; Papadopoulos, Borr & Legg, 1999a; Mizara, 
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Papadopoulos & McBride, 2012), which was previously seen as a primarily cosmetic 
issue with no significant implications for psychological and social well-being 
(Rumsey & Harcourt, 2005). 
As no research to date has been conducted on PsA in which sufferers have 
both psoriasis and arthritis, it thus seems natural to extend the existing literature by 
widening the focus to PsA. It could furthermore be argued that this study’s relevance 
to counselling psychology is augmented by counselling psychology’s interest in what 
Davy (2000) terms liminal experiences. Defined as ‘in-between’ experiences, PsA 
sufferers can thus be understood to be positioned ‘in between’ the medical specialities 
of rheumatology and dermatology and possibly, therefore, as having received scant 
attention as a result (Gordon & Ruderman, 2005). 
Giving voice to this population is therefore consistent with the values of 
counselling psychology as it aims to promote understanding of the experience of PsA 
sufferers undergoing biological treatment in order not only to raise awareness of what 
it is like, but also to potentially identify needs for and gaps in the provision of 
psychological support during their illness trajectory.  
Such undertakings seem in line with recent UK government recommendations 
advocating an increased biopsychosocial approach in healthcare urging for the 
provision of ‘integrated’, ‘holistic’, and ‘patient-centred’ health care for people with 
long-term conditions (Department of Health 2012, 2013a, 2013b), just as the National 
Institute for Health and Clinical Excellence (NICE) has recommended that individuals 
with chronic medical conditions have access to psychological therapy (NICE, 2009). 
Though it is unclear how many counselling psychologists work with clients 
suffering from physical health rather than mental health, data show that counselling 
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psychologists are increasingly employed within the NHS (Orlans & Van Scoyoc, 
2009; James & Bellamy, 2010; Davies, 2016). Whilst understanding health and illness 
through a biopsychosocial lens is not the sole remit of counselling psychologists 
(Chwalisz & Obasi, 2008; Ogden, 2012), recent UK government recommendations on 
an increased biopsychosocial focus in healthcare thus gives the impression that 
counselling psychology is in a unique position to effect service provision by carrying 
out research on medical conditions or treatments that is consistent with counselling 
psychology’s phenomenological and person-centred mode of enquiry (Ponterotto, 
2005). Indeed, involvement in physical health has been argued to constitute an 
important future direction for the field (Karademas, 2009; Mrdjenovich & Moore, 
2004).  
It is therefore the contention of the researcher that phenomenological study 
with the aim of giving voice to subjective, first-person accounts of what it is like for 
PsA sufferers to receive biological therapy is both relevant to and consistent with the 
values of counselling psychology.  
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Chapter II: Literature Review  
The following review of the literature will aim to provide an overview of what 
is currently known about the biological, psychological and social aspects of living 
with PsA.  
Psoriatic Arthritis   
Psoriatic arthritis (PsA) is a chronic autoimmune condition characterised by 
inflammatory arthritis that has been estimated to affect 10–30% of patients with 
psoriasis (Gladman & Chandran, 2009). PsA is currently incurable and typically 
develops sequentially to psoriasis with a typical onset of 10 years after the first 
psoriasis symptoms (Mease, 2009). PsA patients are therefore doubly afflicted; first 
by psoriasis, a visibly disfiguring skin condition, and subsequently by arthritis in the 
joints and connective tissues. 
Psoriasis is a chronic, inflammatory skin condition characterised by the 
development of raised reddish lesions covered by a silvery build-up of scales on the 
skin surface. Symptoms include shedding or flaking of skin, debilitating itchiness 
(Globe, Bayliss & Harrison, 2009), bleeding, cracking, and dry skin and can range 
from mild to severe, the latter of which can lead to hospitalization.  
The arthritis symptoms of PsA manifest as inflammation in the joints and 
connective tissue, which can lead to pain, stiffness, and swelling and, sometimes, 
permanent destruction of the joint structures. Disfigurement of fingers and toes, nail 
changes, and sausage-like swelling of fingers or toes are common, just as spine 
involvement occurs in up to 40% of patients (Gladman & Chandran, 2009).  
The exact pathogenesis of PsA is unclear. The condition occurs equally among 
men and women with an average age of onset of 40 years. The condition is thought to 
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be triggered by an interplay between genetic and environmental factors, although 
evidence points to the primacy of genetic factors (Rahman & Gladman, 2005). 
Reports of prevalence vary, but the data that PsA affects 10–30% of psoriasis sufferers 
(Zachariae, 2003) suggests that less than 1% of the general population have PsA.   1
Like that of many other chronic conditions, the course of PsA is unpredictable 
and typically characterised by multiple periods of remission and relapse. This means 
that while sufferers are dually affected by both psoriasis and arthritis, symptoms may 
not manifest simultaneously. Sometimes symptoms of both psoriasis and arthritis 
develop in concert, other times only few or the symptoms of only one condition 
manifest (Mease, 2011).  
Conventional Medical Treatment for PsA  
Until recently, medical treatment for PsA was not particularly efficacious. 
Control of the inflammation and progression of disease was seldom adequate and 
treatment for the skin manifestations of the disease would involve a separate 
treatment altogether (Gladman & Chandran, 2009). The typical treatment for PsA 
patients would involve the dermatologist treating the skin and the rheumatologist 
treating the joints with each party prescribing a medical treatment according to their 
speciality that would have limited impact on the other condition. The result would 
therefore often be, not only a disconnect in the care of PsA patients, but also poly-
pharmacy and a heightened risk of cumulative end organ toxicity (Gordon & 
Ruderman, 2005).   2
 For further information about PsA, please refer to Appendix A. 1
 For an overview of treatment options for PsA, please refer to Appendix B. 2
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The Emergence of Biological Treatments  
However, the recent development of biological therapies (‘biologics’) has 
revolutionised the treatment prospects not only for PsA, but also for psoriasis and 
related rheumatologic conditions. It is now possible to simultaneously treat both the 
inflammation in the joints and skin by inhibiting specific components of the immune 
system that fuel inflammation (Wolfgang 2010). 
Biologics are administered by injection or intravenous infusion (IV) and must 
be administered continuously to have an effect. Thus, patients either self-inject or 
receive IV at hospital on a fortnightly basis.  
Adverse side-effects to treatment with biologics include injection-site and 
infusion reactions and the increased risk of infections (Gladman & Chadran, 2009). 
Being a relatively new drug, there is still uncertainty about the long-term effects of 
biologics. However, the majority of evidence suggests that approved biological agents 
are generally well tolerated and safe, when used according to guidelines in well-
monitored patients (Soubrier et al., 2014; Basra & Hussain, 2012). 
Biologics are, however, expensive at an estimated cost of £10.000 per annum 
per patient (NICE, 2012). Clinicians are therefore urged to follow a stepped-care 
model, where biologics are only offered to patients with moderate to severe disease 
impairment, who have not responded to or developed intolerance to conventional 
treatment with systemic agents. Alongside disease severity, a further eligibility 
criterion for biologics treatment is the demonstration of significant quality of life 
impairment (NICE, 2012). Thus, biologics tend only to be offered as a ‘last resort’ to 
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patients, who demonstrate moderate to severe impairment on both physical 
parameters as well as on domains relating to QoL.   3
Quality of Life Measures  
In the healthcare literature, QoL or HRQoL have emerged as broad terms to 
describe the personal and social context of patients. Such measures are now routinely 
included in randomized controlled trials (RCT) to supplement clinical measures of 
disease severity and clinical treatment effects. These work by generating a broad, 
overall numerical indicator of the impact a disease or treatment has on the physical, 
social and psychological well-being of an individual, which is thus seen as evidence 
of their effectiveness (Bowling, 2007). 
The most widely used generic HRQoL measure is the SF-36 (Ware & 
Sherbourne, 1992). The advantages of its use are that the data generated can be used 
to systematically compare and contrast across different populations and conditions. 
The use of such measures can therefore yield highly valuable information of the 
extent to which QoL has been compromised by a disease (Rapp et al., 1999).  
The Lack of Disease-specific Measures in PsA  
The scant attention that has, historically, been paid to PsA has resulted in a 
situation in which there is currently no standardized and widely validated disease-
specific measure available (Gladman et al., 2007; Mease, 2009). While attempts have 
been made to develop measures that assess both clinical and QoL domains in a 
manner that capture the patient’s assessment of their impairment of both the skin and 
joint symptoms of the disease (McKenna et al., 2004), such efforts are still ongoing 
(Coates et al., 2014).  
 Please see Appendix C for details on biologics guidelines for psoriasis and PsA.3
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This has therefore resulted in a situation where researchers as well as 
clinicians have had to rely on either generic HRQoL measures, such as the SF-36, 
and/or instruments developed for related rheumatic conditions, such as the ‘Health 
Assessment Questionnaire’ (HAQ) (Bruce & Fries, 2003) for rheumatoid arthritis 
(RA), or the ‘Dermatology Life Quality Index’ DLQI (Finlay & Khan, 1994) for 
psoriasis  (Mease, 2011).  4
Existing Research on HRQoL in PsA 
When it comes to research into the psychosocial aspects of PsA, the majority 
of studies have been comparative quantitative studies that have employed generic 
QoL measures such as the SF-36.  
One of the first studies investigating QoL in PsA patients was a Canadian 
study, which used the SF-36 and the HAQ to compare QoL data between 107 PsA 
patients and the 43 Rheumatoid Arthritis (RA) patients. The study found that even 
though joint damage and decline in physical functioning was more severe in RA, 
patients with PsA reported more limitations due to emotional problems and pain than 
in RA (Hufsted, Gladman, Farewell, & Cook, 2001).  
Similar results were obtained in a Turkish study, which also compared QoL 
and life satisfaction in 40 patients with RA and 40 patients with PsA. It was likewise 
found that both patient groups demonstrated decreased QoL and life satisfaction 
compared to healthy controls, but even though joint damage and physical disability 
were greater in RA, the psychosocial impact was the same for both groups (Borman et 
al., 2007).  
 Please see Appendix D for more information and copies of these questionnaires.4
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In the same vein, HRQoL scores were compared among 469 patients with RA, 
166 PsA patients, 164 patients with ankylosing spondylitis (AS) and 1579 healthy 
controls using the SF-36. Not surprisingly HRQoL scores were significantly lower 
compared to healthy controls for all the conditions. However, overall HRQoL was 
found to be the lowest in patients with RA, whereas the scores for the mental 
component were lowest in the PsA cohort (Salaffi, Carotti, Gasparini, Intorcia, & 
Grassi, 2009).  
A recent Greek study comparing psychological distress in PsA and RA found a 
high level of moderate to severe depression to be present among PsA, especially in 
those with polyarthritis (36.7%) (Kotsis et al., 2012).  
A recent study comparing QoL between 201 patients with psoriasis and PsA 
found that PsA patients had poorer QoL compared with patients with psoriasis alone 
except for on DLQI, a questionnaire designed to measure skin-related QoL 
impairment (Rosen et al., 2012). These studies therefore suggest that QoL is lower for 
PsA patients than in patients with psoriasis and RA, but the studies are 
methodologically not able to investigate the reason for this.  
The limitations of the SF-36, HAQ, and DLQI. Although validated for use 
in PsA (Husted, Gladman, Farewell, Long & Cook, 1997), the SF-36 has been 
associated with a range of shortcomings. While it has been shown to be valuable in 
capturing physical disability or impairment associated with joint damage in PsA, the 
SF-36 has been found to be limited in its ability to assess the disability associated 
with the skin or psoriasis component of PsA (Mease & Menter, 2006; Mease, 2009).  
This is also a limitation that has been directed at the other instrument that has 
been used extensively in studies assessing impact of biologics treatment, namely the 
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HAQ. Originally developed to assess functional disability in RA, the HAQ has been 
widely used to assess disability in a variety of chronic conditions including PsA. 
However, given its explicit focus on disability resulting from the joint-related 
impairment, its utility is limited when assessing the disability associated with the skin 
component of PsA (Husted, Gladman, Long, & Farewell, 1995). 
Both the SF-36 and HAQ have thus been criticized for falling short on 
capturing the skin-related aspects of PsA in terms of not only the physical discomfort 
or disability frequently experienced such as itching and bleeding, but also the 
psychosocial aspects, which have been shown to be an important aspect of having 
psoriasis (Mease, 2009).  
The limitations associated with the SF-36 and HAQ have thus led many 
researchers to include the DLQI in clinical trials (Mease, 2011). However, as the 
DLQI was developed specifically to measure the impairment experienced by patients 
with dermatological conditions, it, therefore, does not contain any questions 
pertaining to the impairment that relates to the joint-related component of PsA.  
The Turn to Qualitative  
Not surprisingly, the reliance on measures in PsA research that are either 
generic or developed for other medical conditions have raised concerns as to whether 
these instruments reliably assess what is relevant to PsA sufferers’ lives (Mease, 2009; 
McKenna et al., 2004).  
This concern has prompted a turning to qualitative methodology to explore the 
patient experience of having PsA with the aim of finding out whether concepts 
important to PsA patients are covered by measures assessing functioning in two 
studies. 
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An Austrian study using thematic analysis interviewed 31 participants in 6 
focus groups about their disease experience. The study found that 19 concepts 
identified as important to PsA patients, translating as 35%, were not captured by any 
of the 9 measures, which included the SF-36, HAQ and DLQI. The authors thus 
recommended further qualitative studies into patients’ experience of disease when 
seeking to develop and refine outcome measures (Stamm et al., 2007).  
An unpublished doctorate thesis utilised interpretative phenomenological 
analysis (IPA) to explore the disease experience of 10 PsA patients (Aitken, Anderson, 
Whyte, Adams, & Poole, 2007). The study’s primary aim was to explore PsA patients’ 
lived experience in order to cross-check fit between themes uncovered from the 
analysis with existing measures. This study likewise found that the use of existing 
outcome measures failed to take into account the psychosocial experience of having 
PsA, which were identified as depression, lack of social support, psychological 
impact of pain, fatigue, and concern about the long-term effects of drug treatment 
(Aitken, 2011). 
From the analysis it emerged that having PsA was experienced as a series of 
losses related to what was now possible in life, in relation to goal-setting, self-identity 
and body image. Low mood and depressive symptoms were present in all participants, 
but were attributed mainly to the impact of the arthritic aspect of PsA. In fact, it was 
found that the impact of psoriasis on sufferers’ lives was experienced as negligible 
compared to the pain and reduced mobility experienced as a result of the arthritic side 
of the condition. However, as noted by the author, it remained unclear whether this 
was because psoriasis at the time of the interviews had cleared following treatment as 
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opposed to participants’ joint pain or because the pain and disability associated with 
arthritis was viewed as far more detrimental than those of psoriasis (Aitken, 2011).  
Summary of Research Findings Into Psychosocial Aspects of PsA  
The majority of studies on the psychosocial aspects of PsA have thus mainly 
employed generic QoL measures, which have been shown to be associated with a 
range of limitations and may not even measure the prevalent concerns of patients’ 
experience of living with PsA. The only study that has attempted to provide an in-
depth understanding of the experience, issues, and challenges associated with PsA 
could be argued to be limited by its aim of reducing these experiences to domains 
with which to check fit with measures used. Hence, research into sufferers’ experience 
of having PsA is still in a ‘fledgling state’ (Mease, 2009, p. 320). 
The Psychological Impact of Psoriasis and Rheumatoid Arthritis  
Given the paucity of studies to inform our understanding of the experience of 
PsA, it is therefore helpful to briefly review what is known about the psychological 
impact of living with psoriasis and RA, with which PsA shares many clinical features.  
Psoriasis. During the last few decades, a large body of research has shown 
that psoriasis is associated with significant psychological and psychiatric morbidity 
(Russo, Ilchef, & Cooper, 2004; Gupta & Gupta, 2003). Quantitative studies have 
shown that psoriasis is significantly correlated with depression and anxiety (Schmitt 
& Ford, 2007; Hayes & Koo, 2010), pathological worry (Fortune et al., 2000), 
suicidal ideation (Gupta & Gupta, 1998), and increased risk of suicide (Kurd et al., 
2010).  
Studies employing QoL measures among psoriasis patients have found that 
these were comparable to those seen in severe and life-threatening conditions such as 
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cancer, heart disease, and diabetes (Rapp et al., 1999). Indeed, it has recently been 
argued that the stigma associated with visible skin disease leads to a significant 
psychological burden that is cumulative over time to the extent that it can 
significantly affect the life course of people with psoriasis (Mattei, Corey & Kimball, 
2013; Kimball et al., 2010; Pearce et al., 2006).  
The high degree of psychological distress among psoriasis sufferers has been 
related to the wider social context of how others perceive and react to someone with a 
visible skin conditions. Experiences of stigmatisation are prevalent among psoriasis 
sufferers (Richards, Fortune, Griffiths, & Main, 2001; Ginsberg & Link, 1989), with 
many reporting experiences of rejection and negative judgements from others with 
devastating effect on sufferers’ self-esteem (Holsinger, 2004; Jobling, 1976; Magin et 
al., 2009; Vardy et al., 2002; Wahl, Gjengedal, & Hanestad, 2002). Both quantitative 
and qualitative studies have found psoriasis to be linked with high degrees of social 
anxiety, embarrassment, shame, impaired self-image, low self-esteem, expectancy of 
stigmatisation among sufferers, and the frequent use of social withdrawal and 
avoidance-based coping strategies (Fortune, Richards, & Griffiths, 2005; Kimball, 
Jacobson, Weiss, Vreeland, & Wu, 2005).  
Furthermore, a sociocultural perspective draws our attention to how powerful 
and pervasive sociocultural ideals of beauty are transmitted via a variety of channels, 
most notably the mass media (Tiggemann, 2011). A qualitative Australian study found 
that failure to live up to the media-generated ideal of flawless skin negatively 
impacted psoriasis sufferers’ self-image and self-esteem, despite their recognising 
these representations of skin perfection to be artificial (Magin et al., 2009).  
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What these studies repeatedly highlight is that clinicians should not 
underestimate the often-significant psychosocial burden experienced by psoriasis 
sufferers, as this frequently does not correlate with clinical disease severity (Russo, 
Ilchef, & Cooper, 2004; Gupta & Gupta, 2003). 
Rheumatoid arthritis. The impact of RA on sufferers’ lives has likewise been 
shown to be considerable (Picavet & Hoeymans, 2004). Patients with RA have been 
shown to be more likely to suffer from anxiety (Van Dyke et al., 2004), depression 
(Dickens, Jackson, Tomenson, Hay, & Creed, 2003), low self-esteem, and poor body 
image (Macsween, Brydson, & Fox, 2004) as well as high levels of associated 
mortality and suicidal ideation (Timonen et al., 2003; Treharne, Lyons & Kitas, 2000). 
Especially pain and the loss of mobility resulting in work disability (Backman, 2004) 
and the inability to pursue valued activities have been associated with the onset of 
depressive symptoms (Dickens et al., 2003; Katz & Yelin, 2001).  
Qualitative studies have identified fatigue as a major impediment to the 
sufferers’ ability to carry out mundane everyday tasks, causing frustration and anger 
(Repping-Wuts, Uitterhoeve, van Riel, & van Achterberg, 2008).  This finding was 
supported by a recent Swedish qualitative study that likewise identified feelings of 
loss, hopelessness, sadness, anger, and irritation when experiencing functional 
restrictions, but also shame and embarrassment pertaining to the visible 
manifestations of the disease, which resulted in avoidance behaviours (Ostlund et al., 
2014).  
Conclusion: Adverse Psychological Sequelae Associated With PsA  
To sum up, compared to the extensive literature on the psychosocial aspects of 
living with psoriasis and rheumatoid arthritis respectively, scant attention has been 
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paid to PsA. This is surprising given that PsA sufferers are distinguished by having 
two diseases, each of which has been associated with substantial psychological and 
psychiatric morbidity on their own accord.  
Taking into account the above evidence, may then suggest what is intuitively 
plausible; namely that it is the additional burden of a skin or joint condition that 
accounts for the lower QoL in PsA patients compared to patients who suffer from 
psoriasis or RA alone as demonstrated in the aforementioned studies (Husted et al., 
2001; Rosen et al., 2012). 
Though what it is like to have both a visibly disfiguring skin condition and a 
painful, mobility-reducing arthritis remains underresearched, given the above studies, 
it seems plausible to infer that the psychosocial burden associated with this condition 
is significant. 
Clinical Trials Assessing the Effect of Biologics on Patient QoL  
As mentioned earlier, biologics have been shown to significantly improve the 
physical symptoms of PsA. Indeed, a plethora of clinical trials assessing the impact of 
biologics on HRQoL have equivocally demonstrated improvements in physical and 
mental health aspects of HRQoL in PsA patients’ lives (Strand et al., 2012; Saad et al., 
2010; Papoutsaki et al., 2013; Gladman et al., 2006; Kaltwasser et al., 2004; 
Kavanaugh et al., 2005; Mease et al., 2005).  
Whilst it is not possible to review all of these studies within the scope of this 
study, there is also evidence of inconsistencies. One example is a recent quantitative 
study that evaluated the impact of biologics (anti-TNF) therapies on QoL and 
functional status in 596 PsA patients using the HAQ and SF-36. The study found 
significant improvements in SF-36 subscales relating to physical components of 
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disease after 6 months (53.2%). However, improvements for the mental health scale 
were much lower at 16.9% (Saad et al., 2010). So although the study found significant 
improvements in HRQoL following biologics, closer scrutiny of scores show a 
significant difference between physical and mental health variables.  
Similar findings have been reported in the literature on psoriasis. One study 
that differentiated between physical and psychological variables found that clearance 
of physical symptoms following a successful course of PUVA-therapy brought about 
immediate reductions in patients’ psoriasis-related disability. However, symptom 
clearance did not bring about significant changes in the patient’s psychological 
distress measured on scales for anxiety, depression, and worry. This was especially 
true for patients who had a longer history of psoriasis (Fortune et al., 2004).  
Such findings were echoed in another study that likewise found that levels of 
distress remained the same or worsened at 3-month follow-up despite evidence of a 
reduction in disability in patients cleared of psoriasis symptoms following a course of 
UV-phototherapy treatment, (Gupta, Long, & Tillman, 1999).  
Though reasons for this remain unclear, the authors suggest that patients with 
a longer history of disease may find it difficult to reappraise their changed disease-
status just as fear of relapse and beliefs pertaining to the controllability of their 
condition are likely to impact psychological well-being despite successful symptom 
control (Fortune et al., 2004). 
The Problem With Generic QoL Research  
Furthermore, it is debatable how much quantitative studies employing QoL 
measures are able to uncover about how treatment with biologics is experienced in the 
lives of PsA sufferers. 
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Firstly, what constitutes QoL and whether it can be meaningfully measured is 
controversial (Finlay, 2005). While the term QoL is intuitively meaningful and 
understandable to most people, it is by its very nature highly idiosyncratic. The 
problem for QoL (or HRQoL) research is how to reach consensus in regard to what 
constitutes QoL and how to measure it (Ogden, 2012). 
Whilst it lies beyond the scope of this study to review this debate (Koller & 
Lorenz, 2002; Testa & Simonson, 1996), suffice it to say that despite its extensive use, 
there is little consensus on how to both define and measure QoL within the value 
system of the individual being assessed, rather than the value system of others. Thus, 
the use of QoL measures is thus based on the assumption that it is possible to make 
objective and measure something that is, by nature, extremely subjective.  
Secondly, it has been argued that HRQoL scores essentially require 
interpretation or unpacking (Marquis, Chassany & Abetz, 2004). Even when data are 
statistically significant, caution should be exercised in assuming that findings are 
causally related to biological disease variables or treatment effects. A difference in 
scores before and after intervention is often taken to represent the effects of treatment. 
However, making such inferences is built on a conception of causality, which many 
would regard as simplistic due to a limited ability to differentiate between 
psychological causal and indicator variables (Boehmer & Luszczynska, 2006). Thus, 
the issue is one of the degree to which one can assign qualitative meaning to 
quantitative scores (Lohr et al., 1996). 
The Gap in Knowledge  
The above examination of the literature shows that research on biologics 
treatment for PsA is dominated solely by quantitative studies. While the inclusion of 
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patient-based QoL questionnaires may provide some insight into how treatment is 
experienced in PsA sufferers’ lives, these measures are associated with a range of 
limitations.  
What can be known about the PsA patient’s experience of receiving biological 
treatment may be limited in a double fashion. One limitation is that studies, to date, 
have all been situated within the parameters of a quantitative methodology, which 
means that what can be known about PsA sufferers’ experiences has been restrained 
by pre-defined categories from the outset. Not only in regard to the illness experience 
of PsA, but the use of QoL measures as gateways into participants’ experiences also 
taps into the controversial debate on how one can meaningfully measure and 
conceptualise a highly subjective construct such as QoL.  
Another limitation pertains to the evidence that suggests that the QoL 
questionnaires used in the existing quantitative studies fail to capture the prevalent 
concerns of PsA sufferers (Aitken, 2011; Stamm et al., 2007; Coates et al., 2014).  
Together these limitations therefore raise the question of how accurately 
studies based on theory-led quantitative methodologies reflect PsA suffers’ 
experiences of receiving biologics.  
There is therefore a gap in the literature of studies that could further 
understanding of how treatment with biologics is experienced from the ‘insider’ 
perspective of PsA sufferers themselves. 
Rationale, Aim and Research Question  
Due to the novelty of biological treatment for PsA an in-depth exploration of 
the lived experience of PsA sufferers receiving biological therapy thus seems 
important to investigate for several reasons.  
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What initially prompted this study was anecdotal evidence from 
dermatologists that many PsA sufferers undergoing treatment with biologics still 
experienced psychological distress despite marked physical improvements. Whilst a 
review of the literature generally demonstrates unequivocal improvements in QoL 
following biologics, one study did however support the anecdotal evidence from 
clinical practice in finding that improvements relating to mental health was much 
lower than for physical health (Saad et al., 2010).  
Hence, an in-depth exploration could be argued to be of relevance in terms of, 
potentially, elucidating these ambiguous findings. This could potentially provide 
counselling psychologists as well as other health care professionals working with this 
patient group with insights into how this client population experiences their illness 
and treatment with biologics, with potential implications for further research and 
practice.  
As counselling psychologists are already working within health care settings 
such as psychodermatology, it is likely that they will encounter patients with PsA. As 
there is currently no counselling psychology research on what it is like to have both 
psoriasis and arthritis, this study could therefore extend understanding of the need for 
psychological counsel to those suffering from PsA.  
In this respect, this study is in line with counselling psychology values of 
privileging the subjective experience and giving voice to those overlooked by existing 
research (Ponterotto, 2005; Strawbridge & Woolfe, 2010; Hoyt & Bhati, 2007) as well 
as being relevant to the increased emphasis on patient-focused and holistic medical 
care within the NHS in terms of its focus on the experience of the patient to 
potentially inform practice (Harper & Thompson, 2012).  
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The aim of this study is therefore to address this gap in the literature by giving 
voice to PsA sufferers by asking them what it has been like to receive biological 
therapy within a methodology that allows for in-depth exploration of this.  
Given the above rationale, the central research question for this study is 
therefore;  
How do patients with psoriatic arthritis experience receiving biological 
therapy?  
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Chapter III: Methodology 
A qualitative methodology, more specifically interpretative phenomenological 
analysis (IPA) (Smith et al., 2009) was chosen as the most suitable method with which 
to answer the research question of this study. The rationale behind this choice will be 
accounted for in the following and reflexive consideration given to how this choice 
relates to the epistemological position of the researcher and the values of counselling 
psychology.  Finally, the practicalities of how the research was carried out will be 5
detailed along with a discussion of ethics and validity in the context of this study.  
The Theoretical Underpinnings of IPA 
IPA was developed in the mid-1990s by Jonathan Smith as a specific approach 
to qualitative research that was grounded in psychology. Concerned with detailed 
examination of individual lived experience and how individuals make sense of that 
experience, IPA has been used extensively in applied psychological research within 
health, clinical, counselling, and educational psychology (Smith, 2011a).  
The conceptual underpinnings of IPA draw on concepts from phenomenology, 
hermeneutics, and idiography (Smith et al., 2009). IPA’s phenomenological roots give 
emphasis to the detailed examination of what it is like to be experiencing a given 
phenomenon for a particular individual. As such IPA wishes to get as close as possible 
to that experience, but recognises the impossibility of gaining direct access to this 
experience.  
Building on Heidegger’s hermeneutic phenomenology means that a particular 
phenomenon can reveal itself only through interpretation. Any interpretative 
 The reflexivity sections are written in the first person in order to better communicate these 5
experiences to the reader 
PSORIATIC ARTHRITIS AND BIOLOGICAL TREATMENT !38
endeavour will, however, be subjective and influenced by the researcher’s own 
understandings and preconceptions (Smith & Osborn, 2003). Any analysis produced 
will always be an interpretation of the participant’s experience, and in a sense, twice 
removed as captured by the term double hermeneutic: the participants trying to make 
sense of their world and the researcher trying to make sense of the participants trying 
to make sense of their world (Smith & Osborn, 2003).  
Thus, holding that it is impossible to engage with something independently of 
our relationship to it means that it is paramount that the IPA researcher adopt a 
‘phenomenological attitude’ (Finlay, 2011) – a careful balancing act between being 
reflexively aware of one’s fore-understandings whilst trying to see or hear or remain 
open to what the participant or text is communicating. Such an approach gives the 
phenomenon under investigation the best possible chance of being seen, whilst 
acknowledging that an objective view is not possible.  
The third pillar of IPA is an idiographic concern with the particular rather than 
the universal (Smith et al., 2009). Each individual experience is seen as a unit of 
analysis in its own right, which means that IPA, in contrast to the nomothetic 
principles underlying most psychological empirical work, is concerned with meaning, 
diversity, and the variability of human experience rather than establishing causal laws 
(Eatough & Smith, 2008). However, this does not hinder IPA from revealing 
‘something very tangible and very real about the constitution of the “object”’ (Larkin 
et al., p. 110). Attending to the particular can reveal something about the universal in 
the sense that if an experience is possible, it can be subject to universalization (Willig, 
2008).  
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The Choice of Interpretative Phenomenological Analysis  
IPA has been extensively used in studies that explore the experience of illness 
and medical treatments from the perspective of the sufferer (Biggerstaff & Thompson, 
2008; Dickson, Knussen, & Flowers, 2008; Bramley & Eatough, 2005; Smith, 2011a).  
IPA’s foregrounding of meanings and experience makes it a suitable choice 
when seeking to ‘give voice’ to experiences that are under researched and to broaden 
understanding of areas of study that have primarily been informed by a quantitative 
methodology such as the current study. IPA’s focus on meanings also aligns well with 
findings suggesting that psychological impact of illness is informed primarily by the 
contextual and personal meaning the illness experience holds for that particular 
individual (Brocki & Wearden, 2006; Leventhal et al., 1992).  
Other qualitative methods, such as discourse analysis (DA) (Potter, 1996) and 
grounded theory (GT) (Glaser & Strauss, 1967) were also considered.  
DA has many similarities with IPA insofar as it is a qualitative approach that 
places emphasis on the importance of language and interpretation. However, DA rests 
upon a theoretical orientation that presupposes that discourse or language constructs 
reality rather than reflect it.  
Drawing on Ricouer’s distinction between suspicious and empathic readings, 
Willig (2012) argues that DA inhabits the ‘suspicious’ camp in the sense that language 
is analysed to reveal underlying discourses reflecting power structures in society that 
the participant may not be aware of.  Decoding the data to draw out these discourses 
thus necessitates the application of a theory that ‘provides us with concepts with 
which to interrogate the text’ (Willig, 2013, p. 42). Thus, the application of DA can 
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itself be labelled an ‘act of interpretation’ which will generate a ‘theoretically-
informed reading’ (Willig & Stainton-Rogers, 2008, p. 8).  
While IPA also assumes that language does not simply mirror reality, it does 
however assume that what participants express is linked to their experiences of a 
particular phenomenon and thus offer insights into their psychological worlds and 
how they make sense of their life’s circumstances (Torodova, 2011).  
Insofar as the aim of this research was to give voice to participants and allow 
for their own perspective and experience to be foregrounded, IPA was thus favoured 
because this would provide a means of getting as close to the participant experience 
as possible by attempting to understand it from ‘within’ (Willig, 2013) rather than 
through the lens of a specific theory, which provided a better fit with the research 
question of this study.  
GT is a qualitative method that likewise shares many similarities with IPA in 
its inductive approach that aims to discover theory that is ‘grounded’ in data. 
However, it has been argued that GT is better suited to study social processes than 
psychological and experiential ones (Willig, 2013). This is because the aim of GT is 
the formulation of a theory that has explanatory value as to why or how something 
occurs within a specific social context. The use of strategies such as theoretical 
sampling, where data is collected until a point of saturation and no new concepts 
emerge, thus allows GT to build theory that is able to generalise and account for the 
phenomenon under investigation.  
The choice of IPA was thus a reflection of this study’s aim. The aim was not to 
build a theory, but rather to give voice to a population and an experience. IPA was 
thus deemed a good place to start in that it allowed for the foregrounding and in-depth 
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exploration of the lived experiences and meanings given to the experience of 
receiving biologics for PsA in a manner that would allow for different and potentially 
idiosyncratic meanings to be explored rather than the generation of theory.  
Epistemological Fit Between IPA and Researcher  
Another reason IPA was an attractive option is because of its epistemological 
openness. On a continuum IPA can be argued be compatible with positions that span 
the spectrum across critical realism, contextual constructivism and the light end of the 
social constructionism (Eatough & Smith, 2008).  
In assuming that what people say actually maps onto what they are 
experiencing, IPA adopts a broadly realist position to knowledge. IPA is therefore 
informed by an ‘empathic’ hermeneutic position that takes at face value what people 
are saying as opposed to a more ‘suspicious’ position, which sees the data as 
representative of something hidden (Willig, 2012). However, given IPA’s 
phenomenological underpinnings, it can also be positioned on a relativist continuum 
in so far as people are seen as active constructors of meaning in their lives. Thus, for 
IPA it is not a problem for the same event to be experienced in multiple and even 
opposing ways. Finally, IPA also leaves room for a contextual constructionist position 
in acknowledging that any construction of experience draws on existing social, 
cultural, and historical influences and as such is central to experience and to meaning-
making (Eatough & Smith, 2008). 
Given its relative epistemological openness, IPA thus provides a good fit with 
my own epistemological standpoint, which I have come to identify as a ‘common-
sense’ position midway between a realist and a relativist position. I take the position 
that there is no single reality that can be revealed through the use of the correct 
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methodology. Rather, knowledge is always ‘local, provisional and situation 
dependent’ (Madill, Jordan, & Shirley, 2000). Human beings are constantly acting on 
the world around them and making sense of it, which means that meaning is 
constantly shifting and being created. Such a position therefore acknowledges that 
every encounter carries within it endless (?) potential readings as a necessary 
extension of the position that holds that what research is attempting to apprehend ‘can 
never be accessed directly or captured in its entirety’ (Willig, 2012, p. 162).  
However, this does not mean that a critical realist position is discarded. 
Critical realism acknowledges that there are stable, enduring features of reality that 
exist independently of human conceptualisation. However, because of the inherent 
subjectivity within the knower, the experience of the world is different for each 
person. In this way an ontological realism and epistemological constructivism can be 
compatible.  
In the context of research, a critical realist position therefore acknowledges 
that findings will be influenced by a multitude of factors: choice of methodology, 
method, the meeting of researcher and participant, the meaning systems of both the 
participant and the researcher, and their sociocultural backgrounds. However, there is 
also an assumption that research findings relate to some kind of reality about the 
experience being examined, albeit under no illusion that this is in any way exhaustive 
or that only one reading is possible.  
Personal Epistemological Reflexivity  
Reflexivity is derived from the Latin verb reflecter, which means turning back 
or bending back on oneself. For researchers the term therefore denotes the ability to 
PSORIATIC ARTHRITIS AND BIOLOGICAL TREATMENT !43
‘move fluidly back and forth between an inside and an outside perspective’ (Hunt & 
Sampson, 2006, p.4) by owning the assumptions that frame how they work.  
The following is an attempt to inhabit a reflexive stance by critically reflecting 
on the ways I might have influenced the research process in regard to the choice of 
methodology.  
Deciding to train as a counselling psychologist was a decision I made in my 
mid-thirties. My initial degree was in theology, which I have come to realise has 
profoundly shaped my epistemological position. Every day would involve exposure to 
many conflicting beliefs and positions, from those who espoused deeply personal 
religious convictions to those fond of espousing Freud’s view of religion being akin to 
a childhood neurosis and feeble attempt to explain the social world. Truth, it seemed, 
was an extremely subjective matter and in the realm of religion, one which lay beyond 
any scientific test or falsification principle (Flew, 1950). I therefore came to develop a 
decidedly social-constructive perspective on knowledge and truth, if not an extreme 
relativist position, where seemingly truth, most definitely, lay in the eye of the 
beholder.  
When I first embarked on studying psychology, I was particularly drawn to the 
scientific aspect of the profession. The allure of science, rationality, logic, facts, 
hypothesis testing after years of engagement with theological and religious thought 
was irresistible. How I cherished being able to say ‘research shows...’ with reference 
to experimental studies that had compressed human experience and behaviour to a p-
value. I relished the legitimacy, sense of certainty, and the air of ‘truth’ that the 
mention of the word science seemed to evoke (Chalmers, 1999).  
PSORIATIC ARTHRITIS AND BIOLOGICAL TREATMENT !44
However, this was short-lived due to my experience working with clients 
within a psychodermatological context. I was reminded of both the diversity and the 
subjectivity of human experience and of how messy and imperfect the real-world 
experience of practice was. The only thing that seemed certain was that how 
individuals coped with their condition had little to do with disease severity; it was 
how the individual experienced and gave meaning to their illness experience that 
mattered.  
As a result I have been drawn towards phenomenological research methods 
that center on experience and meaning-making that, for me, provide a way of 
balancing research and practice or honouring counselling psychology’s commitment 
to the scientist-practitioner model while anchoring this in the primacy of the client’s 
subjective experience and context. 
During the writing of this thesis, another layer of reflexivity emerged that I 
had first not been aware of. I became increasingly aware that I have deeply personal 
reasons for privileging first-person accounts rather than ‘objective’ medical 
representations of data.  
My third pregnancy was complicated by my suffering from a life-threatening 
condition, which resulted in a close brush with death. The complex array of emotions 
that I felt in the aftermath of this ordeal; being told how ‘lucky’ I had been wanting to 
feel grateful to the medical establishment for saving my and the baby’s life, but these 
feelings’ somehow eluding me led me to realize that there can often be two very 
different, albeit co-existing and equally valid, narratives depending on whom you ask; 
one of a successful biomedical intervention and one of a trauma.  
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I must therefore acknowledge a position where I am critical of asking 
participants to give the briefest of answers and reduce their experience to tick off 
boxes, Likert-scales, or categories in preformulated questionnaires when it comes to 
the notoriously complex fields of health and illness. This is not to imply a position of 
disregard, which would be both haughty and akin to a reverse form of methodolatry 
(Curt, 1994), but rather that I am fine-tuned to the ‘loss’ of information that studies 
using numerical measures and attributing findings to statistical tables, averages, and 
the cut-off point of a p-value inevitably entail.  
Given the above, it is clear to me that I may have chosen a phenomenological 
method such as IPA because of a deeply rooted personal assumption that a method 
that enables a researcher to come as close to the participant’s experience as possible is 
somehow something I regard as a more ‘trustworthy’ approach than quantitative, 
objective representations of the same data would entail. 
Procedures 
The following details the practical steps taken in order to address the research 
question of this study.  
Ethics  
Prior to recruitment, ethical approval for the research was sought and granted 
by London Metropolitan University ethics panel (Appendix E). Because the research 
involved recruiting participants receiving treatment from the NHS, ethical approval 
was subsequently sought from the Liverpool branch of the National Research Ethics 
Committee. A favourable opinion was granted on 17th of April 2014: REC reference 
number: 14/NW/0254 (Appendix F). Subsequently, approval was sought from the 
local R&D department and an SSI (Site-Specific-information) form was submitted 
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detailing the involvement of local collaborators. Permission to proceed was granted 
on the 28th of April 2014 (Appendix G).  
Participants  
In line with IPA principles, purposive sampling was employed to select a 
homogenous group of participants recruited for their ability to enhance understanding 
and hopefully yield rich data of the phenomenon under study (Smith et al., 2009).  
Inclusion and exclusion criteria. Inclusion criteria were as follows:  
1. Confirmed diagnosis of PsA with both skin and joint symptoms present;
and
2. Receiving biological therapy for PsA
Exclusion criteria included the following:  
1. Co-existing medical conditions in order to avoid potential issues related to
other conditions confounding the findings of this study; and
2. Due to IPA’s general reliance on participants’ ability to express and
articulate their experiences, participants with reduced English language
proficiency were excluded.
Recruitment 
In accordance with the idiographic nature of IPA research, a sample size of six 
was deemed appropriate for a study of this size (Smith et al., 2009). Posters 
advertising the study were put on display in the dermatology and rheumatology 
departments at the NHS trust where the study was taking place (Appendix H). 
Furthermore, A4 copies of the information sheet (Appendix I) were given to 
the specialised biologics nurses supervising PsA patients receiving biological 
treatment to hand out to potential participants. In an effort to circumvent potential 
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power issues that could lead to participants’ feeling pressurised to take part, staff 
nurses informed only potential participants of the study taking place. If participants 
were interested in taking part, they were asked to contact the researcher directly using 
the email or telephone number provided on the information sheet. This, however, 
proved to be a somewhat unsuccessful recruitment technique, as only one participant 
contacted the researcher in the space of 3 months. 
Subsequently, letters were sent out to 12 PsA patients identified by the 
biologics nurse through the biologics register informing them of the study (see 
Appendix J) along with the information sheet containing the contact details of the 
researcher. This generated a response from one additional participant. After 4 weeks, a 
second letter was sent out (see Appendix J), which led to the recruitment of three 
additional participants. The last participant was recruited after she was referred to the 
department’s psychodermatology service from another NHS trust.  
Informed Consent  
A short telephone conversation was conducted with each interested participant 
as soon as the person contacted the researcher. This was done to give potential 
participants the opportunity to ask questions about the research and make sure that 
participants fit the criteria of the study. Subsequently, individual interviews were 
arranged to take place at the NHS dermatology department at a time and date suitable 
for the participant.  
Before the interview commenced, the researcher went through the participant 
information sheet with the participant, detailing the research question, the voluntary 
nature of participation, options to opt out, the anonymising of data and limits to 
anonymity, as well as measures to ensure confidentiality of data (Appendix I). 
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All participants declared their willingness to participate in the study and a 
signed consent was obtained before the interview took place (Appendix K) 
The six participants were aged between 45 and 67 years. Two were female and 
four were male. None of the participants dropped out after opting in.  
Demographic data is provided in Table 1 using aliases.  
Data Collection Method 
The most frequent means of data collection in IPA is the semistructured 
interview based on a preformulated interview schedule (Smith et al., 2009). This 
approach allows for flexibility in making sure questions relevant to the study are 
covered, whilst allowing the researcher to probe emerging areas of interest or 
meanings important to the participant.  
Table 1 
Participant Demographic Data With Aliases 
The interview schedule was formulated using open-ended and nondirective 
questions in order to encourage participants to tell their story with limited imposition 
Name Age Ethnicity
Number of 
years with 
psoriasis
Number of 
years with 
PsA
Number of 
years on 
biologics
Matthew 45 White-British 25 20+ 3
Hanif 55  White-other 20+ 20+ 6
Jack 60 White-British 10 5 3
Samuel 67 White-British 20+ 5 1.5
Rebecca 52 White-British 30+ 1 3
Alice 48 White-British 46 20+ 10
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of meaning (Smith & Eatough, 2007). Probes were used to get participants to detail 
their experiences and any unanticipated themes that emerged. The interview schedule 
was developed with the help of supervision (Appendix L) 
A pilot interview was conducted to test the interview schedule. This interview 
was subsequently included as part of the data.  
At the beginning of each interview, the researcher stressed that the interview 
was intended as a ‘conversation with a purpose’ (Smith et al., 2009 p. 59) rather than 
a closed yes/no interview. The researcher emphasized that the purpose of the 
interview was to learn as much about that participants’ experience and that there were 
no right or wrong answers. The interviews ranged from 45 minutes to 75 minutes and 
were audio-recorded.  
Debriefing 
Following the interview, participants were given the opportunity to discuss 
their experience and any concerns or feelings evoked. The researcher made sure that 
participants were in possession of the contact details of the researcher and her 
supervisor, and it was stressed that participants could contact the researcher post-
interview if the need arose. A debrief sheet was given to each participant that detailed 
relevant sources of psychological support (see Appendix M). 
Analysis 
The interviews were audio-recorded and transcribed verbatim for analysis. 
Following a step-by-step approach to the analytic process (Smith et al., 2009; Smith 
& Osborn, 2008), several hundred themes were initially identified, which were then 
organised under broad thematic groups and subsequently subsumed under three 
master themes and inherent sub-themes.  
PSORIATIC ARTHRITIS AND BIOLOGICAL TREATMENT !50
Firstly, each individual transcript was read repeatedly and initial thoughts, 
associations, and comments were recorded in the right-hand margin of the transcripts. 
Once such initial observations ‘dried up’, an attempt was made to identify and label 
salient themes in each of the transcripts. These were recorded in the left-hand margin 
of the text in different-coloured ink (see Appendix N for an example of an annotated 
transcript).  
At this stage the researcher employed a deliberate noncritical attitude, noting 
down everything that came up resulting in more than 100 themes per transcript, most 
of which were purely descriptive. These ‘themes’ were then written down and ordered 
under preliminary sub-headings (see Appendix N). At this stage, the researcher put the 
transcripts aside and repeatedly read and re-read the lists of preliminary themes in 
order to cluster similar ones together, resulting in +50 preliminary themes per 
transcript.  
In order to facilitate the conceptualization of ‘cluster-themes’, themes were 
repeatedly re-named, re-arranged, and re-named again, whilst the researcher though 
about how themes related to and differed from one another both within and across 
transcripts (Appendix O).  
During this process, hunches and notes were made regarding links to tentative 
master and sub-themes. These were written down in a notebook and checked against 
the transcript data. This process was then repeated for each transcript, whilst emergent 
themes were gradually filtered down in a cyclical process. 
In an attempt really ‘hear’ what participants were saying and embody the 
‘phenomenological attitude’, the researcher revisited the material after putting it aside 
for a while. As a result, themes and clusters were continually re-arranged and re-
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named as the researcher ‘saw’ new meanings and links emerge in a recursive process 
of interpretation and re-interpretation.  
Finding this process both frustrating and confusing, and at one point fearing 
that the process might be endless led the researcher to further consultation of the IPA 
literature. Here, the researcher found comfort in learning that it was not uncommon 
for interpretations to shift and gradually unfold and be allocated varying degrees of 
significance with each reading as captured by the concept of the ‘hermeneutic 
spiral’ (Smith et al., 2009). 
The challenges encountered by the researcher involved how to separate inter-
linked themes and choose which themes to discard. Gradually, more abstract themes 
were developed, which were subsumed as appropriate and finally turned into three 
super-ordinate themes with three sub-themes each.  
However, the researcher found it was difficult to close the door on the 
interpretative process, and hence, themes continued to be re-arranged and re-named 
on both a master and a sub-level even as the results section was written up, thus 
illustrating not only the iterative, cyclical approach of IPA, but also how open-ended 
it is.  
Quality and Validity in Qualitative Research  
What constitutes good qualitative research has been debated at length 
(Chamberlain, 2000; Madill et al., 2000; Forshaw, 2007). One of the problems has 
been the application of quantitative criteria to evaluate qualitative research, but also 
that there has been a tendency to treat qualitative research as a unified field (Dixon-
Woods, Shaw, Agarwal, & Smith, 2012). It is therefore crucial to consider the 
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epistemological underpinnings i.e. what kind of knowledge the research is attempting 
to generate, before any evaluative criteria can be meaningfully applied.  
The researcher has endeavoured to meet the four principles suggested by 
Yardley (2008) to evaluate qualitative research.  
The first criterion is sensitivity to context. This has been attempted by a 
detailed examination of the existing literature conducted to demonstrate the gap and 
hence the rationale behind the research question. Hence, a methodology that allowed 
the participants’ experiences to be foregrounded was chosen, and the interview 
schedule was constructed to allow for this exploration. Sensitivity to data was also 
strived for throughout the analysis by grounding interpretations in the data and 
carefully considering what participants were conveying.  
The second criterion is that of commitment and rigour. Whilst the depth and 
insight in terms of analysis are ultimately for the reader to decide upon, I have 
endeavoured to make sure that participants in this study were appropriate by the use 
of purposive sampling. Furthermore, an independent person was shown an 
anonymised transcript for a validity check.  
The third criterion relates to coherence and transparency. Epistemological 
coherence was aimed for by considering the fit between the aim of the study, research 
method, and how the analysis of disconfirming data was presented. Transparency was 
aimed for by being explicit about how methodological processes were carried out. To 
this end, a paper trail is provided in the appendices to show how the analytical process 
of turning raw data into the final analysis unfolded. I have also attempted to engage in 
a process of reflexivity throughout the study, addressing this in the preamble as well 
as in the methodology and discussion sections.  
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The final criterion relates to impact and importance. My hope is that as a result 
of ‘giving voice’ to the participants in this study, clinicians involved with PsA 
sufferers will have a better understanding of what it is like to receive biologics for 
PsA, which might have implications for the type of care this population receives at 
different points in their illness trajectory. This will be further elaborated on in the 
discussion section of this study. 
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Chapter IV: Analysis  
The following presents the results of the analysis utilising IPA to learn about 
PsA patients’ experience of biological therapy as interpreted by the researcher. The 
researcher arrived at the three master-themes and inherent sub-themes presented in 
Table 2.  
Table 2 
Master Themes and Inherent Sub-themes 
These master-themes will be accounted for in the following, and 
interpretations will be grounded in the data through verbatim extracts to illustrate and 
support these.  
Master Theme I. New Lease of Life  
The first master-theme that I arrived at through the analytic process was one of 
participants experiencing a new lease of life, with biologics constituting the 
Master Themes Sub-themes
New lease of life Embodying a miracle 
Being able to do normal things again  
Freedom from stigma and shame 
Living with the fear of the unknown It's a firewall not a cure  
Embodying an experiment 
The role of information in facilitating 
agency and choice  
Coping with the fear of tomorrow 
The importance of seeing the person and 
the disease 
I am a person not a petri-dish  
Not knowing the disease 
Mobilising the self to help the body 
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demarcation point between life as it is now and life as it used to be. A key element of 
participants’ experience was one of disbelief that biologics had reversed the path of 
steady degeneration. Biologics was experienced as affording participants a chance to 
re-enter life, which they embraced with a fervour and appreciation that is the 
provenance of people who have lived on ‘the night-side of life’ (Sontag, 1988, p. 3). 
Sub-theme 1: Embodying the miracle of biologics. Treatment with biologics 
was described as defying what participants thought could be possible. To their 
amazement, their psoriasis suddenly vanished. 
It was like magic after a few weeks – gone! (Hanif, 116–117) 
The bafflement and incredulity experienced by participants is given even more 
poignancy in the light of their previous experiences of spending years at the receiving 
end of increasingly toxic, time-consuming medical treatments that, at best, maintained 
a status quo.  
Several participants had experienced severe side effects as a result of previous 
treatments. Hanif experienced liver failure following an alternative treatment, 
Matthew’s skin burnt during PUVA-treatment, leaving him looking as if he’d been in 
a fire. Rebecca experienced a systemic allergic reaction that left her unable to move, 
Matthew’s legs turned black as a result of a sudden allergic reaction to penicillin, 
leaving him unable to be touched due to pain, whilst Alice suffered anaphylactic 
shock. Still, the various, increasingly toxic treatments had little long-lasting effect on 
their condition, which continued to deteriorate.  
Physically my whole body was getting worse, pain-wise and skin [-wise]; I 
was steadily going downhill. (Matthew, 777–779) 
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The thing is… you know, constantly taking a medication which really has no 6
effect is very depressing. (Jack, 184–186) 
Faced with the prospect steady degeneration, participants understandably 
experienced an increasing sense of despair as to what this would mean for their lives, 
compounded by feelings of utter helplessness at not being able to do anything to 
change this.  
It is with this context in mind that the accolades bestowed on biologics must 
be understood. Matthew calls biologics a ‘miracle’, Samuel ‘unbelievable’ (142), 
Rebecca ‘brilliant’ (213), and Jack ‘a huge success story’ (157), while Hanif, as seen 
earlier, likens biologics to a vanishing act.  
You don’t imagine you’ll ever get that (...) I didn’t have a single plaque on my 
body for the first time in so many years. It was, ‘Hold on, this is not right, you 
know?’ I remember the feeling, it was so fantastic (...) the elation…it was from 
the pit of my stomach and it went upwards and up. I know, this is how I got it, 
the feeling went from the pit of my stomach up, and then I got a tingling on my 
hair like Goosebumps, and then I could feel it – look, I’m getting it again now 
a bit... Because I know, I remember it so vividly. What a feeling. (Matthew, 
515, 1052–53, 1034–1040) 
For participants, their now blemish- and psoriasis-free bodies embody and 
make palpable this miracle. Their bodies bear witness to a miraculous transformation 
having taken place, which is accompanied by a sense of disbelief and strong, positive 
psychological states, along with otherworldly physical sensations befitting when 
witnessing a miracle.  
 …indicates omission of words such as erm, uh, to improve fluency for reader.6
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Likewise, Hanif remembers how he sang joyfully in the shower.  
I do remember the time, when my skin was clear, one day when I brought 
myself under the shower, I was singing for the first time, and I was so happy 
because I couldn’t take a shower easily, because when water brought to my 
skin, the pain was terrible and my skin came, became like a baby, very soft. 
(Hanif, 671–678) 
Biologics transforming Hanif’s ‘itchy, broken skin’ (106) to the softness of a baby’s is 
again indicative of biologics being perceived along the lines of a miracle. Biologics, it 
appears, is experienced as an event or point in time which not only demarcates 
between life as it was before and now, but is infused with hope at the new life that has 
suddenly been made possible.  
The miracle of biologics not only heralded a new beginning, but also enabled 
participants to travel back in time to before their lives were changed by disease. For 
Jack, biologics enabled him ‘to go back to before I ever had any manifestations of the, 
of the symptoms’ (157–159).   
For Matthew, biologics transported him back to a time just before his PsA 
became severe.  
I’m back to how I was when I was 18. You know? (445) 
Thus, being afforded a second chance and how this is experienced is explored in the 
next sub-theme. 
Sub-theme 2: Being able to do normal things again. A prominent theme 
characterising participants’ lived experience after commencing on biologics was one 
of life opening up again and being able to do things they had not done for years. 
PSORIATIC ARTHRITIS AND BIOLOGICAL TREATMENT !58
Again, there is a powerful discourse of ‘then’ and ‘now’ with participants 
experiencing varying degrees of liberation from what had hitherto restricted them.  
For Rebecca, biologics enabled her to feel normal. 
I could get up in the morning, I didn't have to start having a bath with oil, sit 
in it for an hour, then put on cream, and then... I, I used to have a bath, like 
sometimes three, four times a day, 'cause I couldn't cope with my skin. And 
everything used to be oily, you know? (…) And here, I just felt like a normal 
person. I could get up in the morning, and get dressed, and go out, and you 
know, like – I just, yeah, I felt normal (…) I felt like everyone else does, you 
know? It was really, really – I really felt good, I really, really did (pause). Like 
my whole mood was good, you know, 'cause like I didn't have to think about it 
the whole time. (241–257) 
For Rebecca, normality is thus the ability to smoothly carry out small, 
everyday, routine tasks such as getting up in the morning, getting dressed, and going 
out. The inability to carry out what for many people are taken-for-granted and 
ordinary tasks thus shows the extent of the disruption wrought by PsA. Being able to 
carry out these tasks again was now experienced in a new light, as in the 
aforementioned example of Hanif’s happiness at being able to take a shower without 
pain.  
The ordinary becomes extraordinary when it becomes possible again, which 
reflects back on biologics’ being experienced as an existential turning point or life-
changing miracle as participants leave behind a period of debilitating dysfunction.  
The theme of life opening up was also emphasised by Samuel, who described 
life after biologics thus:  
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You haven’t got any of those restrictions. You do what you want to do, as you 
want to do it, not because you’re being restricted. So you’ve got a freedom. 
(845–852) 
Likewise, Hanif said that he, after biologics, began ‘to go out and started seeing 
people again’ (693–694), thereby revealing that this was something he had refrained 
from doing.  
There is thus a prominent theme of restrictions and chains being lifted. It 
seems that treatment with biologics is experienced as presenting participants with a, 
now, perceived luxury of freedom and choice; doing things when and because they 
want or wish to do them – in stark contrast to before, when they seem not to have felt 
they had that choice. 
In fact, Hanif described his life before biologics as being in prison.  
I was like a person who is in a prison. My office is in my home, just upstairs, 
actually (…) I was in a prison in my home, 24 hours a day, just I visited my 
client, doing the web design, and searching the internet and that’s it, and go to 
sleep, shower, work, eat (…) And out? No. Visiting people? No. Going on 
holiday? No. (417–437) 
Being a prisoner in one’s home designates a paradox. Prison usually connotes a 
nonvoluntary confinement, where the incarcerated is robbed of choice. Home, 
however, is usually a place imbued with a sense of belonging, where we can be 
ourselves and exercise a degree of autonomy, choice, and freedom that is denied us 
outside the home.  
Questions that readily arise are therefore: What imprisoned Hanif? What 
restricted Samuel? What changed to make Rebecca feel like a ‘normal person’?  
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From all participants’ accounts, it is evident that a major restrictive factor is 
that of the arthritic symptoms of joint pain and stiffness. Participants experienced this 
as the body gradually closing down, evoking images of old age. 
Because it’s like, ‘Is my body breaking down?’ (…) And suddenly, erm, it’s 
something that you think, ‘Well, I’m old now, because this is something which, 
generally speaking in, erm, in, the, the body breaking down. It’s something 
which I associate with a, a, with a (…) a later stage, a, a later or even a sort 
of proto-final phase of life’…You, you think, ‘Well, it’s going to go, it’s all 
going to be degenerative from now on.’ (Jack, 350–361) 
For Rebecca, her body was completely taken over by her arthritic pain in a 
manner more akin to paralysis. When Rebecca described her pain as ‘stopping’ her 
life, she meant it in the most literal sense of the word. Any attempt at movement and 
trying to will life into her frozen form was punished by more pain. Mundane, 
everyday tasks such as walking and going to the toilet thus become acts of bravery 
and defiance against the disease that was stopping her from living.  
It had stopped my life, literally. My life stopped for months (…) I wasn't able 
to do anything, I couldn't hardly go up and down the stairs. Every time I went 
to the toilet it was like, nightmare. Because I couldn't walk to the toilet, I 
couldn't, I, I'm so embarrassed to say this, but I couldn't even wipe myself 
after I'd been, do you know what I mean? It was, everything was hurting me. 
(Rebecca, 1592) 
With biologics reversing this slow bodily demise, pain, and impairment that 
can be construed as a slow death, it is hardly surprising that participants experience 
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intense joy at being able to partake of ordinary, everyday tasks, which for them have 
become symbols of living and life itself. 
Sub-theme 3: Freedom from stigma and shame. Participants, however, 
seemed also to have experienced freedom from another kind of prison, which will be 
explored in the following.  
The shedding of dry skin was an aspect of psoriasis that all participants found 
hard to deal with. 
I used to leave trails of, you know, like scales the whole time (…) Even when I 
went shopping and I tried on a skirt, I was so embarrassed, you know, 'cause 
like all the scales used to come off on the skirt, if I didn't buy it. And you know, 
like, it wasn't… It was, you know, it wasn't, it wasn't nice to live with it. 
(Rebecca, 199–213) 
Many participants commented on the constant self-awareness that would 
accompany them everywhere, as demonstrated by Jack below.  
It’s the fact that you’re shedding skin…and you, you, you, you get into habits 
like, you know, surreptitiously checking a chair where you’ve been sitting… 
Because it, you think, ‘Well, I wouldn’t want to go and sit in a chair that was 
covered with… You know, with, er, with skin particles,’ so, you know, you, you, 
you’re just feeling psychologically, I think, on the back foot all the time. (284–
295) 
For Jack, the mere act of sitting in a chair was experienced as exposure. He was on 
the ‘back foot’, vigilant that he should not cause offence and his shame be exposed to 
others. He readily identified with ‘the other’, imagining how they would feel sitting in 
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his chair. Seeing himself through the eyes of others, it seemed he felt guilt and 
condoned the behaviour of anyone who shunned him.  
Jack went on to describe how  
shedding skin at a, at a kind of mega-dandruff level’ ‘absolutely’ destroyed my 
‘self-image’, ‘because it’s, erm, and, and that may be, that may be very harsh 
(…) But the fact is it’s an unattractive condition (...) it just does make you, it, it 
made me feel, you know, ugly and, er, and, er, it’s like having a deformation. 
(Jack, 231–236) 
By passing judgement on psoriasis as an ‘unattractive condition’, Jack was passing 
judgement on himself. Rooted in a body and in a skin that has altered and de-formed 
him, Jack had become a ‘deformation’ and had become unacceptable to himself. Yet, 
he could not escape or distance himself from this ugliness, as he inhabited it. Thus, 
his feeling merged with a body he wanted to distance himself from is perhaps why he 
experienced his self-image as destroyed.  
Jack relates this to dandruff being a “socially frowned-upon thing (…) one of 
those things where it kind of shows that somebody isn’t looking after themselves 
well” (Jack, 222–229). 
Suffering from psoriasis therefore appears to be an experience that moves 
beyond the confines of the physical symptoms. It spreads to connote something about 
the sufferer to others, which goes far beyond suffering from dry skin but carries with 
it connotations of bad hygiene.  
Lack of self-care therefore implies that sufferers are choosing to not take care 
of themselves. It is perhaps this perceived chosen departure from collective or societal 
grooming norms bound up with a fear of contagion that leads to experiences of social 
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rejection, intrusive questions, and comments from others, which are the norm rather 
than the exception for all participants.  
Strangers would comment on it, and say, ‘What’s that? Can I catch it?’ Can 
they catch it off me, you know? It wasn’t easy, so I tried avoiding a lot of 
social – the social side of anything, I tried to avoid it, you know? (Matthew, 
327–342) 
Suffering from psoriasis therefore becomes a very public illness experience in 
which it seems to be legitimate that sufferers are not accorded the regard and respect 
for social conventions normally in place.  
I was on the Tube on the London Underground and a gypsy came over 
begging with her daughter. She was going through the train begging, and she 
got to me and she was like, she physically screamed. She got down and she 
was grabbing her daughter, ‘Get off, get off. You’ll catch it. Don’t go near 
him.’ In front of the whole train, so in one sense she didn’t beg off of me, but 
she made me – and there was nowhere to go. Once you’re on a Tube train and 
you’re going through the tunnel, there’s nowhere to go. So for the rest of the 
time to the next stop, everyone was just looking at me. It was, you know, 
people’s perceptions. (Matthew, 540–550) 
My psoriasis is bad on my hands and people treat you like a leper or they step 
back and they go, ‘Oh,’ or they stare or, you know, shops are an awful thing 
when they slam the change on the counter, they won’t put it in my hand, ‘cause 
I got psoriasis on my hand. I’ve come out with many – I, I build all my 
confidence, I pluck up the courage to go shopping and, and again. (Alice, 
1370–1376) 
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Alice and Matthew’s accounts are similar in describing the different ways in 
which public disapproval is communicated to them. One is overt, e.g. the gypsy 
screaming and running away from Matthew and shopkeepers recoiling from Alice and 
the shopkeeper slamming down the change.  
The other, whilst more subtle, may be more damning, namely the harsh, 
scrutinising gaze of the other. It has been argued that we assume coherence in relation 
to the gaze of ‘the other’ in the sense that to see ourselves we must be seen (Lacan, 
1977). The other’s gaze is therefore instrumental in how we come to define and see 
ourselves. 
This may account for Samuel’s feeling unclean although he knows he is clean, 
coupled with a societal idea that having blemished and flaking skin is associated with 
impurity and poor hygiene.  
I never felt clean. I never felt clean, and I was always very conscious of the 
flaking skin and so on. (333–334) 
For participants in this study, it seems the repeated encounters with ‘the other’ 
eventually come to define and defeat them. Jack feels ugly. Samuel feels dirty. What 
ultimately comes to determine their worth and sense of self lies outside the self in the 
gaze of ‘the other’ (Lemma, 2010). In this way, ‘the other’s’ gaze has become theirs.  
The taken-for-granted world of everyday life, such as Alice going to the shop 
to buy something, becomes an act of immense bravery that requires careful 
contemplation before being carried out.  
It is thus not surprising that participants’ ensuing experiences of public 
rejection become immensely painful, to the extent that participants eventually retreat 
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to places where they are likely to be protected from the gaze of others and possibly 
themselves. 
Actually, one of the reasons, yes, because when I was out everyone was just 
showing me to each other, you know? (…) Yes, yes, it was terrible, and (…) 
No, strangers (They would point?) Yes. Everywhere, because yes, it was all 
over the skin. I tried to be relaxed, even with shorter sleeves, even out, in 
shorts as well but people just pointing me to each other and yes (…) Actually 
when you feel this way, you don’t feel good when – on the other hand, I had 
pain as well. Then I didn’t go out, because of the people first, and the pain as 
well. (Hanif, 700–718) 
A similar trajectory is exemplified by Matthew, who described not being too 
bothered about his psoriasis when he first developed it, because he had grown up with 
a friend with it and had never ‘taken a second look’ (320). However, over time he 
described coping by avoiding social gatherings or by covering up. 
I just used to cover myself up all the time and try and avoid situations. I didn’t 
have a girlfriend for 10 years because I was too ashamed of how I looked. 
(Matthew, 327–328) 
Psoriasis, it seems, can therefore be construed as a form of social death. Hence, 
participants’ skin suddenly clearing after biologics opens up the possibility of a life 
free from self-consciousness, stigmatisation, and shame.  
One example is Matthew’s joy at being able to join the ranks of the 
untarnished he had envied for so many years by having a picnic with his friends, 
wearing shorts and a t-shirt. Again, the ordinary became extraordinary and a source of 
intense appreciation as Matthew revelled in the freedom of having cast off his stigma. 
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I mean, straight away I could wear shorts, and t-shirts or a vest, you know? I 
could do that, but I’d have to walk around and all my friends might be in 
shorts and I’m in jeans and I’m sweating. Oh, just that. I mean, I still have the 
joint pain so it’s not like I can go back to playing football again or that sort of 
thing, but as regards, I can go out and not feel – I’d be jealous. Friends of 
mine would say, ‘Oh, we went down to the boating lake. We sat there, we had 
a picnic.’ Things like that. I could actually go and do that without being self-
conscious. It was superb. I could sit in shorts, without looking out of place 
because I’d normally have to wear a long-sleeved top and jeans, and everyone 
else is in t-shirts and shorts. You feel very, very different then, so that only 
adds to the self-consciousness. (Matthew, 441–460) 
It is therefore the interpretation of the researcher that Hanif’s previous prison 
metaphor is to be understood as a dual imprisonment brought about by the experience 
of having a condition Jack calls ‘an evil combination of opposites’ (747). One is 
visible and leads to a social death. The other is invisible and leads to the death of the 
body.  
Such was the extent of the pain and imprisonment wrought by PsA that Hanif 
was consumed by hate and wanted to end it all.  
At the time, I didn’t know what is love. I hated everyone (…) I can describe in 
one word. I coming close to suicide. I was suicidal, and it was terrible. It was 
terrible, and I couldn’t sleep. I had pain all the time. I hated people. I didn’t 
want to talk to someone. I didn’t want to see someone. Just a terrible situation. 
(Hanif, 128–133) 
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Treatment with biologics saved Hanif’s life and enabled him to transition from death 
to life, from hate to love, from imprisonment to freedom. 
Yes, I’m very well now and I can love, and I couldn’t love at all. No. (Hanif, 
251–252) 
Master Theme II. Living With Fear of the Unknown  
Despite participants’ experience of biologics affording them a new lease of 
life, it was called a lease to invoke the temporary quality of this experience. 
Participants experienced a pervasive sense of uncertainty in terms of both the future 
effectiveness and long-term side effects of biologics. It is this experience and the 
different ways participants made sense and coped with this that is explored in the 
following. 
Sub-theme 1: Biologics is a firewall not a cure. There is an awareness 
among participants that biologics is only a means of gaining temporary control over 
their condition. Jack’s use of the term ‘firewall’ captures the experience of biologics 
not being a cure, but rather a treatment that demands continuous upkeep to keep PsA 
at bay.  
Going through that self-injecting process is very much a reminder, erm, that, 
you know, I’m, it, I’ve, I’ve got a, I’ve a firewall against something which if I 
stopped doing that would probably return with a vengeance very quickly. 
(Jack, 730–733) 
For the majority of participants, the regularity and means with which biologics 
must be administered, usually by self-injection, is experienced as manageable and as 
freeing up time compared to previous treatments.  
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The biologics, you don't need to go the whole time [to hospital] you just have 
to go for your injection, and that’s it. So for me, it was amazing (…) amazing, 
amazing, it was brilliant, ’cause all I had to do was inject myself. I didn't have 
to take four tablets a day…It was like so easy...It was ever so good, it was 
really, really good. (Rebecca, 172–197) 
But for Alice, the participant who has been on biologics for the longest, the duration 
and repetition of treatment on both a micro- and macro-level has become almost 
unbearable.  
It’s every single week. It has been for the last 5 years. I’ve had other biologics 
previous to that… Erm and very often they work for the first sort of three 
months on me then they stop working. (Alice, 19–26) 
Alice’s current treatment consists of a combination of biologics and 
Methotrexate, the latter of which requires administration every Monday at hospital. 
Due to the side effects Alice suffers as a result, there is thus a fixed pattern to Alice’s 
week.  
Erm, I feel terribly sick after the tablets… and I’d come back after I’d taken 
them, I’d lie on the settee, blanket over me, and the rest of that day or the next 
day I’d feel sick. (200–204) 
…and then I just start to feel better Thursday and Friday and then 
there’s never a break, and then it’s gosh, you know, it’s the weekend…time 
again. So it’s, you know, if it was every month or 2 months, it wouldn’t be so 
bad, but I just start to feel better and I feel better in my head… and then, 
wham, it’s back again. (410–418) 
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The use of the expression ‘wham, it’s back again’ indicates that Alice experienced 
treatment as akin to being hit or punched on a continual basis. Treatment knocked the 
life out of her and she was incapacitated to the extent that she had to lie down for the 
next 2 days. As soon as Alice regained her footing, she had to repeat the cycle all over 
again. There was thus an almost nightmarish Sisyphean quality to how she 
experienced treatment; it was endless and she was condemned to repeat it every week.  
Sometimes Alice did not turn up for treatment.  
I was supposed to have had it yesterday, but I didn’t have it ‘cause I’ve had it 
absolutely up to here with it all and every so often I just can’t stand it. And yet 
I know I need it because about 2 years ago, erm, I’d had enough of it, the side 
effects and, erm, I didn’t, I missed four injections and I was bedridden with my 
psoriasis and my arthritis. I was that bad. So I know I need it. (Alice, 37–42) 
When Alice stopped her treatment, it was not because she was under the illusion that 
this was a viable option. In fact, when Alice missed her injections, her life took a turn 
for the worse.  
I was just in a mess. I couldn’t sleep, I couldn’t get dressed, I couldn’t wash. 
The cream was having no effect at all… I’d be crying all the time… I literally 
wanted to die because I had no quality of life. (Alice, 331–334) 
In Alice’s words, when she stopped treatment, it was rather because;  
I just want a breather. I just want time out. (1082–1087) 
The constancy with which the ‘firewall’ needed to be maintained was experienced as 
suffocating Alice; she was unable to breathe. Taking ‘time out’ was therefore enacting 
the illusion of a choice she knew she doesn’t have, if only for a moment. The paradox 
for Alice was thus that the treatment the she knew she needed in order to live was 
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experienced as relentless in its cyclic, repetitive manner to the extent that Alice 
simultaneously experienced it as killing her.  
Alice was thus faced with the choice of enduring a partial death that lasted 2 
days or being engulfed to an extent that it was as close to death as one can come, 
whilst still living; in bed, unable to move. Choosing the former, Alice experienced 
dying and revivification every week. Such was the relentlessness of the cycle of 
repeated deaths that Alice voiced this desperate plea: 
I want to, I want it to stop, I want an end to it all. (1066) 
It with this in mind that one must understand Alice’s partly self-censored remark, that 
she finds herself envying her friend with breast cancer. However harrowing both the 
disease and treatment for cancer may be, it was attractive to Alice, because it has an 
end.  
This sounds awful, but I had a friend with breast cancer, absolutely awful, she 
had treatment. She was lucky, she got over it. Her treatment has stopped now 
eventually and I know you can’t compare it, but five years, every week and I’m 
sick of it. (Alice, 47–51) 
In sharp contrast to Alice’s experience is that of Matthew. Also recognising 
that biologics is essentially no more than a ‘firewall’, Matthew, on the other hand, felt 
both hopeful and positive in regard to the future. 
I can only assume it’s going to get better and better, because my treatment has 
got better and better over the last 3 or 4 years. It’s been fantastic so to me, 
even if I’m on the same dose of Humira for the next however long, 5 months, 5 
years, whatever it may be, I know my condition will only get better. I’m 
positive about that. (810–816) 
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At first glance, it is plausible to surmise that it is the nature of the side effects 
and the accompanying intrusion on Alice’s time that made her experience so different 
to the other participants’ experience. Albeit important, it is however the interpretation 
of the researcher that what makes their experiences so different is far more wide 
reaching, which will be accounted for in the following. 
Sub-theme 2: Embodying an experiment. Alongside the awareness of 
biologics not being a cure, participants shared a concern about the long-term 
implications of treatment. Given that biologics work by suppressing the immune 
system, concerns about side-effects have crossed the minds of all participants. 
If you’re reducing…your efficacy of your immune system, what are the other 
ailments are you leaving yourself open to?... That was never really explained. 
(Jack, 382) 
There was a sense that beating or rather halting the spread of PsA came at a 
price; namely the stripping of one’s defences. Paradoxically, getting better therefore 
entailed getting weaker by running the risk of leaving oneself open and vulnerable to 
other infections and diseases.  
For Jack, this led to the immediate comparison to the human 
immunodeficiency virus (HIV).  
A terrible part of that disease, of that virus – is…the depression of the immune 
system and leaving individuals open to other sorts of…viruses which…can 
become a serious condition in its own right. (Jack, 391–406) 
The analogy with HIV is thus that beating PsA comes with the risk of paying the price 
of dying of from something else tomorrow.  
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The fear, uncertainty, and anxiety that can ensue from the immensity of such a 
predicament is in stark contrast to how participants experienced the efforts of medical 
professionals to explain this. In fact, as Jack says above, it was never really addressed.  
Not having been offered an explanation is, as far as Jack is aware, to do with 
medical research not having been able to fully understand why biologics work on 
PsA.   
You’re using something which has an effect, but you don’t understand 
(laughter) why it has an effect... It’s just, it is effective. Well, that’s is, is not 
best medicine, in my view. (Jack, 423–434) 
For Jack, certainty and predictability as the antithesis to not knowing comes from 
understanding why something works. Wishing he had been afforded an explanation is 
therefore wishing for a degree of control, certainty, and knowing what’s to come.  
Faced with the limits of medical knowledge and realising that treatment is 
based on trial and error, there was a sense among the participants of being the flesh 
and blood at the experimental frontlines of the battle against PsA. Their lives, their 
bodies are thus an embodied experiment in the sense that no one knows what will 
happen or if there will be a price to pay tomorrow.  
What it’s doing to my body, nobody knows the, the long term side effects 
because they’re relatively new treatments, so what damage is it doing. (Alice, 
543–545) 
Enhancing Alice’s dread was her past experience of having ‘more than a 
lifetime’s worth of treatment’ of PUVA that was promoted as safe, but since 
recognised as linked to skin cancer;  
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I know three people who’ve had skin cancer who had PUVA at the same time 
as me. So I, I’m very fearful. (Alice, 295–296) 
Not surprisingly, Alice’s trust in the medical profession has been destroyed. Any 
assurance or information provided by her care team has been rendered meaningless.  
Just how broken Alice’s relationship is to the medical profession was 
evidenced by Alice’s perceiving the profession as dishonest and operating with a 
hidden agenda, where they would only reluctantly admit to the real risks of treatment.  
They…kept a lot back from me on, on the side effects of these things. They, 
they don’t tell you and then it’s only after you’ve been on it for a while that…
things come to light, ‘Oh yes it does do that, oh yes.’ (Alice, 1124–1137) 
Alice’s experience of being experimented on was accentuated by her experience of 
objectification. Alice described being ‘prodded and poked’ (123), which reveals not 
only how invasively she experienced treatment, but conveys an insensitive, callous 
jabbing of her and a sense of being cruelly goaded to see what her reaction will be.  
The extent of the rupture and distrust was revealed when Alice perceived the 
profession as having immoral, almost criminal motives, where they would happily 
administer her toxic drugs to see what happened. This led Alice to wonder ‘whether 
it’s, it’s a benefit to them to push the drug or they’re, they’re getting, erm, you know, 
money for it, I don’t know’ (Alice, 278–282). 
The heart of Alice’s conflict becomes painfully clear. It was an almost 
irresolvable conflict of knowing that she had no choice but to put her life in the hands 
of a profession she so fundamentally distrusted, and knowing she needed a treatment 
that she at the same time believed was destroying her.  
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Sub-theme 3: The role of information in facilitating agency and choice. 
Surrounded by unknowns, participants seemed to attempt to create a level of control 
or predictability by looking to information to install this.  
Many participants talked about their illness trajectory, wishing that they had 
been forewarned about the possibility of developing the arthritic side of the condition. 
Nobody ever mentioned to me that one of the things that you might have to 
face in future years, X percentage of people who have psoriasis will also have 
psoriatic arthritis. It never was discussed. (Samuel, 662–665) 
However, on reflection, Samuel was more hesitant as to whether he would have 
welcomed such information at the early stages of disease, seemingly indicating that it 
in some instances might be better not to know.  
Maybe not. Maybe not, because you don’t want to be told when you’re going 
to die. You know you’re going to die but you don’t really want to know when 
you’re going to die because you’ll spend your whole life focused on the wrong 
thing. But it was never mentioned at any stage (…) it was never mentioned, so 
when I first got my pains and so on, we didn’t know what it was. (Samuel, 
662–677) 
Samuel voiced an existential predicament here. He was conflicted between 
wanting to know and not wanting to know. Seeking information seemed to represent 
to Samuel a fixture or a point of certainty from which to negotiate the all-pervasive 
terrain or experience of the unknown. However, Samuel also seemed to imply that too 
much information can tip the scales, not towards certainty and control, but towards 
more uncertainty and anxiety that can detract from living and overpower life.  
PSORIATIC ARTHRITIS AND BIOLOGICAL TREATMENT !75
The fine balance was succinctly expressed by Jack, who like Samuel wished 
that more information had been made available about his condition, but emphasised 
that it ‘has to be handled sensitively, because you don’t want to start a fire where …
there isn’t one’ (1197–1198).  
Jack and Samuel’s use of analogies of death, dying, and starting a fire conveys 
that participants felt as if they were living in most treacherous and dangerous waters. 
In this sense, not knowing could protect them and constitute a protective or defensive 
action, which serves to minimise threat to the self.  
This stance was exemplified by Rebecca, who experienced that the 
information provided to her on the potential side effects of biologics provoked her 
anxiety to the extent that she considered not going ahead with treatment.  
So even when they gave me things, leaflets to read and everything, I said, ‘I'm 
not reading it, because then I'm not gonna take the tablets.’ (Rebecca, 168–
170) 
Perhaps reflecting that Rebecca, like Alice, knew that opting out of treatment was not 
a choice she could reasonably make, she instead came up with a relatively simple 
solution to her predicament. Namely to read the information on potential side effects 
only after treatment had commenced and started to work. Though this path was thus 
different from that of many of the other participants, the shared motivation lay in self-
protection. 
A crucial difference, however, was that providing Rebecca with information 
placed the choice of what to do with it with her. So even if there fundamentally really 
is no choice, information becomes linked to a degree of choice, which might instil in 
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participants a degree of agency and control that makes their utter powerlessness in the 
face of not having a choice more tolerable.  
That information seems to be linked to participants’ perception of having a 
choice is illustrated by Alice’s account of when she was first put on biologics.  
The very first time I went on a biologic, I was sort of forced into it. I wasn’t 
given lots of information about it… I was told…basically ‘Well, if you don’t 
have this treatment, ‘cause I said I’m a bit worried about the side effects, well, 
if you don’t have this treatment, if, if the treatment doesn’t kill you, the disease 
will.’ So virtually you got no option but to go on it. (Alice, 343–350) 
Thus being denied both a choice and information about the treatment she was about to 
receive, explains a lot about the fear and powerlessness that underpinned Alice’s 
experience. Alice was angry that she was never given a choice, and this contributes to 
the resentment she felt towards the medical profession, as those who were in power to 
make choices that related to her body but never bothered consulting her.  
Well to me the patient has the right to know, I have the right to know… I’d 
rather, it’s my body, it’s not their body… I’d rather, I’d like to know 
everything…and then and then weigh up the pros and cons…and then it’s my… 
(Alice, 1180–1194) 
It is quite possible that Alice, had she been given a choice, would have a different 
perception of her treatment. By not providing her with information, and thereby 
choice, Alice was made powerless and her sense of agency and ownership of her body 
were taken from her.  
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So, while the participants in this study may have known that they did in fact 
not have a choice, the sharing of information may have served to re-install agency and 
ownership in their lives.  
Sub-theme 4: Coping with the fear of tomorrow. With the many unknowns 
all around them, participants were forced to negotiate different ways of making sense 
and coping with their predicament.  
Several participants coped by making their predicament more tolerable by 
comparing their situation to that of other people perceived to be less fortunate. One 
aspect regards treatment itself, such as Matthew comparing his own situation to that 
of his grandfather, who also had psoriasis.  
Back then when he was a young man, there was nothing. There was nothing. 
You might get a load of coal tar and that was it. Smother yourself in that or 
put petroleum jelly. That was it. (398–400) 
Reminding himself that he was lucky and that there is always someone worse 
off became a sort of coping mantra for Matthew.  
No, you’re lucky you’ve got some treatment (…) And there’s always someone 
worse off than you.’ You know, so you can keep on thinking that every day of 
the week, every day of the week. It’s what might get you up. You know, it 
probably got me up out of bed a few times, you know? (Matthew, 647–651) 
Having to constantly remind himself that he was lucky thus seemed to be a way of 
taking the potency out of a predicament that otherwise threatened to overwhelm 
Matthew. It needed to be said ‘every day of the week’, thus indicating that it might be 
a form of psychological survival without which Matthew would ‘go and lie down, 
curl in a ball and cry’ (747).  
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It seems that the drive to construct an image of oneself as fortunate by 
comparing oneself to others perceived less fortunate is mainly something that happens 
under threat. This can therefore be seen as a coping mechanism against which 
Matthew and Rebecca defended themselves against the threat of destruction and 
therefore a form of survival.  
Throughout their accounts Matthew and Rebecca make a series of 
comparisons to people with serious medical conditions, such as Rebecca describing 
coming out of a doctor’s waiting room thinking,  
Thank God I have my psoriasis, because other people had so much worse. 
(Rebecca, 897) 
There is, however, also a social facet to this downward comparison, which 
taps into making participants feel that they are not alone in their suffering, which can 
become a source of inspiration and strength. One example is Rebecca reading about a 
paralysed lady who was ‘so positive, and so, erm, like smiles, and, and, and you know’ 
(1111) and another, Matthew, comparing himself to terminal cancer. 
I think to myself, ‘Well, look at them. They’re getting up and going.’ You 
know? (Matthew, 747–753) 
Another way of coping with the unknown was represented by Samuel and 
Hanif and summed up in the following;   
I don’t concern myself about the future. I’ve learnt to live for today and not in 
excess, but to take each day as it comes. (710–712) 
Samuel did, however, concede that this stance was not so much a development 
that had emerged out of having PsA, but had always been part of his general 
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philosophy of life. Rather, Samuel attributed this life lesson to his having lived in 
Israel when he was younger. 
I would have been like that if I hadn’t had the illness. I learnt very early on 
when we went to live in Israel, Israel is a troubled place at the moment… But 
one of the things we learnt because of that stressful type of society that Israel 
is, because of what goes on there, was that you need to live for today because 
you don’t know what tomorrow will bring and I think that most of us in 
England don’t have that attitude, purely and simply because our lives are, 
well, we don’t expect to be living in a warzone. (Samuel, 736–748) 
That the closest analogy Samuel employed was that of living in a warzone seems 
poignant as it may denote something about the terror and extent of helplessness that is 
perhaps experienced by participants, not knowing what tomorrow brings, indeed, if 
tomorrow brings death or mutilation.  
Likewise, it could be argued that Samuel used the people living in England as 
an analogy for people who have not experienced the powerlessness that comes with 
having a chronic illness like PsA and who still live with the illusion of control. The 
implication therefore seems to be truly fathoming that the only certainty in life is the 
‘now’ is a perspective that can emerge out only of suffering.  
Living and breathing the unknowns of tomorrow has perhaps made Hanif and 
Matthew more attuned to a paradox influencing a society that places great value on 
predictability and control, namely how much effort goes into eliminating uncertainty, 
undertaking actions that foster an illusion of certainty, control and predictability, 
which was never possible in the first place.  
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An example is Hanif relating what he found himself thinking when listening to 
a programme on the future mortgage interest-rates  
Oh, it’s going to be blah-blah-blah in this country, the most part of your 
earning goes for the mortgage and I said to myself, ‘How about now? If it’s 
going to be in a few years’ time, in 6 months’ time, I will think about it then, 
not now.’ (Hanif, 801–807) 
Hanif droves home his point of how there are no certainties in life by relating what a 
man suffering from a terminal illness had said to an interviewer, asking him how he 
felt knowing he only had a few more years to live. 
Is there any guarantee that you [will] live more than me? (789) 
Hanif seems to be making the point that feigning that anyone can know anything 
about what tomorrow brings is an illusion. Having to deal with not knowing what 
tomorrow brings is not only a predicament that the participants of this study have to 
negotiate. Rather, it is a condition shared by all humanity. Thus, Hanif’s predicament 
is normalised. By normalising it, Hanif became just like everyone else, which perhaps 
made his predicament more tolerable.  
Whilst one is trying to live in the present, the past is however lurking just 
around the corner. Maintaining a focus on the now thus implies not letting your mind 
drift to past or future, which is sometimes difficult. Hanif described not wanting to 
think about the possibility of his condition coming back, but also noted that he is 
sometimes overwhelmed when he remembered how it was.  
I do remember before the biologic medication, even after that for a few years, 
I couldn’t talk to any doctors and medical team, and when I remembered the 
pain I had, I cried. I couldn’t stop myself (…) I didn’t want to go back, and I 
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didn’t want to think about it, and even a few days ago I found one of my 
images taken from my body, naked body and oh my god... Yes, for a second, 
and I tried to just forget the past. (Hanif, 737–752) 
For Hanif, the memory of the years living with PsA were still very raw and traumatic. 
The horror of what it was like seemed to lurk just beneath the surface and if triggered, 
was threatening enough to engulf the now.  
For Alice there was no respite. She was deeply conflicted – trapped in an 
irresolvable predicament of loathing what she needed to stay alive.  
I knew then that I needed it, that it was keeping me well and yet I still hate it. I 
don’t understand, ‘cause it’s doing me good but I hate it. (Alice, 336–338) 
Alice experienced high anxiety on the days leading up to her treatment, and the only 
way she coped on the morning of treatment was by pretending she was not going to 
go, only to go at the last minute. 
So the weekend, I spend all weekend worrying and my stomach’s churning 
because I’m dreading going to the hospital on Monday. So then my 
appointment’s Monday morning right at the last minute I’m thinking I won’t 
go, I won’t go and that’s how I get myself through the morning ‘cause I think 
I’m not going. Erm, then I always do go, very often I go. (Alice, 365–377)  
Despite her dread, Alice’s rational self won over her emotional self, thereby locking 
her in an exhausting and continuous cycle of emotional distress.  
As this master-theme has hopefully demonstrated, living with the fear of the 
unknown is an existential predicament that accompanies participants’ experience of 
receiving biologics. It is the contention of the researcher that this can only be made 
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tolerable when trust in and support from the medical health provider are present, 
which will be explored in the final master-theme.  
Master Theme III. The Importance of Seeing the Person and the Disease 
As was seen from the two previous master-themes, negotiating the balance 
between the ‘new lease of life’ and a future full of unknowns is a taxing experience. 
This master-theme is about the importance of recognising and attending participants’ 
illness experience as a whole rather than just the disease.  
Sub-theme 1: I am a person, not a petri-dish. Like treatment with biologics, 
there is no shortage of accolades bestowed on the medical care participants in this 
study are receiving. Matthew called it ‘out of this world’, ’superb’, and credited it 
with just making him ‘feel so much better’ (956). Jack stated he felt ‘very positive to 
this hospital’ (701) and Rebecca said she has ‘really been happy, and everyone's been 
really nice (…) They really, really care. I can't get over it’ (731), before adding; 
Like, if I ever complain about the NHS, I don't complain any more (laughs). 
(1917) 
It may not be a coincidence that Alice – the only participant being treated at 
another hospital – was the only participant who did not join in the chorus of accolades 
bestowed on biologics. Whilst certainly deeply conflicted, beneath all the layers of her 
despair Alice actually stated that she was ‘quite happy’ with her current biologics, 
which she credited as ‘helping me’.  
Thus, it is the researcher’s interpretation that a main reason Alice felt de-
stabilised by receiving biologics is inextricably connected to her experience of the 
medical care she was receiving. 
PSORIATIC ARTHRITIS AND BIOLOGICAL TREATMENT !83
They just, I don’t know, the medical profession, they, I feel they really don’t 
give a damn. It’s not their bodies, it’s me. They don’t care, we’re just a number 
and they’ll just treat us, you know, they wanna get the, their numbers of 
patients out, and they don’t care. (Alice, 562-566) 
Alice’s repeated emphasis on the medical profession not caring conveyed how she felt 
that she was someone no one wanted to see, hear or listen to. When Alice attempted to 
tell medical staff about the side-effects she was experiencing, she reported, 
It’s like no one wants to know. They, they ask me when I have my 
Methotrexate, ‘Oh how are you?’ And I’d tell them, but it’s all like [lip] 
service. They don’t really take note, they make light of everything. (Alice, 
1094-1098) 
When the depth of Alice’s pain and her cries for help were not acknowledged, but 
instead made ‘light of’ it was as if her whole existence was negated. She didn’t matter 
to those who were supposed to care for her. It wasn’t about her; it was about getting 
through a certain number of patients per day. Alice was a ‘number’ in a factory’s 
assembly line – she was not a person, she was dehumanised.  
The disparity between the existential angst and torment Alice was feeling and 
how this was met with superficial chitchat that characterises the kind of service one 
would encounter in a shop only amplified her loneliness, suffering, and psychological 
torment and added another layer of understanding to why treatment with biologics 
was almost impossible for her to bear. 
There are strong parallels between Alice’s account and the way Jack and 
Matthew experienced the treatment they received at their previous hospital.  
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You know, when I noticed the two different sides to the treatment, it was like, 
‘Wow.’ All I’ve been doing at [previous hospital] was, I was just going through 
the motions: ‘Turn up, take them, go away. Turn up, take them, go away’ and I 
did that for so many years. (Matthew, 973–979) 
The image of a mechanical treatment that Matthew robotically complied with is 
accentuated by ‘turn up, take them, go away. Turn up, take them, go away’, where one 
can almost hear the sounds of this patient’s assembly line. Matthew then went on to 
qualify wherein the difference between his previous treatment and his current one lay.  
Everyone I see [now], all of it, is based on you as a person, not just you as a 
patient. (591) 
What Matthew meant by his distinction between being seen as a person and patient 
becames clearer when he described his relationship to his previous doctor.  
It was terrible because not once, I saw him for about 4 or 5 years and not 
once did he look me in the eyes in all those times. He was always staring at his 
paperwork. He’d look at my skin, but not once in my eyes, and then say, 
‘Right, those tablets and that cream aren’t working. Here’s another set’ and 
that’s all I ever got for 4 or 5 years from the one doctor. (Matthew, 350–365) 
It seems clear that Matthew, for this doctor, represented a disease alone. For 
Matthew, being a patient thus seemed to denote that he was objectified, scrutinised, 
and studied. To look Mathew in the eyes would mean to recognise, to see the person 
behind the disease and engage with what it is like to for him to live with this disease. 
When this doctor turned his gaze away from Matthew, Matthew was, like Alice, 
dehumanised, disregarded, and reduced to a bunch of cells gone awry.  
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Yes. He might as well have been looking in a petri dish. Yes, he might as well 
have just been looking in that, because that’s all he saw the skin as. He 
never...You know? (Matthew, 374–377) 
Jack described a similar experience with the medical care he received at a 
previous hospital, which he found was not ‘particularly sympathetic’ (55). Though 
Jack was the only participant to reference it, what eventually made him reach the end 
of his tether, stop taking his medication because he was so ‘fed up with it all’ (118), 
was the disconnect in his medical care.  
I’d be going regularly for blood monitoring and monitoring things for the 
psoriasis and a separate se-, a completely separate series of appointments for 
rheumatology. And it seemed to be they, it was just stuck in a ridiculous loop 
where each department had an idea about what Methotrexate dosage there, 
there should be, which varied, but they didn’t seem to speak to each other, erm, 
it, meanwhile, both conditions were worsening. (Jack, 68–80) 
Seeing Jack as a patient thus meant subsuming him under a system in which increased 
sub-specialisation results in an absence of a coordinated effort to treat PsA as one 
disease. And it was the person, Jack, who paid the price of this disconnect with his 
condition, paradoxically, worsening as a result.  
Sub-theme 2: Not knowing the disease. Most participants in this study went 
through a long process and several misdiagnoses before their joint pains were linked 
to PsA. The most extreme example of this is Matthew, who went for 20 years without 
medical professionals linking his psoriasis with the pain he was feeling in his joints.  
Before I came here, there was no link. Even though I was in pain and it all 
coincided at the same time, there was no actual link. They said, ‘You haven’t 
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got rheumatoid arthritis.’ I said, ‘Right, fine, but I’ve got pains.’ No, that’s it, 
you haven’t got rheumatoid [arthritis]. They didn’t link it with the psoriasis, 
you know? (31–35) 
Likewise, Alice described an incident at A&E, where a nurse and a doctor told her 
that the pain due to arthritis in her rib cage was not possible.  
‘You don’t get arthritis there.’ And this was a doctor, and the nurse laughed at 
me, ‘You don’t get arthritis there,’ and I was saying, ‘Well actually I do, I get it 
in my rib cage, I get it here.’ And they just laugh at me, ‘You don’t get arthritis 
there.’ Even the medical profession aren’t aware of it. (Alice, 724–735) 
Both Alice and Matthew found it difficult to describe what it was like not to be 
believed. Matthew thought he was ‘losing it’ (48), as he was beginning to question 
whether he could be imagining his pain, since doctors were so adamant that there was 
nothing wrong with him.  
For Alice, not being believed, having her pain denied as real, and being 
ridiculed by professionals she came to for help, was like being invalidated at the most 
fundamental level of her existence. It had such a devastating effect on her, to the 
extent that she couldn’t find the words.  
I can’t even, I can’t even put it into words. It, it, it just, I, I can’t explain it. It 
affected me that badly I can’t even find words to, you know, again it’s not 
being believed. (Alice, 737–739) 
But even after diagnosis, there appeared to be minimal support for patients 
with PsA. Several participants noticed the disparity between the support offered and 
information being made available to patients with other rheumatoid conditions, and 
wondered why there was never anything for PsA.   
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There’s all these posters all around the, the clinics and the wards, you know 
[for] rheumatoid arthritis, lupus, osteoarthritis, it’s all these leaflets for 
arthritis, there’s never anything for psoriatic arthritis. There’s, there’s nothing. 
There must be other people with it. (Alice, 695–701) 
Alice tried to communicate her struggles and repeatedly asked for support to 
help her ‘to cope with, with my treatment (…) and to try and help me accept my 
condition’, but no resources were made available to her. 
Oh no, there’s nothing like this. You, you could go somewhere privately, you 
could do this, do that. (Alice, 1207–1211) 
It is clear that medical professionals’ turning a deaf ear to her struggle and distress 
only amplified her loneliness and isolation. Owing to her own research and ingenuity, 
Alice went to her GP, who referred her to a London hospital, 6 hours away, for 
psychological support. 
I’ve got this [condition] but I’m having to fight all the time. Why should I 
fight, why isn’t stuff offered to, for treatments for things. So again skin 
rheumatology, just wash their hands. (Alice, 1222–1226) 
For Alice, her struggles were thus exacerbated by what she perceived as the 
complete lack of support and of recognition of PsA as a serious disease. 
It is a serious illness and it just gets you down, makes you feel run down. 
There should be things to help along the way. (Alice, 1306–1312) 
This was echoed by Samuel and Jack, who also found that there was a lack of 
recognition of the psychological toll PsA can have. 
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They usually give you a leaflet, and I find that the leaflets are oversimplistic in 
some respects, and they don’t do anything about conveying emotion. They only 
just talk about hard facts. (Samuel, 577–589) 
The already substantial existential and psychological pain of living with PsA is thus 
amplified by medical professionals, who seem unaware of the existence of the 
condition, and of the devastating impact living with and being treated for PsA can 
have.  
The last sub-theme explores the importance of recognising PsA sufferers’ 
experience and what happens when this does not take place.  
Sub-theme 3: Mobilising the self to help the body. Attesting to the all-
encompassing influence that medical care of his PsA has had on his life, Matthew said 
that changing hospitals was:  
The best decision, other than marrying my wife, it’s probably the best decision 
I’ve ever made in my life. Honestly. (920–922) 
Further qualifying this, Matthew said;  
I know everything that gets done here is totally proactive and it’s for my own 
good, you know? I know it’s all for me. You know, that’s how I get made to feel 
here. It’s proactive for me (…) It’s all for me and to feel like that, it does, I’m 
sure it must have something to do with the fact that my skin is so good anyway, 
now it has to have, you know? Because if you get – the feeling that it’s all for 
you, it puts a positive spin on everything because you’re thinking, ‘Oh yes, it’s 
because they’re focused on me. I’m going to focus on me. I’m going to beat 
this.’ (1013–1022) 
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Evident in the repeated use of ‘me’, it is clear that Matthew now feels that he 
constitutes the epicentre of medical care as opposed to before. He is no longer a 
patient, disease or petri dish, but his persona is at the centre of everything. Crucially, 
Matthew also seems to imply that being treated as a person has improved his 
psoriasis, which deteriorated during the years when he was neither seen nor heard.  
I’ve probably gone maybe a whole year at one stage where I had about 95% of 
my skin covered and everything. But I’m positive that had something to do 
with it. The fact that they wouldn’t recognise the pain I was in. I’m sure that 
made the skin flare up. (Matthew, 90–96) 
The implication of Matthew’s account seems to be twofold. Being treated as a person 
made Matthew stronger and gave him the confidence that he, now, with his new ally 
at his side, can defeat his condition. Being treated not only as a disease, but as a 
person, as a self (with a disease) united the former divide, strengthened him, and 
made him whole.  
When the pain of their illness experience is not recognised, participants are 
also denied the opportunity to integrate or come to terms with the loss and pain 
connected with having PsA. By blocking out, ignoring, not hearing what it is like to 
both have PsA and be treated with biologics, the existential pain that these 
participants feel is deemed unacceptable. However, the irony is that the sole focus on 
disease in chronic illnesses like PsA does not help the suffering go away, but rather 
amplifies it to make an already difficult situation almost intolerable to bear. 
This connects to the other implication of Matthew’s account, where he links 
mind (psychological state) to body (psoriasis severity). Matthews seems to imply that 
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turning a blind eye to the suffering of participants in the service of curing or fixing the 
disease paradoxically seems to worsen the disease it is attempting to cure.  
Thus, the traditional biomedical model’s sole focus on disease pathology 
aimed at alleviating the suffering of those afflicted with diseases like PsA 
paradoxically ends up weakening sufferers by insisting on a divide between mind and 
body. In this manner, the biomedical model actually enhances the suffering of people 
with chronic illnesses like PsA by amplifying their psychological suffering and 
thereby physical suffering.  
As the following excerpt illustrates, the connection between mind and body is 
complex and intricate. Forcing herself to have a treatment she at the same time 
perceived as destroying her caused Alice’s body to rebel.  
The tablets, they’d make my mouth blister… I’d put it in my mouth and if I 
couldn’t swallow it straightaway where the tablet had been I’d get blisters in 
my mouth. I could feel it stick all the way down (Alice, 179–186) 
I’ve never had a problem with, with having my blood taken or 
cannulas, but I think it’s my, my veins have, have, when they’re overused, if 
they sunk or something or they, they’re scarred so the cannula pops out and I 
dread having that done, ‘cause it’s three or four attempts now having that in. 
(110–114) 
It is clear that Alice’s body is acting out and voicing the fear Alice feels. In a 
protective gesture her veins curl up, her throat dries up, thus trying to save Alice by 
making both the infusion and tablets almost impossible to be administered. However, 
whilst defending her, her body could also be construed as betraying her, because Alice 
needed this treatment to live. Her body’s actions can thus be seen as a somatic 
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representation of the heart of her conflict – namely, being unable to resolve whether 
treatment with biologics was killing or saving her.  
I keep writing lists of pros and cons every week…shall I have, shan’t I…I’ve 
got this constant battle going on in my head. I don’t know whether to go ahead 
with it or not. But then when I didn’t have it, I was in a real mess and I 
couldn’t cope anyway. (Alice, 306–312) 
Thus guilty of not seeing or hearing Alice’s cries for help and focusing solely on the 
remediation of disease, Alice’s medical caregivers can be seen as responsible for 
underpinning and fuelling this conflict. Not surprisingly, the lack of being seen or 
heard has meant that Alice is on the verge of giving up – just as Jack was at his former 
hospital. 
I’m exhausted. I’m exhausted with it all. Every so often I think I’ve had 
enough, I’ve had enough of everything, there’s no escape from it and I just 
think I’ve had enough. (Alice, 481–487) 
I’d got to the point where I came in here for a meeting…for a, consultation 
and I, I burst into tears (Laughter) because I, I was just so frustrated and, and 
the fact that really what was the point? (Jack, 429–439) 
The importance of seeing, hearing, and recognising the pain of what the person is 
going through beyond a sole focus on disease pathology is illustrated by the contrast 
between Hanif’s and Jack’s accounts.  
Like Alice, Jack remembered asking for help at his former hospital when he 
was struggling to cope with his pain.  
I was absolutely exhausted and worn out by pain. I was on quite strong pain 
killers and there seemed to be, I don’t know, maybe a, maybe a (pause) 
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complete insensitivity that it was because I – maybe if you’re in that kind of 
department, all your patients are going to suffer from pain (…) But I 
remember saying, you know, ‘I really need some help for managing pain.’ And 
getting really nothing (…) But, yes, it was really, when I think about it, it was, 
I was, it was really painful. Getting to sleep was really difficult. Waking up 
and then you were incredibly stiff. And try, and getting out of bed in the 
morning and standing up and getting dressed were painful processes… And 
there was no help for it. And I was thinking, well, I was aware of the concept 
of pain management yet it wasn’t offered. (Jack, 1371) 
Reflecting on this experience Jack said the following: 
Well, it makes you angry... And then ultimately, I think it does make you 
depressed… Because, because, you know – if you could, if you could maybe, 
or for me, if, if, if one could pinpoint the origin of depression (…) it originates 
out of an area of…frustration of not being able to be in synch with…how 
maybe you would like things to be (…) and not having a successful mental 
stratagem for dealing with how they are (...) And that divergence spirals into 
depression (…) Because it’s, it, it’s like an inability to cope. (1262–1278) 
Evident in Jack’s account is the utter powerlessness he felt being at the mercy 
of a pain could not get rid of and did not know how to cope with. Not being heard 
when he cried out only cemented his feeling of powerlessness and, like Alice, brought 
him to the verge of giving up.  
In contrast, Hanif, likewise in excruciating pain, was offered to participate in a 
pain-management programme offered by his care team, which he credits as being 
transformative in his life.  
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I don’t know how to explain, it’s nothing changed, but the way I think about 
the pain is totally different (…) If I have pain now, I don’t go to my cupboard 
and take the medication straight away. I try to think about the pain first, try to 
be relaxed, try to be calm and breathing helped me a lot, deep breathing. 
Breathing in and exhaling, and going out, even for 5 or 10 minutes of walking. 
(Hanif, 1024) 
Hanif seemed to indicate that reliance on painkillers promotes a form of helplessness 
that gradually overpowers the self as a locus of choice and control. By learning new 
ways to cope with the pain, he becomes empowered and installed with a sense of 
agency that counters helplessness. Hanif learnt how to live with his pain, not by 
getting rid of it, but by transforming his relationship to it and learning new ways to 
respond to his pain. 
For instance, last night, I had pain. I had pain on my ribcage. The pain was 
under the rib and I had this pain with each breath in and out, one deep pain in 
and one deep pain out, in time, and I could see it, and with breathing, I could 
manage to stop the pain. (Hanif, 531–536) 
It is perhaps this sense of agency that has been put back into his former 
helpless self, knowing that he is now able to cope with the pain that explains why 
Hanif says he is ’fine’ despite still describing his pain as ‘unbearable’ (443–451).  
I can’t walk very fast, with the walking stick, even 100 metres, 200 metres can 
help you to ease your pain, or cope with your pain, and socialising with 
people helps as well. I was not able to smile, and all the time I was sad, and 
tired because I couldn’t sleep. Actually, even now, I can’t sleep because of the 
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pain I have in my chest. My maximum time of sleep is two and a half hours, 
three hours but I’m fine. (Hanif, 443–451) 
Hanif’s account is therefore interesting because it indicates that there are other ways, 
when the traditional biomedical path fails. However, it would be a mistake to think 
that the provision of psychological therapy or programmes aimed at promoting 
adaptive coping can stand alone.  
Though Hanif expressed a belief that he would have ‘suffered less’ if he had 
had access to a ‘good psychologist’ who could have taught him to ‘manage [himself] 
psychologically’, he had second doubts, upon reflection, as to whether it would have 
helped due to the extent of his physical pain and disability at the time (329–334). 
Actually, on the other hand, I just went back to 15, 16 years ago, at a time 
when psoriasis was all over my body, even if a good psychologist advised me 
something, did I listen to him or her, or not? (Hanif, 989–993) 
What Hanif seemed to imply is that it is not a question of juxtaposing psychological 
and medical treatment. When it comes to the experience of participants with PsA, 
both treatments have limitations on their own and both are needed.  
In the words of Hanif, with the help of both, he’s found a way.  
Yes, I’ve found a way (…) I found a way and now I can cope with it. (Hanif, 
543–545) 
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Chapter 5: Discussion 
Man is said to be composed of soul and body. However proper this language 
may be in religion, it is not so in medicine. He is, in the eye of the physician, a 
single and indivisible being, for so intimately united are his soul and body, 
that one cannot be moved, without the other.  
—Benjamin Rush, Sixteen Introductory Lectures, 1811 
The aim of this study was to gain an in-depth understanding of participants’ 
experience of receiving biologics for PsA. The idiographic focus of IPA meant that 
this study was able to offer a richer, more complex, and nuanced ‘insider’ account of 
this experience. 
The following will consider the three main themes that emerged from the 
researcher’s interpretative engagement with the data in the light of existing research 
and consider the clinical implications of these findings. The limitations of this study 
will also be discussed along with considerations of methodological and personal 
reflexivity.  
First Master Theme: New Lease of Life  
Bury (1982) compared developing a chronic illness to a biographical 
disruption. The ability to carry out routine behaviours is disrupted and taken-for-
granted assumptions are challenged. In the words of Bury (1982), living with a 
chronic illness ‘involves a recognition of the worlds of pain and suffering, possibly 
even death, which are normally only seen as distant possibilities or the plight of 
others’ (p. 169). 
The first-master theme showed how the improvements pertaining to both the 
skin and joint symptoms of PsA following biologics were life-changing for 
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participants. Participants’ experience of treatment with biologics can thus be seen as 
an undoing of this disruption. Participants are given a second chance and experience 
euphoria and elation at being able to re-enter life and do things again as their psoriasis 
disappears, their mobility improves, and pain lessens. This finding therefore supports 
the plethora of quantitative studies that demonstrate significant improvements 
pertaining to QoL after commencing treatment with biologics (Strand et al., 2012; 
Saad et al., 2010; Papoutsaki et al., 2013). 
In this respect, participants’ description of their lives before biologics shows 
the devastating impact that having PsA can have. Participants’ lives were dually 
impacted by pain and reduced mobility that restricted functioning and participation in 
even the most everyday tasks. Alongside this, participants also suffered from 
psoriasis, which put them at the receiving end of deeply rooted stigmas surrounding 
fear of contagion and what it means to have blemished skin (Goffman, 1963).  
Whilst the illness experience of PsA sufferers was not the explicit research 
question of this study, but was relevant in terms of informing the context in which 
participants’ experiences of biologics had to be understood, “sometimes reading 
destabilises purposes” (Davy, 2010, p.79). In other words, the immensity of the 
participants’ suffering and their experience of the lack of awareness surrounding PsA 
was so pervasive that not to highlight this would border on being unethical in the 
sense that a key aim of this study was to give this population a voice.  
The devastating impact that PsA can have on participants’ lives was summed 
up by Jack’s stating that living with PsA was a ‘double whammy’ consisting of an 
incredibly ‘evil combination of opposites’.  
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Making sense of participants experience of living with PsA can be partly 
illuminated by research findings of what a stigmatising experience having psoriasis 
can be (Richards, Fortune, Main & Griffiths, 2003; Schmid-Ott et al., 2005; Vardy et 
al., 2002). All participants related experiences of stigmatisation and rejection that they 
experienced as having a devastating effect on their self-concept and body image 
(Khoury, Danielsen, & Skiverin, 2014). Indeed, the participants in this study seemed 
to have formed negative beliefs about themselves such as feeling unclean, 
unattractive, and almost guilty at giving offense (Jobling & Naldi, 2006). 
Indeed participants in this study increasingly withdrew in order to avoid 
negative reactions from others (Richards, Fortune, Griffiths, & Main, 2001); 
supporting findings that show that concealment and avoidance of social interaction 
are common coping strategies employed by psoriasis sufferers (Fortune, Richards & 
Griffiths, 2005; Magin et al., 2009), though acceptance, active coping and positive re-
interpretation are also frequently used (Fortune, Richards, Main, & Griffiths, 2002).  
This suggests that it would be misguided to locate the source of psychological 
distress only within the individual. Clearly people’s lives and self-concept are affected 
by how others judge and treat them (Thompson & Kent, 2001). Goffman (1963) used 
the idea of social identity to identify stigma as something that disqualifies an 
individual from full societal acceptance. When an individual departs from the norm 
and does not meet societal expectations, that person is devalued, discounted, and 
disqualified.  
Studies show that people hold negative attitudes towards people with skin 
conditions, suggesting that automatic negative stereotypes appear to be activated 
(Grandfield, Thompson, & Turpin, 2005), and that they even consider the sufferer as 
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responsible for their condition due to beliefs that the person must have done 
something to deserve this (Shaw, 1981; Novak & Lerner, 1968). 
Furthermore, the influence of mass media’s constant barrage of messages 
about beauty ideals which promote flawless skin as desirable for success and 
happiness should also be considered (Orbach, 2009). Though the extent to which 
these media-perpetuated societal ideals contribute to psychological distress in people 
with visible skin conditions requires more research, the current epidemic of 
appearance-related concerns among the general population suggests that the 
communication of, mostly, unattainable ideals confers a powerful point of social 
comparison for people both with and without visible differences, with implications for 
psychological well-being and social functioning (Rumsey & Harcourt, 2005, 2012). 
Insofar as PsA results in visible differences in relation to not only the skin, but 
also the joint aspects of the disease, it seems that it is important to consider the 
challenge of living within the wider sociocultural context of an ‘appearance-obsessed 
society’ (Rumsey & Harcourt, 2012, p. 680) with an appearance that is different from 
the norm.   
Because there is a dearth of studies on the experience of pain in PsA, it is 
necessary to look to studies on chronic pain and pain in RA. One of the most 
consistent findings emerging from the literature on pain is that avoidance behaviours, 
where one actively seeks to avoid activities that cause pain, are linked to higher levels 
of disability and psychological distress (Burns, Mullen, Higdon, Wei, & Lansky, 
2000). This is thought to initiate a vicious cycle whereby the fear of pain is 
maintained and possibly intensified, which exacerbates negative appraisals of pain 
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and its consequences, leading to a decline in physical activity and to increased 
emotional distress and pain related-disability as a result (Roditi & Robinson, 2011).  
Participants in this study thus seemed to be affected by both psoriasis and 
arthritic pain in equal measure, albeit not always simultaneously. Interestingly, this 
does not support the findings of the only other study that has explored the lived 
experience of PsA sufferers, which found that participants had little to say about what 
it was like to live with psoriasis (Aitken, 2011). Indeed, several participants 
commented that the impact of psoriasis was more difficult to deal with because of the 
stigma associated with it compared to the more acceptable societal attribution to 
walking with a limp.  
It might, however, be argued that what is relevant in this context is to 
recognize the devastating impact that PsA can have on sufferers’ lives. The suffering 
and distress experienced as a result of PsA is evident in participants’ accounts. One 
participant even described himself as feeling suicidal before being put on biologics. 
Whilst biologics may have been able to significantly improve the lives of 
participants, it is important to bear in mind that this treatment is expensive and is 
offered to sufferers only as a last resort in accord with the stepped care model (NICE, 
2012). This invariably poses the question of how many other PsA sufferers are 
experiencing a similar illness trajectory to that described by the participants in this 
study.  
Given the substantial impact that suffering from both a skin and a joint 
condition was found to have on participants’ lives, it is extraordinary that this 
phenomenon, to a large extent, remains unrecognised. Though biologics is 
experienced as life-changing, this master-theme also attests to how vulnerable PsA 
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sufferers are and suggests this population would benefit from additional awareness 
and support throughout their illness trajectory.  
Second Master Theme: Living With the Fear of the Unknown  
Despite distinct physical improvements, uncertainty regarding what to expect 
both in terms of the future efficacy of biologics and potential side effects pervaded 
participants’ experiences.   
Uncertainty can be understood as the ‘cognitive state created when the person 
cannot adequately structure or categorise an event because of the lack of sufficient 
cues’ (Mishel, 1990, p. 225). In this way, the dearth of information surrounding 
biologics can be seen as fanning the flames of uncertainty with participants 
experiencing their bodies forming the front lines of dangerous, experimental 
treatments.  
However, it was also clear that participants appraised and gave different 
meanings to uncertainty, with only Alice being destabilised by it. This fits with 
theorists concurring that uncertainty is neither good nor bad, but can be appraised 
along a continuum of threat (fear) to opportunity (Mishel, 1999).  
As was seen from the analysis participants managed uncertainty and the 
emotions associated with it in different ways. Alice was at one end of the spectrum 
appraising the uncertainty as a threat. Alice’s psychological state thus fit with threat-
related attribution being associated with poor adjustment, maladaptive coping, higher 
psychological distress, anxiety, and depression (Mishel et al., 1991; McCormick, 
2002).  
Though the other participants also lived with the uncertainty surrounding 
biologics treatment, most managed to find adaptive ways of coping with this 
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uncertainty. This echoes the literature that living with uncertainty is the hallmark of 
living with a chronic disease (Mishel, 1990, 1999), but it needs to be appraised as a 
threat to have a detrimental effect (Johnson, Afari, Zautra, 2009).  
Indeed, uncertainty can also be appraised as an opportunity for re-evaluation 
that can herald new ways of being in the world. Hanif, Samuel, and Rebecca all 
described experiencing an increased appreciation for life, a greater focus, and 
meaning being attributed the present and day-to-day activities , which have often been 
reported in the literature as ‘benefit-finding’ (Carver & Antoni, 2004; Sodergren, 
Hyland, Crawford, & Partridge, 2004) and post-traumatic growth (Hefferon, Grealy, 
& Murie, 2009). 
Seeking out information also emerged as a prominent way of managing the 
uncertainty experienced by participants. This is supported by research showing that 
that information-seeking is a common way of trying to manage illness uncertainty and 
uncertainty-related anxiety (Hogan & Brashers, 2009; Mishel, 1990; Brashers, 2007).  
There thus seems to be a link between information and uncertainty insofar as a 
lack of information denies the person the opportunity to form a frame of reference 
(Mishel, 1988). Participants’ wish that their health care provider had made more 
information available to them thus contrasts with the reality of having a chronic 
illness, where the ability to provide accurate information is usually compromised.  
When the availability of information was scarce, participants often resorted to finding 
their own information on the internet. In this way, seeking information may be linked 
to participants’ efforts to gain a measure of control over their uncertainty by forming a 
representation of what’s going on that they can give meaning to. 
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A notable exception was Rebecca, who appeared to want less information. 
This suggests that patients will differ in their preferences. Some patients may actually 
prefer to have their health care professional make the decisions and not wish to be 
more involved. 
Indeed, some studies have found that increased involvement actually worsens 
outcomes for some patients (Savage & Armstrong, 1990). This therefore again 
suggests that one of the key aspects of medical care is the ability of the professional to 
act sensitively and to recognise the patient’s desired level of involvement in decision-
making (Guadagnoli & Ward, 1998).  
Another prominent way that participants attempted to cope with an uncertainty 
that perhaps threatened to overwhelm them was by downward social comparison. 
This is also supported by the literature showing that comparisons with others 
perceived as being less fortunate is frequently employed to promote positive affect 
and well-being (Buunk & Ybema, 2003; Festinger, 1954). By construing themselves 
as fortunate, participants in this study may thus have been actively trying to reduce 
the adverse impact of PsA on their lives.  
It was thus found that uncertainty, albeit appraised and given meaning to in 
different ways, was a key aspect of participants’ experience of receiving biologics. It 
is thus possible that it is the appraisal of biologics as a threat that accounts for the 
discrepancy in findings in quantitative studies, where participants score significantly 
lower on psychological than physical QoL dimensions after the administration of 
biologics (Saad et al., 2010). 
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Third Master Theme: The Importance of Seeing the Person Behind the Disease 
It was the similarities between Alice’s experience of her medical care and how 
Matthew and Jack described their medical care at a previous hospital that led the 
researcher to infer that participants’ relationship to their health care provider was 
crucial in shaping their experience of biologics. 
From participants’ description of the two different types of care, it seemed that 
this difference could be conceptualised as a difference between a biomedical and a 
biopsychosocial model of health care.  
The following experiences can thus be seen as representative of a biomedical 
model of care with a sole focus on the remediation of disease. The clear signs that 
Alice was in severe emotional distress and was struggling to cope were ignored just as 
her direct cry for psychological help was overheard. Jack’s asking for psychological 
help to manage the pain that he experienced as overwhelming was likewise ignored. 
Despite being treated for psoriasis, which is widely recognised to have a significant 
impact on sufferers’ lives, Matthew’s doctor never asked him how he was – in fact he 
never even looked him in the eye. The lived experience of illness and the 
psychological burden associated with this is, it seems, considered outside the remit of 
this type of medical care.  
Whilst research on PsA is still in its infancy, the literature on psoriasis has 
repeatedly advocated a patient-centred approach, which in the current context will be 
considered synonymous with a biopsychosocial approach (Feldman, Behnam, 
Behnam, & Koo, 2005; Kimball et al., 2005; Moon et al., 2013). Given that psoriasis 
is associated with high levels of psychological distress that is related to adverse 
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clinical outcomes (Moon et al., 2013), it is surprising that so few dermatology units 
have access to specialist psychological care (Psychodermatology UK, 2012).  
Though there is a dearth of studies investigating pain in PsA, research on other 
medical conditions that involve chronic pain attests to the limitations of a biomedical 
view of pain. Viewing the intensity of pain as proportionate to or in linear 
correspondence to the degree of tissue damage has not been supported by research. 
Instead, findings suggest that pain must be understood from a biopsychosocial 
perspective that views pain as a ‘complex and multifaceted experience emerging from 
the dynamic interplay of a patient’s psychological state, thoughts, emotions, 
behaviours as well as socio-cultural influences’ (Roditi & Robinson, 2011, p. 42).  
Whilst it is not possible to review the literature on pain in RA within the scope 
of this study, suffice it to state that these studies support the biopsychosocial view on 
pain as complex and multidimensional. Psychological factors such as perception of 
control and helplessness have been found to be the strongest predictors of depression 
and pain among RA sufferers (Covic, Adamson, Spencer, & Howe, 2003). 
The experiences of Jack, Matthew, and Alice therefore suggest the continued 
stronghold of biomedical assumptions such as the clear divide between physical and 
psychological within the health care delivery system, despite policy level calls for a 
biopsychosocial care model that integrates physical and psychological aspects of 
chronic disease (‘Better Integrated Care Could Save the NHS Millions,’ Department 
of Health, 2012). 
The findings of this study also suggest that there is a lack of awareness and 
knowledge about PsA, even among medical professionals. All participants, except 
Samuel, described going for many years before their joint pains were linked with 
PSORIATIC ARTHRITIS AND BIOLOGICAL TREATMENT !105
psoriasis. The worst case was that of Matthew, whose symptoms of joint pain were 
dismissed for over 20 years. This is supported by research finding that patients with 
PsA often take long to be correctly diagnosed (Kane & Pathare, 2005, suggesting that 
clinicians should be urged to be attentive to signs of arthritis among psoriasis 
sufferers (Mease et al., 2014).  
It thus seems that the physical and psychological suffering incurred by PsA is 
amplified by a lack of awareness and recognition of the severity of disease, and not 
only in terms of the psychological impact that not being believed had on Alice and 
Matthew, who both struggled to find words to describe this. But Matthew suffered 
severe consequences from the failure to identify his joint pains as PsA as his joints 
were permanently damaged, rendering him unable to work. Likewise, Jack’s 
experience of PsA being treated by separate medical departments is also supported by 
the literature, where this disconnect in patient care is attributed to the historical 
neglect of PsA (Gordon & Ruderman, 2005).  
Furthermore, there is also evidence to suggest that paying attention to the 
illness experience and psychological distress of PsA sufferers has direct clinical 
relevance. A growing body of evidence shows that negative views of illness held by 
patients are associated with poorer health outcomes (Petrie & Weinman, 2006; Hagger 
& Orbell, 2003). As mentioned in the literature review, disease severity has been 
found to have little bearing on how individuals cope and adjust to having a chronic 
illness. Instead, it has been found that it is patients’ beliefs or representations of 
illness that most significantly explain coping behaviours, psychological impact, and 
adherence to treatment (Leventhal et al., 1992). 
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There is preliminary evidence that patients’ beliefs or illness cognitions predict 
level of disability and HRQoL in PsA sufferers (Kotsis et al., 2012) echoing findings 
in RA (Graves, Scott, Lempp & Weinman, 2009; Os, Norton, Hughes, & Chilcot, 
2012). Likewise, studies on psoriasis demonstrate that patients’ illness representations 
predicted levels of disability that could not be explained by disease severity (Fortune, 
Richards, Main, & Griffiths, 2000; Scharloo et al., 2000). This therefore suggests that 
a focus on the illness experience and the specific representations of illness could serve 
to identify vulnerable patients who may go undetected if the focus is on severity of 
disease alone.  
For example, despite Alice’s recognising that treatment with biologics has 
significantly improved her PsA symptoms, her representation of treatment as unsafe 
can thus account for her psychological distress and resentment of biologics. In line 
with research linking psychological distress with poor treatment adherence (Katon, 
2002), this manifested in Alice’s reluctantly turning up for treatment that she 
paradoxically also recognised as making her better. Likewise, Matthew’s belief in the 
controllability of his PsA symptoms following biologics can also explain Matthew’s 
positive psychological state despite his still being quite impaired by pain.  
What is, however, perhaps more relevant in the current context, is that if 
illness representations form the basis of emotional responses and coping, a focus on 
these can inform interventions within the context of cognitive-behavioural 
psychological therapies. As such there is evidence to suggest that psychological 
intervention targeting maladaptive illness cognitions can both improve psychological 
distress and reduce disease severity in psoriasis (Fortune et al., 2002b; Fortune et al., 
2004; Zachariae, Oster, Bjerring, & Kragballe, 1996; Lavda, Webb, & Thompson, 
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2012). Likewise, psychological intervention based on a cognitive-behavioural 
perspective has been successful in helping patients to manage pain in arthritic 
conditions such as RA (Sharpe et al., 2001; Turk & Monarch, 2002). 
Though no studies, to date, have investigated whether psychological 
interventions are effective in managing the distress associated with PsA, this topic 
may warrant further exploration.  
Hanif’s experience of participating in a pain-management programme, which 
he credited with transforming the way he dealt with his arthritic pain, is particularly 
significant. This supports findings showing that that there are other pathways to 
manage pain when the biomedical model’s attempt to eliminate or manage the 
physical cause of pain through, for example, medication fails. Hanif’s experience is 
therefore illustrative of the evidence supporting psychological approaches to pain 
management and thus suggest that this could be a fruitful avenue of intervention for 
PsA sufferers (Kerns, Sellinger & Goodin, 2010; Veehof, Oskam, Schreurs, & 
Bohlmeijer, 2011).  
Another facet of Hanif’s experience may be related to his self-efficacy in the 
sense of feeling more in control of his pain. Research suggests that self-efficacy is 
enhanced when patients succeed in solving a problem, which they can be taught to do 
through the use of self-management skills (Roditi & Robinson, 2011). Hanif’s 
description of how he was able to manage his pain through breathing rather than 
relying on medication for relief could thus be seen as enhancing his sense of self-
efficacy and belief in his ability to deal with the psychological demands of his pain.  
Furthermore, evidence supporting the use of psychological intervention to 
improve physical health outcomes is emerging from the hard sciences themselves. 
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The emerging field of psychoneuroimmunology is increasingly able to show that 
negative emotions and stressful experiences can lead to immune modulation (Carver, 
Scheier & Segerstrom, 2010; Harter, Conway & Merikangas, 2003; Kendall-Tackett, 
2010). This link between mind and body, the so-called ‘brain-skin access’ is often 
emphasised within dermatology, with several studies suggesting that psychological 
factors play a role in triggering and exacerbating psoriasis (Chapman & Moynihan, 
2009; Fortune et al., 2003; Hunter, Griffiths & Kleyn, 2013).  
This was supported by several participants in this study, who experienced their 
skin flaring up during periods of increased psychological distress, with Matthew’s 
experience of his skin being 95% covered by psoriasis during the time his joint pains 
went unrecognised being exemplary in this regard.  
This theme therefore highlights the need for a biopsychosocial approach to 
management of PsA, which considers the individual illness experience of sufferers as 
they go through their different stages of their illness trajectory in line with the 
emphasis on person-centred care in the context of chronic illnesses such as PsA 
(Naylor et al., 2012).  
Implications of Findings for Counselling Psychology in Health Care Settings 
The findings of this study suggest that living with PsA is associated with 
considerable psychological distress and life impact that is not yet widely recognised. 
There is therefore little doubt that there is room for improvement to address the 
significant psychological and social challenges PsA sufferers are likely to experience 
at different stages of their illness trajectory. Further research into how psychological 
interventions can be employed as an adjunct to conventional medical management to 
improve the lives of PsA sufferers is therefore needed.   
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For the practitioner psychologist working with clients with visible differences 
such as PsA, it is natural to focus on psychological aspects implicated in the aetiology 
and maintenance of distress. However, counselling psychology’s explicit concern with 
the unique experience of the individual also means attending to the biological, 
psychological and social aspects of the PsA sufferer’s illness experience. It is 
therefore imperative to resist being drawn into locating or explaining the source of 
psychological distress solely within the individual, but rather to “remember the social 
(….) within a truly biopsychosocial model of understanding and 
practice” (Strawbridge, 2008, cited in Douglas, 2016, p. 161 ). 
As counselling psychologists we are reminded to recognise the powerful 
sociocultural factors surrounding what it means to live with a visible difference – both 
on the level of what appears to be deeply rooted stigmatizing attitudes to blemished 
skin, and in terms of critically engaging with how ideals of perfection are fuelled by 
the mass media and a global beauty industry with a vested interest in having 
consumers strive towards, often unattainable, ideals of beauty (Orbach, 2009; Rumsey 
& Harcourt, 2012).  
In order to engage with actions that reflect or ‘talk the talk’ (Rafalin, 2010, 
p. 51) counselling psychologists are therefore urged to venture beyond the therapy 
room to engage with sociocultural issues to effect change in wider society as well 
(Milton, 2010; Vera & Speight, 2003).  
There is therefore also a pressing need for involvement in public health 
campaigns and organisations, such as Changing Faces, that aim to educate the public, 
to promote acceptance and diversity of appearance, to view people with disfigurement 
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as ‘just that. People first, who happen to have a disfigurement rather than a population 
apart’ (Rumsey & Harcourt, 2012, p. 681).  
Whilst there is undoubtedly a gap between the need for and provision of 
psychological support in physical health, increasing budgetary restrictions within the 
NHS mean that the provision of psychological services within units such as 
dermatology may not be prioritised. Counselling psychologists are therefore called to 
disseminate research findings beyond academic journals to demonstrate at policy 
level the need for the provision of specialist psychological care (Corrie & Callahan, 
2000). 
Reflexivity on Methodology and Process 
On reflection, there were pros and cons associated with the choice of IPA for 
this study. On one hand, this methodology provided rich data anchored in the 
subjective life-world of participants with which to answer the research question of 
this study. On the other hand, a challenge I persistently grappled with was how to 
balance IPA’s focus on “the person-in-context and their subjective experiences” 
Torodova, 2011, p. 35) with the sociocultural context in which participants’ 
experiences were embedded.  
During my analysis I kept finding that participants’ experience of biologics 
could not be understood in isolation from, for example, their experiences of previous 
medical treatments, the social meaning that having a skin condition seems to be 
imbued with and their experience of the medical care in which it was received.  
It was only when I read Torodova’s (2011) commentary that I was able to 
explicate the nature of my challenge, namely how to maintain coherence – a 
synchrony of epistemology, methodology, and methods – whilst allowing for a 
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deepening contextualisation. The last master-theme could thus be argued to straddle a 
fine line between invoking a higher-order category to explain participants’ experience 
rather than capturing their experience.  
However, it has also been argued that IPA offers a position of epistemological 
flexibility (Smith et al. 2009), and it is important that IPA should expand its 
interpretative and contextualising potential (Larkin et al., 2006). Hence, I can only 
admit awareness of what Torodova (2011) terms pushing the ‘envelope of what 
coherence means’ (p. 37) by perhaps venturing into an epistemological perspective 
that borders on explanation rather than interpretation. But at the same time, I hope this 
has been done in the spirit of avoiding methodolatry (Chamberlain, 2000), understood 
here as the strict adherence to method with an ensuing ‘sacrifice of content and 
substance’ (Torodova, 2011, p. 37).  
On reflection, therefore, in light of how salient the last master-theme was 
deemed to be, grounded theory may also have been a suitable alternative mode of 
enquiry. However, at the outset of the study, the main aim was to access participants’ 
experiences and therefore IPA was chosen.  
Although I, on a personal level, have long been sceptical of any claims toward 
objective knowledge in research, this process affirmed the epistemological position 
adopted for this research. I feel I have been instrumental in the creation of this 
account, from the wording of the interview questions to analysing to the best of my 
abilities what I thought participants were conveying. 
Two reflections arose from this. Participants were invited to participate on 
headed paper bearing the name of the NHS department responsible for their medical 
care, and most interviews took place there. I therefore wondered about whether 
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recruitment was influenced by participants’ seeing me as a representative of that 
department too. The five participants who agreed to participate all felt very positive 
towards their care. Perhaps participants with negative experiences did not want to 
participate because they saw me as a representative? Perhaps it was no coincidence 
that the only person with a predominantly negative experience received her medical 
treatment elsewhere?  
Another cause for reflection was that the importance of personalised medical 
care of which I am an avid proponent seemed to have been affirmed by this study. 
Thus, I did wonder about the extent to which I influenced these findings in terms of 
the questions I asked participants, the prompts I used, and how I responded to what 
participants were saying as well as of course the process of analysis and interpretation 
itself.  
The themes that emerged from the analytic process were a result of bringing 
the double hermeneutic to life (Smith et al., 2009) in the sense that interpretation of 
the wealth of data in the interview transcripts involved both selection of what to focus 
on as well as my filling in gaps, making meaning out of ambiguities and what I 
thought participants were saying to allow a coherent narrative to emerge.  
During the analytic process I realised that I found this power unsettling. I 
realised that I was initially uncomfortable with making interpretations that went 
beyond what I was sure participants were saying and that I would rather err on the 
side of caution than to risk interpretations that might conflict with participants’ self-
understanding. What if they didn’t agree with my interpretations of their experience? 
What if I was ‘forcing’ my assumptions onto participants’ accounts in an attempt to 
create a coherent and convincing account?  
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Willig (2012) argued that putting ethics at the heart of interpretative research 
is essential. For me, this research process has highlighted that interpretative methods 
such as IPA open up fundamental ethical issues of ownership and power that become 
necessary to engage with.  
Thus finding the responsibility of interpretation enormous, I feel a sense of 
humility and responsibility to the participants in this study who put their story in my 
hands. I was struck by the immensity of participants’ suffering and, during the 
interviews, I strongly felt and still feel that this is a much-neglected client population 
in need of much more support. Thus, I must acknowledge becoming emotionally 
invested with the plight of the participants in this study. Yet I have tried to ‘tread 
carefully’ and to achieve a balance between interpretative depth and staying close to 
the data. I hope I have done participants justice in interpreting the meaning of their 
experience.  
Limitation of Study and Direction for Further Research 
This study presented an in-depth understanding of participants’ experience of 
receiving biologics for PsA. A limitation of this study was that participants had all 
been on different types of biologics for varying lengths of time. Thus, it is unclear 
whether the length of time each participant had received biologics for had affected 
their experience. It is possible that participants who had been on biologics the shortest 
length of time were still in a ‘honeymoon period’ compared to those participants who 
had been on biologics the longest and may have wearied of treatment.  
It is also possible that the recruitment of five out of six participants were from 
a dermatology unit that practices person-centred care may have had a bearing on the 
overall positive experience of treatment, as indeed was the contention of this study. 
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Recruitment from this unit may have skewed the experience of biologics in a positive 
direction, as it is possible the sample in this study may not be particularly 
representative of PsA sufferers receiving biologics.  
Further qualitative research conducted in different healthcare settings and 
more longitudinal qualitative examination of the same participants’ experience of 
biologics at different stages of treatment might yield interesting data relating to how 
the experience of receiving biologics may change over time and how medical care 
potentially affects this experience.  
Conclusion  
Whilst it is not possible to generalise on the basis of the methodology used in 
this study, the findings of this study highlighted that treatment with biologics was 
experienced as complex. While biologics significantly improved sufferers’ lives, 
treatment brought with it challenges of its own such as worries and uncertainty about 
what to expect both in terms of the future efficacy of biologics and potential side 
effects. This suggests that a biopsychosocial approach that attends to the 
psychological and social aspects of the PsA sufferers’ illness experience in adjunct to 
the biomedical aspects of disease management is warranted even when positive 
changes in health status are experienced, such as those following treatment with 
biologics.  
This study highlighted the discrepancy between the considerable impact that 
having PsA can have on sufferers’ lives and the level of support offered to this patient 
population. Despite wide consensus that a biomedical approach is inadequate when it 
comes to caring for individuals with chronic dermatological and rheumatoid 
conditions (Psychodermatology UK, 2012; Roditi & Robinson, 2011) the experiences 
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of participants in this study suggest that the implementation of a biopsychosocial 
model on the level of practice leaves much to be desired.  
PsA patients suffer from the dual impact of skin and joint conditions, both of 
which are associated with considerable psychological distress and life impact. Given 
that psychological distress is related to adverse clinical outcomes (Moon et al., 2013) 
and significant financial burden on the healthcare system (Naylor et al., 2012), it is 
surprising that PsA sufferers going through the different stages of their illness 
trajectory have little access to specialist psychological care.  
However, what was perhaps even more striking was the lack of awareness and 
knowledge about the condition, even among dermatologists and rheumatologists 
treating the condition. This suggests a pressing need for further research and 
education about PsA so that this condition can be identified and managed 
appropriately. 
Given the paucity of studies on PsA, there is little doubt that there is 
considerable room for improvement in the way the care for patients suffering from 
this condition is managed. This study therefore calls for a multidisciplinary 
collaboration among psychologists, dermatologists, and rheumatologists on both 
research and practice levels to further develop, implement, and demonstrate the need 
for psychological counsel for PsA sufferers as they pass through various stages of 
their illness trajectory. It is thus hoped that insights from this study can be a stepping-
stone to improve the support for this population.  
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Appendix A 
Further Information on Psoriatic Arthritis  
What is psoriatic arthritis? 
Psoriatic arthritis (PsA) is a form of arthritis affecting the joints in around one 
in in five people with psoriasis. PsA often affects the hands and feet causing swelling, 
stiffness, pain and problems moving the joints. Once it develops, is a long-term 
condition.  
The pain and swelling of PsA are caused by an overactive immune system, 
which inflames the tissues around the joint. Typically, symptoms will flare-up and 
recede periodically. 
Psoriasis preceding the arthritis symptoms of the disease is estimated to occur 
in about 70-80% of cases. It is, however, possible for the manifestations of arthritis to 
precede the onset of psoriasis, just as a simultaneous sudden onset of both skin and 
joint symptoms has also been seen. 
Psoriasis can develop at any age, but PsA usually happens later, often between 
the ages of 25 and 50 years. About two to three per cent of the population, have 
psoriasis. Of these, about 20 per cent will develop PsA.  
There are five different kinds of psoriatic arthritis. 
• Asymmetric arthritis makes up about 70% of all cases of psoriatic arthritis. 
It often involves one or a few joints, like the knee, hip or fingers. Although 
it's frequently mild, it can sometimes be debilitating. The inflamed joints 
may be red and hands and feet may be swollen. 
• Symmetric arthritis is the second most common form of psoriatic arthritis. 
It often causes symptoms in the same joints on both sides of the body. 
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Symptoms are similar to rheumatoid arthritis and symmetric arthritis can 
cause permanent damage. 
• Distal interphalangeal predominant (DIP), a less common form of 
psoriatic arthritis, affects the joints close to the fingernails and toenails. 
The nails are often affected too. 
• Spondylitis can make movement painful, especially in the neck and back. 
It can also cause inflammation of the spinal column. 
• Arthritis mutilans is a rare and often debilitating and destructive form of 
psoriatic arthritis. It often affects the hands and feet and sometimes the 
back and neck, and it can result in permanent deformity. 
What are the symptoms of psoriatic arthritis? 
The symptoms of psoriatic arthritis are similar to those of other kinds of 
arthritis. They include: 
• Stiffness in the joints 
• Pain or swelling in the joints 
• The presence of psoriasis will make diagnosis of psoriatic arthritis easier 
How is psoriatic arthritis diagnosed? 
PsA can be diagnosed through blood tests, joint fluid tests and X-rays in order 
to examine the affected areas and rule out other diseases. 
What is psoriasis?  
Psoriasis is a chronic inflammatory skin disorder. The underlying cause is not 
known, but the immediate casue of psoriasis is the rate of growth and differentiation 
of the epidermis (the outer layer of the skin). In unaffected skin, the epidermis is 
renewed approximately every 28 days. With psoriasis, however, the epidermis is 
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renewed every four days, a process referered to as hyper-profileration. The effects of 
hyper-profileration result in psoriatic plaques from the thickening and reddening of 
the skin; the sloughing of silvery scales; pruritus (severe itching) of the affected areas; 
and thickening and yellowing of the fingernails and toenails. The surface area of the 
body affected varies from small patches to total skin coverage.  
Psoriasis also affects the nails by causing discolouration, oitting and loosening 
of the nail from its bed (onycholysis) and abnormal growth of the nail bed 
(hyperkeratosis) 
Two-thirds of people have type 1, which typically presents before the age of 
30. It has a strong hereditary component. Type 2 occurs after the age of 30. Men and 
women are equally affected, but there is a large variation between ethnic groups. 
Psoriasis is most common in white skin. 
Psoriasis may present in one of 5 forms, though approximately 80% present 
with plaque psoriasis or psoriasis vulgaris. This is characterized by raised, inflamed, 
red lesions covered by a silvery scale, typically found on the elbows, knees and scalp, 
lower back. 
Inverse psoriasis are red, shiny lesions, located in the armpits, groin and 
skinfolds. It is brought on by irritation from rubbing and sweating and tends to be 
more troublesome in overweight people with deep skin folds. 
• Erythrodermic psoriasis is a form of psoriasis that affects most of the body 
surface and is characterized by periodic, widespread, fiery redness of the 
skin often accompanied by severe itching and pain. This form can lead to 
severe illness as infection, pneumonia and congestive heart failure brought 
on by erythrodermic psoriasis can be life-theratening. 
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• Guttate psoriasis is a form of psoriasis that often starts in childhood or 
young adulthood and usually appear on the trunk or limbs. This form often 
has a sudden onset and can be brought on by respiratory infections, 
tonsillitis, stress, injury to skin and administration of certain drugs. 
• Pustular psoriasis is primarily seen in adults. It is characterized by white 
pustules surrounded by red skin. It is cyclical in nature, often starting with 
reddening of the skin followed by formation of pustules and scaling. This 
form may be triggered by internal medications, overexposure to UV light, 
pregnancy, systemic steroids, emotional stress. 
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Appendix B 
Overview of Treatment Options for Psoriatic Arthritis 
Drugs for the treatment of PsA can be divided into several categories:  
• Nonsteroidal anti-inflammatory drugs (NSAIDs). These drugs decrease 
inflammation, pain and stiffness and include over-the counter medication 
such as aspirin and ibuprofen. 
• Disease-modifying anti-rheumatic drugs (DMARDs). These are 
immunosuppressants, which reduce the activity of the immune system. 
They work by slowing disease progress and can therefore reduce the 
amount of tissue damage making it an effective treatment for more severe 
symptoms of psoriasis and PsA.  Examples include methotrexate 
(Maxtrex), sulfasalazine (Salazopyrin) and leflunomide (Arava). Most are 
taken in tablet form, but may sometimes also be administered by injection. 
They can have serious side effects, so you will be carefully monitored. 
• Oral steroids. These can be used to treat acute joint pain, but cannot be 
used safely for long periods of time. Stopping treatment with steroids 
suddenly can also cause a flare-up of symptoms. 
• Biologics. These are the newest class of drugs and are genetically 
engineered proteins derived from human genes. They are designed to 
inhibit specific components of the immune system that play pivotal roles 
in fueling inflammation, which is a central feature of rheumatoid and 
psoriatic arthritis. 
Biologics are used to treat moderate to severe psoriatic arthritis that has not 
responded adequately to other treatments. They differ significantly from traditional 
PSORIATIC ARTHRITIS AND BIOLOGICAL TREATMENT !147
drugs used to treat arthritis in that they target specific components of the immune 
system instead of broadly affecting many areas of the immune system.  
The most common side effect seen with biologics is pain and rash at the 
injection site. This occurs in less than 30% of patients. Since biologics given by 
infusion (in the vein) have the potential to cause an allergic infusion reaction, patients 
are monitored during infusions. Symptoms of infusion reactions include flu-like 
illness, fever, chills, nausea, and headache. 
As with any drugs that suppress the immune system, biologic therapy poses 
some increased to infections and other diseases. Biologics may also cause some 
chronic diseases that are dormant (such as tuberculosis) to flare, and they are not 
recommended for people with multiple sclerosis and other conditions such as severe 
congestive heart failure. All patients should be skin tested for tuberculosis prior to 
starting biologics, and many are also tested for chronic hepatitis. 
There are a number of different biologics licensed for use in the treatment of 
PsA in the UK. These include targeted therapies (alefacept) and anti-cytokine 
therapies (anti-tumor necrosis factor (TNF) therapies such as adalimumab, etanercept, 
infliximab and a monoclonal antibody against interlukin (ustekinumab). 
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Appendix C 
Guidelines for Biologics for Psoriatic Arthritis 
!  
Figure 1. Recommended treatment algorithm for psoriatic arthritis. (Retrieved from 
http://www.rheumatology.org.uk/includes/documents/cm_docs/2012 
/b/bsr_guidelines_2012_treatment_of_psoriatic_arthritis_with_biologics.pdf, p. 5) 
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Appendix D 
Examples of Quality of Life Questionnaires (DLQI, SF-36 & HAQ) 
DLQI: The Dermatology Life Quality Index (Finlay & Khan, 1994) is a dermatology-
specific QoL measure that has been developed specifically to capture the impact of 
skin disease on patient’s quality of life. Developed on the basis of 120 dermatology 
patients with a variety of skin conditions responses to the impact of their skin 
condition on their lives.  
It is a short, self-administered questionnaire that consists of 10 questions with 
each question having four possible responses: not at all, a little, a lot, and very much. 
A total score can range from 0-30, with a higher score indicating greater QoL 
impairment.  
HAQ: The ‘Health Assessment Questionnaire ‘ was originally developed in 1980 by 
Fries et al. (1980) to assess physical function in rheumatoid arthritis and was one of 
the first measures to assess outcomes from the patient perspective. Because the HAQ 
emanated from rheumatology, it has sometimes been characterized as a disease-
specific instrument, but should be seen as a generic measure because the dimensions 
assessed are widely applicable across many different diseases.  
The HAQ consists of 20-items divided into 8 domains: dressing and 
grooming, arising, eating, walking, hygiene, reach, grip and common daily activities. 
Respondents rate the degree of difficulty they have had in the past week on a 4-point 
scale, ranging from 0 (no difficulty) to 3 (unable to do), The highest scores in each 
category are summed (0-24) and divided by the number of categories scored to yield a 
summary score of 0-3. 
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SF-36: The Short Form-36 (SF-36) is a 36-item questionnaire developed by 
Ware & Sherbourne (1992). It has been widely used to assess quality of life across a 
range of medical conditions.  
The SF-36 measures health across 8 domains; 4 domains of physical health 
(physical functioning, bodily pain, role limitations due to physical problems and 
general health perceptions) and 4 domains of mental health (social functioning, role 
limitations due to emotional problems, psychological functioning and vitality/fatigue). 
The responses to items within each dimension are summed to produce a health profile 
consisting of 8 scores, which can be subdivided into 2 summary scores – a physical 
and mental component score. These scores are then transformed into standard scores 
ranging from 0 (lowest health status) to 100 (highest health status).  
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Appendix E 
Ethical Approval From London Metropolitan University 
!  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Appendix F 
Ethical Approval From National Research Ethics Committee  
!  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Appendix G 
Site-Specific Information (SSI) Approval 
!  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Appendix H 
Recruitment Poster  
 
        
PARTICIPANTS NEEDED FOR 
RESEARCH STUDY 
Do you have psoriatic arthritis? 
Have you received treatment with biological agents? 
My name is Eva Schepelern and I am a doctoral trainee on the counselling 
psychology programme at London Metropolitan University. I am looking for 
participants to take part in a study on psoriatic arthritis and how treatment with 
biological therapy has affected their lives. 
You would have to be willing to share your personal experience of what having 
psoriatic arthritis has been like for you and how you feel now after biological 
treatment. 
Taking part in this study involves taking part in an interview about your experience 
for approximately 60-90 minutes at a location here at the Royal Free Hospital. 
The interview will be audiotaped and transcribed for analysis purposes, but any 
information you provide will be anonymised to protect your confidentiality. 
To receive an information pack with further details, please contact Eva Schepelern on 
e.schepelern@nhs.net or ask reception here at the Dermatology/ Rheumatology 
clinic for one. 
Thank you for your time. 
This study has been reviewed by, and received ethics clearance  
through the NHS research committee and the Office of Research Ethics, London 
Metropolitan University.  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Appendix I 
Participant Information Sheet 
INFORMATION SHEET FOR PARTICIPANTS 
You are being invited to take part in a research study that investigates the 
experience of having psoriatic arthritis and how the treatment with biologics 
has affected your life. Before you decide whether you would like to participate, 
please take the time to read the following information to help you understand 
why the research is being carried out and what it will involve for you.  
Who is the researcher? 
My name is Eva Schepelern. I am a Trainee Counselling Psychologist and I 
am carrying out this study as part of a Doctorate qualification in Counselling 
Psychology at London Metropolitan University in collaboration with the 
Dermatology and Rheumatology Departments at the Royal Free Hospital. 
What is the purpose of this study? 
The purpose of this study is to gain an in-depth understanding of how 
treatment with biological therapy for your psoriatic arthritis has affected your 
life. There has been very little research done on what it is like to have 
psoriatic arthritis, and what the psychological impact of living with this 
condition may be and no research has yet investigated how treatment with 
biological agents impacts on psoriatic arthritis patients’ quality of life.  
What will taking part in this study involve? 
Taking part in the research will involve taking part in a 60-90 minute interview 
with. The interview will not follow a set of pre-set questions, but be more of a 
conversation that evolves between you and me about what your experience of 
having psoriatic arthritis has been, what it has been like to receive biological 
therapy and what impact the treatment has had on your life and how you feel 
now. 
Do I have to take part? 
You are under no obligation to take part. Participation in this study is entirely 
voluntary and your decision will not affect the standard of care you receive in 
any way either now or in the future. 
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What should I do if I want to take part? 
If you have decided to take part in this study, please contact me using the 
contact details below. We will then either arrange to meet in person or have a 
conversation by phone where you get the opportunity to ask any questions 
you may have about the research. If you decide you want to take part, you will 
be asked to sign a consent form and given a copy to keep and we will arrange 
for the interview to take place.  
What if I change my mind? 
Should you at one point change your mind about taking part in this study, you 
are free to withdraw from this study within three weeks of the interview taking 
place without having to explain your reasons. You are merely asked to do this 
for practical reasons before the data is analysed and written up. You do not 
have to give a reason for leaving the study and this will not affect the care or 
treatment you are receiving in any way.  
What will happen to the information I give during my interview? 
The interview will be audio-taped and transcribed for the purpose of analysis. 
A professional transcription service may be used which would mean that the 
person transcribing will listen to the interview. In this case, potential 
transcribers will not have access to your identity and confidentiality 
agreements will be signed. This means that transcribers will be legally bound 
to maintain full confidentiality in regard to any information revealed during the 
interview.  
The audio-recordings and the typed out interviews will be anonymised and 
kept in a secure facility. The anonymised transcripts will be used for data 
analysis. The only people, apart from me, who will have access to the 
anonymised interview data are academic supervisors and representatives 
from assessment bodies that assess the quality of the research. Following 
transcription, the audio-recordings of interviews will be destroyed. 
The results of this research be written up and submitted in the form of a 
Doctorate thesis, which will be deposited in the University Library. However, it 
is also intended that the results of the research will be disseminated in the 
form of one or more articles in scholarly journals. 
It is therefore important that you are aware that it is highly likely that you will 
be quoted in the write-up of this study. However, any information which might 
contribute to identify you and other participants in this study (names, 
references to places, of work, study, schools etc.) will be changed, and the 
original names only be known by me.  
What are the risks of taking part? 
You will be asked to discuss your experiences of having psoriatic arthritis and 
how the medical treatment you have received has impacted on your life. This 
may or may not be distressing to you. If during the interview you are asked a 
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question you do not wish to answer, you may skip it. Likewise, should you 
experience distress, you will be given the option of taking a break or stopping 
the interview all together. Following the interview, I will be available for you to 
contact if you need to talk or reflect on some of the issues raised. I will also 
provide you with details of where you can receive counselling, if you should 
find that you need additional support.  
What are the potential benefits of taking part? 
Though I cannot promise that there will be benefits involved from taking part 
in the study, the information you have provided may help to improve 
understanding of what it is like to be treated with biologics for psoriatic 
arthritis, which may improve treatment for others in the future. You may also 
appreciate having the opportunity to talk openly about your experiences. 
What if I have concerns about the study? 
If you have concerns about any aspect of this study, you can contact me at 
any time and I shall do my best to answer your queries. In the event that you 
wish to speak to someone else, you can contact my academic supervisor Dr. 
Philip Hayton at London Metropolitan University. You may also contact the 
Patient Advice and Liason Service at the Royal Free Hospital (please see 
contact details below).  
Will my taking part in this study be kept confidential? 
The material collected during the course of the research will be treated with 
utmost confidentiality in accordance with the data protection act. No other 
person, besides me, will have access to the raw interview material. You will 
not be identified by your real name, but by a study number, and nothing that 
identifies you will be made available to others.  
However, it is important to make you aware that in the event that you disclose 
any information, which suggests that either you or someone else is at risk of 
harm, I am obliged to breach confidentiality and inform someone. However, 
this will not be done without your knowledge and I will do my best to discuss 
this with you first.  
What if there is a problem? 
If you wish to complain, or have any concerns about any aspect of the way 
you have been approached or treated by members of staff you may have 
experienced in connection with your participation in the research, National 
Health Service complaints mechanisms are available to you. Please ask me 
or your research doctor if you would like more information on this. 
In the unlikely event that you are harmed by taking part in this study, 
compensation may be available to you. If you suspect that the harm is the 
result of the Sponsor (London Metropolitan University) or the hospital’s 
negligence then you may be able to claim compensation. After discussing with 
your research doctor, please make the claim in writing to Eva Schepelern, 
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who is the Chief Investigator for the research and is based at Dermatology, 
clinic 6, 1st floor at the Royal Free Hospital. The Chief Investigator will then 
pass the claim to the Sponsor’s Insurers, via the Sponsor’s office. You may 
have to bear the costs of the legal action initially, and it is recommended that 
you consult a lawyer about this.  
If you have any questions regarding the nature of this study, please do not 
hesitate to contact me at e.schepelern@nhs.net or 0798 4289 774, and I shall 
do my best to answer your questions.  
Thank you for your time! 
Contact details 
Eva Schepelern (Chief Investigator)  
Dermatology Clinic 6, 1st floor 
The Royal Free London NHS Foundation Trust  
Pond Street 
London NW3 2QG 
Email: e.schepelern@nhs.net 
Mobile: 0798 4289 774 
Academic supervisor 
Dr Philip Hayton 
Counselling Psychology Programme 
London Metropolitan University 
Room T6-20 
Tower Building 
166-220 Holloway Road 
London N7 8DB 
Email: p.hayton@londonmet.ac.uk 
Tel: 0207 1332 667 
Patient Advice & Liason Service 
The Royal Free London NHS Foundation Trust 
Pond Street 
London NW3 2QG 
Telephone: 020 7472 6446 / 6447 
(020 7472 6445 – 24 hour answer phone) 
Fax: 020 7472 6463 
SMS/Text number: 447860023323 (for use by D/deaf, hard of hearing and 
hearing impaired patients only) 
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Appendix J 
Letters Sent out to Participants 
Royal Free Hospital 
Dermatology Clinic 6 
Pond Street 
London NW3 2QG 
Email: e.schepelern@nhs.net 
Mobile: 0798 4289 774 
May 2nd 2014 
Dear xxx,  
My name is Eva Schepelern and I am a counselling psychologist working at the 
psychodermatology clinic at the Royal Free hospital, where I have a particular interest 
in medical conditions such as psoriatic arthritis.  
I am writing to invite you to participate in my study, which looks at how people with 
psoriatic arthritis experience receiving biological therapy. This is a very 
underresearched area. Understanding more about how treatment with biologics affects 
people’s lives is therefore important in order to identify how to better help people 
with psoriatic arthritis.  
Participating in this study would involve for us to meet at a location that is convenient 
for you and for you to tell me about your personal experience. Our conversation will 
be audio-recorded and transcribed for analysis. It is anticipated that it will last about 
an hour.  
I am including an information sheet that includes further details about the study. 
If you are interested in participating, please contact me either on my mobile 0798 
4289 774 or by email e.schepelern@nhs.net . 
I will of course be happy to answer any questions you may have, so please do not 
hesitate to contact me if there is something you would like to clarify. 
I would be extremely grateful for your help and will of course compensate you for 
both your time and any travel expenses you may have.  
Many thanks for your time. 
Hope to hear from you.  
Kind regards, 
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Eva Schepelern 
Royal Free Hospital 
Dermatology Clinic 6 
Pond Street 
London NW3 2QG 
Email: e.schepelern@nhs.net 
Mobile: 0798 4289 774 
July 22nd, 2014 
Dear xxx,  
My name is Eva Schepelern and I am a counselling psychologist working at the 
psychodermatology clinic at the Royal Free hospital.  
I hope you received my previous letter inviting you to participate in my research 
study. The study is looking at how people with psoriatic arthritis feel after receiving 
biological therapy. This is a very underresearched area. Understanding more about 
how treatment with biologics affects people’s lives is therefore important in order to 
identify how to better help people with psoriatic arthritis.  
I am sorry to send out a second letter to you, but unfortunately not many people have 
contacted me about participating. So this is just a further invitation to participate and a 
friendly reminder to contact me at the earliest possible convenience if you would 
consider telling me about your experience. It is anticipated that it will last about an 
hour.  
You can contact me on my mobile 0798 4289 774 or by email e.schepelern@nhs.net 
and I will be happy to answer any questions you may have. 
I would be extremely grateful for your help and will of course compensate you for 
both your time and any travel expenses you may have. 
Many thanks for your time. 
Hope to hear from you.  
Kind regards, 
Eva Schepelern 
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Appendix K 
Participant Consent Form 
 
        
CONSENT FORM FOR PARTICIPANTS IN RESEARCH 
STUDIES  
Please complete this form after you have read the Information Sheet and/or listened 
to an explanation about the research. 
REC REF: 14/NW/0254 
Title: The experience of psoriatic arthritis patients receiving 
biological treatment: A qualitative study  
• I confirm that I have read and understand the information sheet, version 4 issued 
14.04.2014 for the above study and have had the opportunity to ask questions 
which have been answered fully. 
• I agree to the interview being audio recorded and transcribed for further analysis. 
• I agree to the use of anonymised direct quotes in the writing up of the study. 
 
• I understand that my participation in this study is voluntary and that I am free to 
withdraw within 3 weeks of the interview taking place, without giving any reason 
and that this will not affect the medical care I am receiving.  
 
• I understand that data from the study may be looked at by regulatory authorities or 
by persons from the Trust where it is relevant to my taking part in this study. I 
agree to these persons having access to this information. 
Please initial 
all boxes
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By signing this consent form, I agree to having understood the above and agree to 
take part in this study  
Participant: Printed Name  
______________________________________________________________ 
Date and Signature  
______________________________________________________________ 
Person taking consent: Printed Name  
______________________________________________________________ 
Date and Signature  
______________________________________________________________ 
 
I would like to be informed of the outcome and results of this study. 
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Appendix L 
Semi-Structured Interview Schedule 
• Looking back can you tell me about when you were first diagnosed with 
psoriatic arthritis and the treatment you received until you were offered 
biologics?  
• Can you tell me about your experience of receiving biological therapy for your 
psoriatic arthritis? 
• How has having psoriatic arthritis affected your life? (physically, emotionally, 
socially, work-life)? 
Prompt: what has been the most difficult part to cope with?  
• How has treatment with biologics affected your life? (physically, emotionally, 
socially, work-life)? 
Prompt: What has changed? What are you able to do now that you couldn’t 
before? 
• Can you tell me about how you feel now both emotionally and physically 
compared to before? 
• Considering the impact biologics has had on your life, are there any aspects of 
your life that you are struggling with and that you would like to receive help 
with/ has not changed as a result of treatment?  
• Looking back what do you think you would have liked to have been made 
available to you, which might help others with psoriatic arthritis receiving 
biologics? 
• What has it been like to talk about your experience? Is there anything you 
would like to add that we have not talked about?  
• Prompts: Can you give me an example of that? Could you tell me a little bit 
more about that? What do you mean when you say…? 
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Appendix M 
Debrief Participant Sheet 
 
        
REC REF: 14/NW/0254 
Study title: The experience of psoriatic arthritis patients receiving 
biological treatment: A qualitative study 
Debriefing information sheet 
Thank you very much for taking part in this study.  
The study aimed to explore how the lives of people with psoriatic arthritis are affected 
by treatment with biologics. I was interested in: 
• How psoriatic arthritis has impacted on your life 
• How having psoriatic arthritis has affected you emotionally 
• How treatment with biologics has impacted your life and how you feel now  
Existing studies show that there can often be a significant psychological burden 
associated with having a chronic illness. However, what the experience of psoriatic 
arthritis is like is a very under-researched area and there is an almost complete lack of 
research investigating the psychological impact of this condition on people’s lives. 
Furthermore, there is a widespread assumption that people will start to feel better 
psychologically, once their symptoms improve. But the literature shows that this this 
does not necessarily always happen. The aim of this study was therefore to find out 
more about why this might be, so that the challenges facing people with psoriatic 
arthritis may be better understood. 
This study is, to the best of my knowledge, the first of its kind, so this is what your 
participation has helped towards. So thank you again for taking part and making this 
possible.  
Sources of support 
Sometimes talking about difficult experiences can leave us feeling low or upset. This 
is quite normal and should pass within a few days. However, if you find that these 
feelings persist and you think you might require additional support, here is a list of 
counselling organisations that you may consider contacting.  
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• The Samaritans (tel. 0845 90 90 90;  www.samaritans.org). The Samaritans 
is a national helpline, which is open 24 hours a day for anyone in need.  
• Mind (0300 123 3393; www.mind.org). Mind is a national organisation with 
local branches in boroughs all over the UK. Mind provides individual 
counselling sessions for a small fee. Mind also has helplines that are open 
Monday to Friday 9 am – 6 pm. 
You are of course welcome to contact me at any point to discuss any aspect of your 
participation in this study, to share any concerns you might have or to ask questions. 
Contact details 
Eva Schepelern 
Royal Free Hospital 
Dermatology Clinic 6 
Pond Street 
London NW3 2QG 
Email: e.schepelern@nhs.net 
Mobile: 0798 4289 774 
If you have any concerns that you would like to raise with London Metropolitan 
University, you can contact my academic supervisor: 
Dr Philip Hayton 
Doctorate in Counselling Psychology Programme 
London Metropolitan University 
Faculty Of Life Sciences and Computing 
Room T6-20 
Tower Building 
166-220 Holloway Road 
London N7 8DB 
Email: p.hayton@londonmet.ac.uk 
Tel: 0207 133 2685 
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Appendix N 
Example of Annotated Transcript and Subsequent Identification of ThemesAlice 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Alice  
Not being understood  
Legitimate disability 
Pain is invisible 
People don't understand 
It's not legitimate walking with a stick 
at my age 
No excuse not to work  
I'm not lazy 
I'm not a scrounger 
Not recognised or understood 
People don't understand what it takes 
Exhaustion  
Misattributions of others 
Troubles attributed to age 
People can't see and expect me to carry 
on as normal 
People think I'm lazy 
Normalisation "it's just your age" 
Make light of 
It's only one hour at the hospital 
Perception of care 
I detest my treatment 
Never-ending  
Relentless  
Stop working after 3 months 
Improvement followed by relapse 
Every week for 5 years 
Conflicted self   
Deep conflict between what I want and 
need 
You should be grateful 
Fed up/Can't stand it 
I hate what is there to help me 
I was worse when I didn't have it 
I need what I loathe  
I don't understand as I know it's doing 
me good 
Unable to assimilate what I need as 
being good for me 
Violation of body 
Intrusion 
Needle phobia 
Constantly prodded and poked 
Objectification  
I'm prodded and poked 
Constant intrusion 
I'm not a person, but an object 
I am an experiment 
Withhold information  
Let's see what happens  
Wool over my eyes 
Not being honest with me 
Comparison with other conditions/
disadvantaged self 
Comparison with cancer: at least 
treatment ends 
Pamper days 
No information pamphlets  
PsA ignored 
No help for people with PsA 
No leaflets  
Awareness in dep. that it's underfunded 
Impact on self: Isolation.  
Am I the only person in the world? 
Neglected status of PsA 
Side-effects/vulnerability/poison 
Worry about side-effects 
Poison in my body 
Fear 
History of side-effects previously 
Scary reactions (anaphylactic shock/
vomiting) 
Side-effects: mouth blister 
I'm putting  highly toxic material that 
people won't touch in my mouth 
Uncertainty about future 
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What's going to happen 
Worry about future side-effects 
Prior experience of treatment promoted 
as safe 
Fearful of future implications of 
treatment  
Experiment  
Current health problems because of 
biologics? 
What's it doing to my body? 
Relationship to medical care team/
Perception of medical profession 
Don't trust them 
No independent advice 
Can't get an honest answer 
Resentment of medical profession 
They don't care about me 
Should listen but don't  
I know but they say I don't  
They don't care 
Ulterior motives 
Hidden agenda 
They're the enemy 
Not being listened to 
I am an inconvenience 
Not honest with me 
Lack of trust 
No explanation  
At least tell me 
Medical profession don't care/
understand 
There to get a job done 
Don't want to know 
Dismissal 
Keep a lot from me 
Experiment nightmare  
Let's see what happens  
Only when you've been on it for a 
while 
Oh yes, that can happen 
Only admit when absolutely necessary  
The less initiated are more honest 
(student doctor) 
Profound lack of trust 
Keep information from me 
Not honest with me 
Contradicted by personalised 
strategy (nurse) 
Lack of trust 
In bed with enemy 
No independent advice 
I am an experiment (callous/cold-
hearted medical profession) 
Only people advising you are the 
people pushing the drug 
Interesting use of word : push vs. 
grant  
I want options 
Information and options 
Self-efficacy 
Experience of care  
Dismissal 
Lack of trust leads to information 
search on internet  
Swept under the carpet 
I have to fight all the time  
Fear 
Insensitivity of medical (poster) facts 
I'm just a number  
They don't care 
Lack of info 
Nobody tells me anything 
No understanding from medical 
profession 
No one cares or wants to know 
When she tells them how she's feeling, 
it doesn't lead to anything 
Compared to "service" in shop 
(superficial) 
Seeking information 
The role of the Internet 
Lack of validation leads to internet as 
source of validation 
Negative cycle established 
PSORIATIC ARTHRITIS AND BIOLOGICAL TREATMENT !175
Turn to internet for information  
Makes it worse 
Don't know what is true 
Impact of unsolicited internet 
information  
Nasty cycle 
Cumulative effect in both positive 
and negative direction  
Vicious cycle of mistrust (internet)  
Ownership 
It's not their body it's mine 
I have a right to know 
Reclaiming what's mine 
I have the right to know 
It's my body  
Euthanasia analogy really 
Ownership 
I want to know in order to weigh up 
pros and cons 
Benefits of biologics 
Happy with biologics  
I was worse when I didn't have it 
The body talks  
Body rejects 
Body speaking/voicing what she feels 
(veins sunk) 
Couldn't swallow 
Hairs fell out, went brittle 
Symbol of poison 
Conditioner ineffective  
Harm herself - can't do it (needle 
phobia) 
Emotional impact  
Worry about reaction 
Weekend ruined due to worry 
Exhausted 
Negative emotion: angry,upset tearful 
Helplessness 
Social support  
Lack of interest/support 
Everyone else is used to it, but not me 
Process over time 
No adjustment 
Harder rather than easier 
Opposites 
Harder rather than easier 
Harm rather than help 
Body over mind 
Time-consuming 
Eats your time 
Never a day to myself 
Taken over life 
All-engulfing 
Cyclical relentless regime 
But endless cycle, no cure  
Never-ending (get tired of it all) 
Get over it and then time again 
So it's treatment needs to be recovered 
from 
Relentless cycle 
Need a breather 
Just a day to myself, when I don't feel 
bad 
Luxury of time on this particular 
biologics treatment (methotrexate) 
Eats you up/time  
Not being believed/Not being heard/
seen 
You're wrong  
This is not a side-effect 
Top-down communication 
That didn't believe me (doctors/nurses) 
Pathologised 
Objectified 
Non-personal care 
It took the two years before they 
believed me 
Sudden change - believe me with no 
logic to it 
Appearance concerns 
I looked a mess (hair) 
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Self-consciousness  
Poison 
Slow death 
Poison effect 
Tastebuds altered 
Impact on self/mind 
Affects my head/thoughts 
Fuzzy head 
Muddled head 
Can't understand anything 
Can't explain  
Lack of choice  
I don't have a choice 
Treatment (biologics) forced on me 
No option 
I have no choice  
There's no alternative  
No solution  
Helplessness 
Not that anything can be done  
Rebellion: Reclaiming choice  
Stay away  
Coping by pretending has the choice 
not to go 
Goes last minute 
Fear/avoidance problem solving  
Had enough/refused my injections  
The illusion of choice 
Reclaiming choice she knows she 
doesn't have 
I hate toxicity  
Rather spend a month in hospital than 
having all this rubbish put into me 
I don't want it 
Battle in my head 
Constant worry 
Constantly weighing up pros and cons 
Not rational 
Battle  
Emotional impact  
Ambivalence  
I'm worse without it 
In a way biologics keep me going 
Biologics help me walk a bit further  
PsA illness experience 
Attack on self 
Loss of basic self-care skills/abilities 
No sleep 
Psoriasis bad 
Sucks you dry 
Couldn't do anything (wash my hands) 
Pain  
Emotional impact 
Wanted to die 
Emotional impact of treatment/
reaction  
Panic symptoms 
I dread hospital 
Fear 
Impact of not being seen 
Emotional impact  
Exhaustion/stressed/tears 
Fed up 
No understanding  
Impact of treatment   
Incapacitated as result of methotrexate  
Pattern to week 
Relentless 
Wham: like getting punched 
Information and choice  
Information leads to choice 
Habituation  
My body constantly needs stronger 
stuff 
Reduced effectiveness 
Body is used to it 
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Always being at the hospital is normal 
to everyone else, not for AH 
Everyone else is used to it 
Lack of support and understanding 
from people  
Dependency on biologics  
I can cope with being bad for a few 
weeks because I know it's going to go 
away soon 
Infringement on life/Chained to 
hospital 
No freedom/flexibility 
Too dangerous for local GP to 
administer 
Won't take responsibility 
Obstacles put in my way 
No flexibility  
No leisure  
Tried to be pro-active  
Go on holiday 
Ticking bomb 
Exposure  
Lack of regard/care reflected in 
surroundings 
No privacy 
Put on display 
Pull-around curtain 
Shoved down in corner 
3 upright, uncomfortable chairs 
Violation in public 
Not worthy of a room 
Exposure in front of others 
On show 
Emotional impact  
Embarrassed 
Arrogance and misinformation  
You are misinformed about your own 
condition  
Lack of awareness even among 
medical profession 
We know better  
Tremendous impact of not being 
believed 
What you're saying/experiencing 
doesn't exist 
Ridiculed by medical profession 
Beyond words 
(Hunger for validation) 
Impact on life outside hospital /
personal relationship 
I've become irrational 
Flare up at nothing 
Loneliness  
Worry 
Anxiety 
The hunt for diagnosis  
Misdiagnoses 
Started with unexplained symptoms  
Long time for it to be diagnosed 
Impact of treatment/illness  
Impact on work life 
Had to give up work 
Hospital appointments alone were too 
much 
Impact of disease 
Some days I can't do the simplest 
things 
Another system that doesn't recognise 
psa 
Ability to do housework symbol of 
disease progression 
Loss of skills/stamina 
I'm behind with everything 
I'm ashamed (house a mess) 
Can't keep up 
Some days it takes all my effort to 
cook a meal, drink 
It takes all my energy 
Sounds stupid 
Takes all my energy 
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Exhaustion 
Fatigue 
Takes over 
Current state: Limbo (mixture of 
sitting/pottering about) 
Fatigue that affects mind and body 
All-encompassing 
Frustration 
Duality mind/body 
When mind is willing, body is not 
Body lets me down  
Monster 
Disease threatening to engulf you  
Instead of giving in to it (monster), 
alien presence, threatening to engulf 
you 
In the beginning I'd fight it 
Tricky creature: when do too much, 
body would punish you 
Difficult to pace myself  
Losing the fight (self as weaker) 
Losing battle against it all 
Avoidance becomes a way of dealing 
with it 
Defeat 
It's just easy 
Self-berating 
I should be able... 
Life without treatment  
Bedridden 
Skin and joints bad  
My goal is to be normal / have a 
normal life  
Work, shop, do nice things  
Just a few normal days  
Get up in morning refreshed, get 
dressed, walk around shops 
Aversion  
Can't face going 
Can't be brought in contact with it 
Skip dose in order to be normal 
Paradox (treatment in order to be 
normal) 
I'm alone/no support 
Nothing was/is offered/available 
(psychoderma report - unacceptably 
scarce) 
Sympathy (?) but no advice 
No help 
Going to go away and deal with it on 
my own again 
Isolation  
Frustration 
Shocks but no follow-up to support 
I'm left to deal with it on my own 
Adjustment not possible because you 
simply don't know what you're dealing 
with 
Note: pro-active information seeking is 
actually recommended for adjustment 
isn't it? Seems to be denied her 
Growing resentment of medical 
profession 
Been told later it's got a nasty side-
effect 
Wool pulled over my eyes 
Lied to 
Medical profession are dishonest and 
lie to you 
It's not fair to be kept in the dark 
Withhold information  
I'm more than my condition 
My condition is not just my skin or 
joints, it affects me 
I'm more than my physical symptoms  
Lack of person-centred treatment 
(holistic) 
Experience of obstacles/being pro-
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active 
Self-referral 
Proactive strategy 
Asked for help dealing with situation 
Again can't refer her  
They are treating me (must be experts) 
Yet can't refer med to specialised 
colleagues 
Obstacles again 
Good GP  
Thank goodness - gratitude is afforded 
the GP 
Not part of medical profession 
I have to fight all the time  
Wash their hands 
It's not fair 
Only biomedical goals (my own 
thyroid experience) 
What I would like 
More awareness from medical 
profession is necessary  
Group meeting 
Social support from group  
Meeting others like myself  
(Why this helps... Comparison not with 
others but with people who 
understand) 
Alternative treatments to weigh up 
pros and cons 
Things being made easier on a 
practical level 
Comparison to cancer (even doing that 
in own homes, this is just an injection) 
Little things would help (massage for 
arthritis, hydrotherapy) 
Can't afford it now as on benefits  
Little treatments aside from purely 
biomedical intervention  
Obstacles all around/lack of freedom 
Holiday made possible  
I can't go anywhere  
Chained to my treatment  
Lack of freedom 
Prison  
I would like it to be recognised/
comparisons with other conditions 
Included in centres  
Possibilities (yoga, massage, 
aromatherapy) afforded others should 
be afforded to psa sufferers  
Pamper days  
Comparison with other conditions  
It's a serous illness - not recognised 
Now I have found help, it's ironic that I 
can't get here 
Only alternative is to get a taxi because 
of crippling social anxiety  
Traumatic 
Psoriasis experience 
Social outcast  
People treat you like a leper 
Stare at you 
Social interaction in shops dreadful 
(slam down change) 
Takes all confidence to go out - then 
devastating  
Staring/comments  
You become a public thing, because 
violating social norms  
Hypersensitivity to rejection  
Slam down change/ threw receipts at 
you  
Intrusion  
People don't believe you 
Don't be silly - that didn't happen 
Validated when saw with his own eyes 
(seems like it's never enough when it's 
just me saying it) 
Negative expectation from others 
Staring and judging when using a stick  
Interpretation: limp (not legitimate vs. 
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others) 
I've made somebody aware - it's a 
relief  
GP is person she goes to 
Normalises it - just a bit of a downer 
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Appendix O 
Clustering of Themes Across Transcripts 
Cluster I: The miracle of Biologics: informed by 
a strong then/now and before/after dichotomy.
Past history crucial (backdrop to 
biologics)
Sneaky creature that evades 
diagnosis (no treatment,
disease allowed to progress, 
deterioration)
Unpredictable, symptoms wax and 
wane
Keeps you on your toes/ tricky 
creature: when do too much, body 
would punish you
Unpredictability of disease
No telling what’s next
Extraordinary (evil) combination 
(monster)
Two very different diseases 
Such different conditions
Monster
Disease threatening to engulf you 
Instead of giving in to it (monster), 
alien presence, threatening to 
engulf you
In the beginning I'd fight it
Super-Ordinate Themes Sub-themes
The miracle of biologics Turning back time/second chance/new 
lease of life 
I can be normal/freedom from shame/
restrictions of disease 
Euphoria/intense appreciation of things 
most people take for granted
Living with uncertainty The role of information as agency of 
choice 
The role social support 
Making sense of it/present-moment 
focus
Being seen/treated as aperson Seeing the person vs. being treated as a 
disease 
Everybody needs something different/
variation
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Difficult to pace myself 
Losing the fight (self as weaker)
Losing battle against it all
Avoidance becomes a way of 
dealing with it
Defeat
It's just easy
Mysterious/gradual onset of 
PsA 
Body/disease wins
Progression of disease
Monster eats your time as well, 
turns you into a recluse/social 
pariah and takes away your skills, 
mobility
Battle/fight/defeat
I tried it fight it, but was defeated 
(monster/battle - gradually wears 
you down)
Battle image of disease
It never defeated me
Enemy 
Battle
Defeat: Feared future scenario 
(experience/images)
ii) Lack of awareness of link 
between psoriasis and joint pain
Not being believed/ dismissal
"Live one day in my shoes and then 
tell me I haven't got the pain" 
Not aware of link between skin and 
joint pains 
Didn't mention to dermatologist 
iii) Emotional impact of not being 
believed is extreme 
Effect on self: Doubting oneself/
am I the problem?
You seek an explanation for pain. 
Driven towards seeking to 
understand what is causing this. 
Turns toward oneself if no one can 
offer explanation. Pathologising of 
people when disease has no name.
Alone/no support
Frustration (stress)
Physical impact: exacerbated 
psoriasis (95% covered)
Nearly cry because of pain (yet not 
believed)
Limp when it hurt, but soldier on
iv) Evaluation/Remembering 
what life was like before 
biologics 
Still vivid (l. 739)
Overwhelmed with emotion looking 
back
Cried for a few years after in front 
of doctors
Couldn't cope – too much/cruelty of 
disease
Being on the other side/coming 
out into the light again
Hell: I don't ever want to go back 
there
A place he has now left
‘Beyond’ discourse
Making it through defies 
comprehension 
Multiple hospital admissions 
Don't know how I coped (l.257)
Unbearable/beyond words
Sighs, don't know how got through 
it, terrible, terrible time 
Looking back 
You forget how you were
You want to forget 
Don't want to remember
You forget how bad you were
Before PUVA was most miserable 
time
Fighting a losing battle
Battle/fight/defeat
I tried it fight it, but was defeated 
(monster/battle - gradually wears 
you down)
Couldn't cope
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v) Impact of the double whammy 
of PsA (Pain, reduced mobility 
and social exclusion)
Effect of disease
Reduced stamina
Restriction/freedom
Psoriasis experience of stigma
Specific experience: Friend let him 
know it wasn't acceptable for him to 
enter a busy pub at lunchtime (saw 
himself through eyes of others) 
Become public property because 
you violate social norms
Become an object
Being pointed at (look!)
Violate social norms 
(Unacceptable, people get out of 
your way,
Leper, gypsy example: screamed 
on train when saw him (by social 
outkast)On train: no where to go
Skin
Holiday marred by self-
consciousness 
Avoidance of exposure
Leisure limited
Physical aberrations (pockmarked, 
welts)
The other's response
Ignorance brings fear
Comparison with leprosy
Fear of contagion
Outkast: On the fringes
Staring, judging by others
Social pariah/ Outkast
Fear of contagion
Strangers ask if they can catch it
Emotional/psychological impact 
(skin)
In a terrible place (in a place with 
no light)
Dark place with no love 
Love/hate discourse
Miserable existence
Psychological impact: 
depression, Self-pity
Self-mutilation (itchiness) what 
is the PD understanding of 
itchiness
Despair leading to 
Tear myself apart (lion)
Viciousness 
Draw blood
Extensive pain 
Itchy, broken skin
Skin pain, it's everywhere (not 
localised)
Eruption image (angry)
Skin cracks
Eruption (volcano, force cannot be 
kept back)
Welts
Self-image challenged (skin)
Impossible to maintain image of 
yourself as well-groomed 
Dandruff 
Unwelcome attention
Embarrassment
Shame and embarrassment
Feeling unacceptable
Can't show body
Felt dirty
Shedding
Constant self-awareness
No escape
No respite
Self-consciousness
Can’t relax
Can’t enjoy yourself on holiday
It’s with you all the time
Constant checking if shed skin
I wouldn't want to sit in that chair
Leaving a trail
Hyperawareness
Psychologically on the back-foot all 
the time
PSORIATIC ARTHRITIS AND BIOLOGICAL TREATMENT !184
Psychological place 
Close to suicide, hate, isolation
Hated people, isolation 
(Withdrawal: didn't want to see/talk 
to people)
Bad feeling in yourself
Mentally hard to deal with
Became very self-conscious, 
shame 
Social outcast 
People treat you like a leper
Stare at you
Social interaction in shops dreadful 
(slam down change)
Takes all confidence to go out - 
then devastating 
Staring/comments 
You become a public thing, 
because violating social norms 
Hypersensitivity to rejection 
Slam down change/ threw receipts 
at you 
Intrusion 
Outkast
Meaning of shedding of skin
Socially unacceptable
Stigma
I am frowned upon/break rules
Psychological  impact of 
psoriasis (you change)
(The psoriasis experience/ 
psychological effects of psoriasis 
on self-image)
Destruction of self-image
I’m a deformation
I am ugly
I am unattractive
Disgust
Feeling dirty
You’re not looking after yourself
Dichotomy: now: love / before hate, 
isolation, shut down, constant 
anger, suicidal 
Physiological situation 
Pain unbearable 
Beyond measure (20 on a scale 
from 1-10)
No sleep
Constant pain
Concomitant health-problems
Blood pressure up
Depression (refusal of anti-
depressants)
Impact on life: Arthritis/joints
No life
Able to do less and less
Reduced to basic functioning
Reduced to an illness: just going to 
hospital 
Overwhelming pain
Sapped of strength
Getting weaker
Pain
More frozen (visner/stivner)
Effect: Vicious cycle of 
avoidance and further 
deterioration
Double-whammy of psoriatic 
arthritis
Nothing worked
Emotional impact: burst into tears 
in from of consultants
What is the point?
Life with PsA 
Life changes 
Little things like taking the bus 
become subject to careful planning
Painful to walk
Constant pain
Describing pain is difficult
Pain leads to breakdown of 
function and mobility
Your body is not working anymore/
properly
Methotrexate treatment
Toxicity of previous treatments 
(methotrexate)
Top ends in terms of safety
Higher doses, but not improving
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You’re in hospital all the time
Before biologics 
My life would have been dreadful 
without biologics
Misery
Disruption
Treatment or disease takes over 
your life
Inability to work
Impossible to maintain work
Intrusiveness
Time-consuming
Just maintenance, not cure, makes 
it impossible to work
Minor ailment with major impact
PsA
Evil combination of opposites
Two such different manifestations 
of same disease
Loss of skills
Simple things made difficult
Normal things difficult
Can't join in with other people
Some days I can't do the simplest 
things
Couldn't do anything (wash my 
hands)
Household chores/walking symbol
Able to do less and less
Degeneration (slow death)
Impact of treatment/illness 
Impact on work life
Had to give up work
Hospital appointments alone were 
too much
Impact of disease
Ability to do housework symbol of 
disease progression
It takes all my energy
Loss of skills/stamina
I'm behind with everything
I'm ashamed (house a mess)
Can't keep up
Some days it takes all my effort to 
cook a meal, drink
Exhaustion
Fatigue
Takes over
Judging with eyes of other/
defies normality
Sounds stupid
Just an hour at hospital
Attack on self
Loss of basic self-care skills/
abilities
No sleep
Sucks you dry
Pain 
Emotional impact
Wanted to die
Feeling sorry for myself
My body is turning on itself/
breaking down
Comparison to leprosy
Comparison to cancer
Skin cells gone wild
What’s wrong with my body?
Body is betraying me
Later life stage
Feeling old before time
Vulnerability
I’m too young for my body to be 
breaking down
My body body breaking down is 
supposed to happen later
Degeneration
It’a all going to go downhill from 
now
Beginning of the end
Degeneration/slow death
Psoriasis experience (skin)
Leave a trail
Snow inside
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Baths and moisturizer
Impact of psoriasis: Social 
embarrassment when sheddig
Self-consciousness when trying on 
clothes 
Have to sit in bath for an hour
Baths 3-4 times per day
Psoriasis experience
Embarrassed about visible 
manifestations on face
Intrusive comments and questions
Fear of contagion
Ignorance
Lack of awareness from others
Stupid questions
Outsider/stigma
What pushes over edge
Itchiness is the final strawItchiness 
was unbearable
Can’t cope with itchiness
Itchiness is constant 24/7
Relief: bath
Relentless reminder
You can never forget about the 
itchiness
Relentless itching
Constant intrusion
Self-mutilation
Scratch until you draw blood
Psychological impact 
PsA experience: triple whammy
I ate when I couldn’t do anything/
boredom
Joints were the worst
Immense impact: Reduced to not 
being able to do anything (bath, 
peel…open a tin, can’t lift, carry, 
walk up stairs, couldn’t go to toilet, 
wipe myself)
Helplessness and pain and 
itchiness
Triple-whammy unbearable
Couldn't walk
Household cleaning symbol of 
disease progression (like AH)
Seems like there is a symbol/
comparison of regression for 
everyone 
Arthritis impact: couldn't move
Restricted mobility: Nothing, neck, 
jaw, teeth.
I really wasn't good
Couldn’t get out of the bath
PsA experience
Unable to fulfill household chores
“How can I go to the doctor when 
I’ve got nothing to tell him”?
Don’t understand what’s happening
Invisible
One day I couldn't move
Escalation: I didn't react, and it 
spread through my entire body
Sudden onset: paralysis
Couldn't do anything – not move sit 
or get up
Early signs, but didn’t know what it 
was
Feeling very tired all winter, joints 
swollen and tender
Pain for 2 days from holding on to 
window
Misattribution: I am lazy
No reason for tiredness
Couldn’t do anything (change a 
nappy)
PsA experience (psoriasis on the 
inside and outside)
Emotional impact
Fright
Beginning of the end/
Degeneration PsA
Beginning of the end
Allergic reaction?
Emotional impact of illness 
(varied)
It stopped my life.
Frozen
Crying all the time
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Defeat
Never going to get better
Humour as coping
Later life-stage (degeneration)
Image
80-year old ladies with sticks were 
faster than me
This is me now
Loss 
Big business had to close
Loss of job (source of validation 
and pride) 
Source of self-esteem
Irreversible joint damage 
Altered life-course
No longer fit/ability to work (medical 
evaluation)
Incapacitated/loss of job/source of 
validation 
Have to accommodate losses 
associated with disease 
Reinvention necessary: What do I 
do now?
Re-invent his career to something 
sedentary 
Overall/combined impact
Couldn't smile
Couldn't sleep
Always sad 
I was in prison (own home)
Reduced to basic functioning: work, 
sleep, eat, sleep
No leisure
No enjoyment
No seeing people
Life-stage matters
Late teenage years difficult
Detrimental impact on social life 
(no girlfriend for 10 years)
Coped by avoidance
Avoidance becomes coping 
mechanism (Cover up, avoidance 
of exposure, social events, shy 
away from exposure)
Did not utilise social support 
(isolation/withdrawal)
I didn't want to explain/discuss 
situation
Kept to myself
Only partly effective
No hiding as skin would still shed
Visible in leaving a trail
You're snowing
Comments 
Outside looking in: I used to be 
jealous of friends having a picnic/
my wife's skin
(Limp more acceptable)
Power of knowledge/ awareness/
information counters fear
Pub incident: defended by stranger 
Awareness changes behaviour 
Was ok with it himself because had 
grown up with friend who had it
I never took a second look
Have to talk back to yourself and 
instincts to hide (self-talk)
Why hide? 
Build-up courage not to hide
It's not going to get better by hiding 
v) Experience of previous 
treatments: Abuse of body 
Bruised and battered, time-
consuming, no time for anything 
else
Losing hope/nothing works
You're the last one here/doesn’t 
work
I was steadily going down-hill
Everything was deteriorating 
Filling my body with toxins 
(medication overload)
Medication overload/fatigue but 
PSORIATIC ARTHRITIS AND BIOLOGICAL TREATMENT !188
nothing really helps
Excessive cream use
Desperation led to bad stress (BP 
200)
(Also lost his business)
Serious side-effects of prior 
treatment (back-drop of 
biologics)
Chinese herbs treatment led to liver 
failure, covered in white spots
Swollen, couldn't breathe, skin 
burnt, like being in a fire, excessive 
steroid use
Experience of previous 
treatments
Sick on pills before PUVA (loathe 
vomiting)
 
Desperate search for cure/help 
(alternative/private): Chinese, 
homeopathy, private, NHS  
Treatment is time-consuming 
(the beast requires constant 
monitoring, tending to)
Moisturising 2-4 times per day
Maintenance requires you to stay 
at home
Treatment is taxing compared 
with relative ease of injection
Intrusiveness of treatments
Tedious and time-consuming vs. 
injections easy (compared to 
tedious previous treatments)
Quick and painless effect
Distinct difference
Self-care and discipline
Dread
Hospital appointments become a 
source of dread (helplessness, 
impersonal care)
Impact; Short-tempered
I was steadily going down-hill
Everything was deteriorating 
The impact of pain: 
helplessness/something 
particular nasty about this kind 
of helplessness that may lead to 
depression
Disturbance of normal processes: 
sleep, getting out of bed, waking 
up, getting dressed marred by pain
Coping 
You just have to manage
I didn’t have a choice
The kids needed me
Responsibilities of home 
Doesn’t help to stay in bed
Didn't have time to look in the 
mirror
II) Miracle of biologics (skin)
Defies belief (magic trick)/
vanishing act/ disappearance/ Soft 
skin - not used to it/Vanished after 
a few weeks/ Just a few spots now 
but calls it "nothing, gone"/ My skin 
is clear
Superlatives Amazing, Fantastic, 
Superb, Helped me a lot
Psychological/physical reaction: 
Euphoria, elation
massive orgasm, goosebumps, 
physical reaction, still vivid, so 
happy, Singing in shower (l.25) 
Skin clearing up was happiness
What is the meaning of singing in 
the shower? Archetypical image of 
happiness, joy in life, looking 
forward to what the day brings. 
Biologics amazing (Before/after 
dichotomy)
Ineffective to helpful to 
unbelievableI felt like a different 
person
I felt like a different person 
immediately
Immobility to mobility
Rigid softened
Frozen to flexible
New lease of life
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Better now than ever
Biologics is worth every penny
I was miserable then/lucky
Emotional gains
I'm a nicer person
Easier to live with
Benefits of biologics
Happy with biologics 
I was worse when I didn't have it
Helped me walk a bit further
In a way biologics keep me going
Biologics help me walk a bit further 
Biologic amazing
Biologics freed up time
Biologics were amazing
Easy
Ever so good, really good
I only had to inject myself and not 
take tablets all the time
Amazing biologics l. 905.
“They were like, the best thing”  (l. 
1912)
Attribution: Biologics healthier than 
tablets
Biologics compared to life on 
other treatments
Biologics were less time-
consuming
Sense of normality
Freed up time: could get up, not 
have to sit in bath for an hour
3-4 times per day
Impact of biologics
I felt normal
I could do normal things like 
everyone else
Normal routine
I felt like everyone else
Freed up mental space
I didn't have to think about it all the 
time
Paved way to normality  – freed up 
time get up, not have to sit in bath 
for an hour
Baths 3-4 times per day
Biologics made me normal as 
opposed to before
I didn’t feel normal before, do you 
know what I mean?
Iron health: Didn't even have a cold
The success of biologics
Remission/cleared up/no mobility 
issues
Going back in time/turning back the 
clock
Progression of disease halted 
Renewal
Reversal/going back in time
Life-changing, altered life course 
Back till when I was 18
Skin like a baby
Given a second chance/reversal 
of fortune
Regaining skills/ability to do things 
again:
Able to shower without pain
Go to gym
Note: mundane tasks that many 
people take for granted become a 
source of happiness
All-encompassing (positive) 
effect (like its counterpart 
negative effect)
Affected all aspects positively
Cumulative positive effect 
 
New life (Re-entry into life)
Freedom from self-consciousness
Go on holiday like my friends
Opened the door
Started life again (see people, went 
out, gym)
Freedom from shame/social 
things 
I could do things without feeling 
self-conscious 
Sit in shorts/ Stopped covering up 
(wore shorts & t-shirt)
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Freedom (go away, be 
spontaneous
Going to public places
Emotional health after biologics
I can love again 
Enjoy life now (embracing life 
with a fervor)
Wants to look forward
Doesn't want to get stuck in 
negativity
Normal No longer the odd one out
Things can’t do 
Still can't go back to playing football
Still pain
Pain reduced but still there (9/10 to 
7/10)
Cumulative (positive) effect 
Made me able to bear pain of joints 
because happy with appearance 
Positive cycle: cumulative effect 
of both positive and negative 
More stamina, more flexibility, 
doing more, enjoying more (as 
opposed to negative cycle)
Time is a great healer (life-events) 
vs. leading to deterioration 
injections easy (compared to 
tedious previous treatments)
Quick and painless effect
Distinct difference
End/beginning of new? Biologics 
is the demarcation point.
It's over
It's behind me
Too busy to think about it
Self-managed until got fed up
Previous disgusting tar-treatments
Bothered me when on hands and 
face
Couldn’t cope with itchiness
The impact of itchiness: no sleep
Time-consuming self-care
I don’t have time to sit in the bath 
all day
Time-consuming aspect of 
treatment
I was in hospital all the time
Close monitoring
Treatment was very time-
consuming
Time/intrusiveness
Hated the one in which I needed an 
injection every day
Biologics are judged for the 
intrusive effects they have
The less time is involved the better 
(hated the daily one)
Prior treatments-time
Busy running to hospital all the time
Treatment prior to biologics 
consumes your life
Invades your life
Side-effects/taking medication 
Went against the way I was raised 
to take medication
I don’t want to know about the side 
effects of tablets 
(methotrexate)because the I won’t 
take them
II. Cluster: Living with uncertainty 
It’s a firewall, not a cure/
temporary aspect 
Temporal aspect: Cyclical 
relentless regime/ one is before/
after another is endless/cyclical. 
But endless cycle, no cure 
Never-ending (get tired of it all)
Get over it and then time again
So it's treatment needs to be 
recovered from
Relentless cycle
Need a breather
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Just a day to myself, when I don't 
feel badLuxury of time on this 
particular biologics treatment 
(methotrexate)
Eats you up/time 
Temporary  barrier
It has to continue forever
There is no cure
There is no end
Not knowing why it works/the 
uncertainty/all that is unknown
No one knows why it works
Suspended in time/Limbo/neither 
here nor there
Stronger and stronger stuff
Worry about side-effects /What 
is going to happen? 
Uncertainty about what would 
happen
Comparison with HIV
Suppression of immune-system
Leaving yourself open to 
infection
Leaving yourself open
Exposure
Vulnerability
Importing info from other diseases 
So much is unknown
Nobody really knows
Lack of knowledge and 
understanding
Why does it work?
Accidental discovery
There is a lot we don’t know
We still don’t know why it's effective
Using something that has an effect 
but don't know why
Is anyone any wiser than  20 years 
ago?
Psoriasis is underresearched 
medically
Medicine is a broad brush stroke 
where you just hope you get 
something right.
Some things we can know, but a lot 
of it is just down to luck and chance
Worry about impact of treatment 
(experiment)
I need stronger and stronger stuff
I am an experiment
Leap of faith
Uncertainty
Gamble/experiment
Giving yourself up to 
experimentation
Psoriasis is under researched 
medically
Feeling safe
Role of social support from 
medics or others important 
Self-referred (best decision ever 
made apart from marrying my wife)
They care about me (perception 
of care)
Out of this world, superb, makes 
me feel so much better, proactive 
treatment, fill out forms to monitor, 
it's all for me
Being treated as a person not 
just a patient (l.594)
Effects of being seen
Positive spin on everything 
Gives me strength to fight it
Feeling better in yourself can only 
help whatever condition you've got
Normalisation: not worried about 
side-effects (every med has side-
effects) 
Positive about future
It's just going to get better and 
better
Came out stronger (can deal with 
anything life throws at me)
Feeling unsafe/ Side-effects/
vulnerability/poison
Worry about side-effects, poison in 
my body
fear, I'm putting  highly toxic 
material that people won't touch in 
my mouth
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Note: All share past history of bad 
side-effects, but the others are able 
to not let this impinge on biologics, 
why? 
History of side-effects previously, 
scary reactions (anaphylactic 
shock/vomiting) and mouth blister
No support/lack of regard/
Exposure 
Lack of regard/care reflected in 
surroundings
No privacy
Put on display
Pull-around curtain
Shoved down in corner
3 upright, uncomfortable chairs
Violation in public
Not worthy of a room
Exposure in front of others
On show
Emotional impact 
Embarrassed
Arrogance and misinformation 
You are misinformed about your 
own condition 
Lack of awareness even among 
medical profession
We know better 
Tremendous impact of not being 
believed
What you're saying/experiencing 
doesn't exist
Ridiculed by medical profession
Beyond words
It’s temporary / habituation 
My body constantly needs stronger 
stuff
Reduced effectiveness
Body is used to it
Always being at the hospital is 
normal to everyone else, not for AH
Everyone else is used to it
Lack of support and understanding 
from people 
Positive experience of medical 
profession 
Evidence of personal care
Hug and kiss when see each other
She knows me very well
Testimony of relationship
Cried in front of them
Sole confidantes through years of 
suffering (wasn't talking to anyone 
else
Doctors are generally good guys/
allies
Uncertainty about future
What's going to happen
Worry about future side-effects
Prior experience of treatment 
promoted as safe
Fearful of future implications of 
treatment 
Experiment 
Current health problems because 
of biologics?
What's it doing to my body?
Accepting what’s against one’s 
ethos: Medication overload not 
the real me (so ambiguity)
The real me - I wouldn’t even touch 
a panadol
I went from nothing to loads/ filling 
my body with everything 
Petrified of side-effects/how 
cope (experiment)
Chose not to read
Fear would prevent her from taking
Chose not to know
Reading about it doesn’t make you 
wiser
Safeguard themselves
If you read it, you’d never take 
anything
Information overload
Coping strategy: read after when 
it’s started to work to 
counterbalance fear
Relationship to medical care 
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team 
Enemy/ Not on my side/ In bed 
with enemy
 
Experiment nightmare (callous/
cold-hearted medical profession)
Only people advising you are the 
people pushing the drug
Interesting use of word : push vs. 
grant
Let's see what happens 
Hidden agenda 
Ulterior motives
Keep a lot from me
No explanation 
At least tell me
Swept under the carpet
Information withheld
Only when you've been on it for a 
while
Oh yes, that can happen
Only admit when absolutely 
necessary
The less initiated are more honest 
(student doctor)
Lack of trust 
Don't trust them
Lack of trust
Profound lack of trust
Lack of trust leads to information 
search on internet 
Contradicted by personalised 
strategy (nurse)
Psychological impact of not 
being acknowledged
I have to fight all the time 
Fear
Not honest 
No independent advice
Can't get an honest answer
Not honest with me
Keep information from me
Not honest with me
Lack of info
Nobody tells me anything
Don’t care about me 
They don't care 
There to get a job done
Don't want to know
Medical profession don't care/
understand
Compared to "service" in shop 
(superficial)
Insensitivity of medical (poster) 
facts
I'm just a number 
I am not seen/heard/dismissal
No understanding from medical 
profession
No one cares or wants to know
When she tells them how she's 
feeling, it doesn't lead to anything
I know, but they say I don't 
They don’t listen 
Should listen but don't 
Not being listened to (talking to 
blind/deaf ears)
I am an inconvenience
Lack of trust leads to internet for 
information
The role of the Internet
Lack of validation leads to internet 
as source of validation
Negative cycle established
Turn to internet for information 
Makes it worse
Don't know what is true
Impact of unsolicited internet 
information 
Nasty cycle
Cumulative effect in both 
positive and negative direction 
Vicious cycle of mistrust (internet) 
Ownership
It's not their body it's mine
I have a right to know
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Reclaiming what's mine
It's my body 
Euthanasia analogy really
Information 
I want to know in order to weigh up 
pros and cons
I want options
Information and options
Self-efficacy
The role of information (linked to 
self-efficacy, taking charge when 
feels unsafe)
Pro-active information-search 
(internet)
Done my own research
Internet is the Wild West (not 
reliable source)
Can draw you in
The role of social support 
(medical staff here subsume)
Comfort of knowing there are 
others who are going through and 
coping with it
More information
Misattributions of others
Troubles attributed to age
People can't see and expect me to 
carry on as normal
People think I'm lazy
Normalisation "it's just your age"
Make light of
It's only one hour at the hospital
Not being believed/Not being 
heard/seen
You're wrong 
This is not a side-effect
Top-down communication
That didn't believe me (doctors/
nurses)
Pathologised
Objectified
Non-personal care
It took the two years before they 
believed me
Sudden change - believe me with 
no logic to it
Perception of care
I detest my treatment
Negative emotion: angry,upset 
tearful
Helplessness
Perception of care
Hospital is amazing (perception of 
care)
Everyone has been really nice
They really care. I can’t get over it.
Building of relationship
I see the same people all the time
They are so nice all of them, like 
really, really nice
I hate toxicity 
Rather spend a month in hospital 
than having all this rubbish put into 
me
I don't want it
Emotional impact of treatment/
reaction 
Panic symptoms
I dread hospital
Fear
Growing resentment of medical 
profession
Been told later it's got a nasty side-
effect
Wool pulled over my eyes
Lied to
Medical profession are dishonest 
and lie to you
It's not fair to be kept in the dark
Withhold information 
Perception of treatment
Harm/poison
Incapacitated as result of 
methotrexate
Wham: like getting punched
 
Pattern to week
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Relentless
Information and choice (be 
treated like a person)
Information leads to choice
What I want
Sensitivity to context
Information and support
Validation
Understanding
The role of doctors is surely to be 
on top of this?
Never-ending 
Relentless 
Stop working after 3 months
Improvement followed by relapse
Every week for 5 years
Time-consuming
Eats your time
Never a day to myself
Taken over life
All-engulfing
Infringement on life/Chained to 
hospital
No freedom/flexibility
Dependency on biologics/
chained to treatment 
I can cope with being bad for a few 
weeks because I know it's going to 
go away soon
No leisure 
Tried to be pro-active 
Go on holiday
Ticking bomb 
Too dangerous for local GP to 
administer
Won't take responsibility
Obstacles put in my way
No flexibility 
Uncertainty: Seeking 
explanation/knowledge/wanting 
to understand 
Where does my PsA come from?
Low down on genetic research
Low priority
Why does it happen?
Link to processing of stressful 
events?
Result of mental inability to 
process?
What is the connection of body and 
mind?
Can you make yourself ill because 
of stress?
Why is it irreversible? Stress goes 
down
Perception of care/medical 
treatment 
NHS is wonderful
Self-referred (best decision ever 
made apart from marrying my wife)
Out of this world
Superb
Makes me feel so much better
Amazing treatment here
Been on other side
Coping must be here: focusing 
on now I think, either spirals AH 
into future-thinking, feeling more 
unsafe, out of control or the now.
Choice of coping strategy
Humans characterised by ability to 
adapt
Choice: You either overcome or 
overcompensate
You manage
Coping
No choice but to get on – I had 
children
Coping
Many people have it: Normalisation 
(as opposed to AH: am I the only 
person in the world?)
Everybody’s got something
People always want more/
something else
People aren’t happy with what 
they’ve got
People want to make their breasts 
bigger or change their noses
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She happened to find out that what 
life gave her was good, but you 
don't always get the opportunity to 
find out
Social support/ Neglected status 
of PsA
Not being understood (can be 
subsumed under social support?)
Legitimate disability
Pain is invisible
People don't understand
It's not legitimate walking with a 
stick at my age
No excuse not to work 
I'm not lazy
I'm not a scrounger
Not recognised or understood
People don't understand what it 
takes
Exhaustion
Support
Gift of (good) counselling
Sympathy is overrated
Meaning of sympathy (when 
nothing can be done)?
Classic doctor’s manner: Sympathy 
and acceptance (written off? Now 
deal with it)
I'm alone/no support
Nothing was/is offered/available 
(psychoderma report - 
unacceptably scarce)
Sympathy (?) but no advice
No help
Going to go away and deal with it 
on my own again
I have to fight all the time 
Wash their hands
It's not fair
Shocks but no follow-up to support
I'm left to deal with it on my own
Social support 
Lack of interest/support
Everyone else is used to it, but not 
me
Impact on self: Isolation. 
Am I the only person in the world?
Isolation
Frustration
Secret club
Psoriasis is initiation marks/
membership to club in Dead Sea
Social support: meeting others like 
yourself
Information sharing
Coping with uncertainty (current 
life-perspective)
Present-moment focus 
Don't want to think about past or 
future
I think about now (l.798)
What tomorrow brings no one 
knows
Pointlessness of worry
No one knows anything anyway 
No guarantees in life (even for the 
well) TV-analogy
I'll cross that bridge when I come to 
it 
Futility of worrying about future and 
trying to safe-proof yourself 
Ruins the moment, which is all 
there is
Philosophy in life
Living in the moment
People spend too much time 
worrying 
/planning for future  (like AK's 
mortgage example)
You are not in control
Illness brings about a perspective 
that you are not in control?
Perspective brought about with age
One day at the time
NB! Interesting that can draw 
parallels between disease and 
being at war which supports battle 
image and that disease becomes 
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an existential thing/dilemma, which 
forces you to think about life. 
Life-lesson in troubled place
Learning from life
We forget we are not in control
Israel/England 
Attempts to minimise impact 
(others or self?)
Pull yourself together 
Dismissal of impact 
Man up
Worse things could happen (which 
you know on a rational level)
Different coping mechanisms for 
different times
Denial
Rebellion
Self-care and discipline
Note: What is coping: it’s deciding 
on a strategy in a difficult/
challenging situation. 
Fine line: Managing 
uncertainty (both in regard to 
progression of disease and effects 
of treatment). 
Uncertainty/what to expect
The role of information 
I am an experiment
Withhold information 
Let's see what happens 
Wool over my eyes
Not being honest with me
Drugs : Gamble/experiment 
More information sharing
The whys of treatment 
Leap of faith
What's going to happen 
The role of information
No warning that psoriasis might 
lead to arthritis
Balance between information/
causing worry
Fine line
You don't want to start a fire
Note enough information
Familiarity with disease
Informed of treatment possibilities
Proactive information sharing/
support
The importance of an empathic and 
proactive approach
It has to be handled sensitively 
because you don’t want to start a 
fire
Proactive information sharing
Information and choice 
Information is important for choice
It's my body
Ownership
Empowerment 
Information as road to 
empowerment via choice - regain 
sense of control in an 
uncontrollable situation
Scared to hope
Not too high hopes/ Scared to 
expect/hope
Note: Times have changed. An 
abundance of information is now 
available at the click of fingertip/no 
longer the privilege of the 
physician. Lack of trust and 
uncertainty leads to internet with 
more uncertainty to follow. Trust is 
paramount that got your best 
interests at heart. 
How I coped
Withdrawal (I always kept it to 
myself) and burden discourse 
Not impinge on surroundings 
(implication being that don't won't 
be a burden) with build-up of 
pressure (links back to volcanic 
eruption)
Role of faith
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Everything that happens is for your 
good
Trust in life
Analogy of parent giving injection to 
child for their benefit (God) but the 
child doesn’t understand
What happens is good keeps us 
going
Everything is from God
There is a plan, sometimes we 
don't understand it but you have to 
trust in life and God
God doesn’t send you anything you 
can’t cope with
There are no coincidences, 
everything is pre-ordained, meant 
to happen
I would say I would have had to 
have had it (PsA) and the good lord 
has made it as easy as possible
You can’t demand from God
You make sense of it but also must 
believe the things you can’t make 
sense of are good
Sometimes you see/understand 
and sometimes you don’t
I'm not alone/coping
Everyone has got something to 
battle (comparison with other 
diseases IBS, migraine)
So many people in the world are ill
Rebellion: Reclaiming choice 
Stay away 
Coping by pretending has the 
choice not to go
Goes last minute
Fear/avoidance problem solving 
Had enough/refused my injections 
The illusion of choice
Reclaiming choice she knows she 
doesn't have
Chained to treatment – results in 
lack of freedom: go in circles 
forever: Obstacles all around/
lack of freedom
Holiday made possible 
I can't go anywhere 
Chained to my treatment 
Lack of freedom
Prison 
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III. Cluster: Being seen as a person and not just 
a disease (does not work in LT conditions)
Seeing the person in the disease
Not being seen/a bunch of cells
Never looked me in the eyes
Paperwork and skin
Might as well been looking at a 
Petri dish
Impact of not being seen
Emotional impact 
Exhaustion/stressed/tears
Fed up
No understanding 
Overwhelming joy of diagnosis 
Happiness 
Brilliant/Fantastic )
Self-belief restored (To be 
validated/ Vindication/Wasn't 
deluded after all) Shift of locus of 
problem from inside persons to 
disease 
Explanation/ It's got a name! 
Knowing what you are dealing 
with
Note: Weight off my 
shoulders (what does this mean?) 
Not alone anymore, burden/
suspicion on him lifted. Wandering 
through desert for 20 years!
Self-efficacy and agency (note: 
role of PMP is that it counters 
helplessness)
Activates the self 
(Meditation)
I can cope through the 
subconscious 
I can cope now 
Finding my way
Personal coping strategies: 
Downward social comparison
Evaluation (I’m lucky to have 
treatment available compared to 
granddad)
Comparison with others and 
other diseases 
There's always someone worse - 
coping mantra
Young cousins died of cancer
Thinking there's always someone 
worse than you might get you up in 
the morning (inspiration looking at 
others in similar situations Look, 
they get up) 
Note: Is feeling fortunate healing? 
Is it feeling lucky or not being alone 
in suffering or inspiration?
Being treated as a person not 
just a patient 
Spill over effect of being seen
Person subsumed under system
Separate treatment/Disconnect in 
patient care
Opposing ideas of treatment
Ridiculous loop
They didn’t speak to each other
Result was frustration and negative 
emotion  
Patient caught in the middle
Negative experience (this person 
is interesting as has tried both)
Like Alice Jack experiences doctors 
not sympathetic
Physical status under prior 
treatments (methotrexate)
Condition continually worsening/ 
progression of disease/nothing 
worked
Incapacitated: walk with a stick
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Side-effects of methotrexate: Body 
begins to alter/warning signs/
Rebellion/Fed up (like AH 
stopped medication)
Prior negative experience of care
Disregard
Discounting impact of pain
Not being seen or heard
De-sensitisation to pain impact
Worn out by pain/depleted
Asking for help but being dismissed
Only way to manage pain was 
through painkillers
There was nothing else
Shift in perspective 
Not bothered about little things
Gratitude towards NHS/department
Cumulative positive effect (want to 
give back)
More tolerant
Don't let little things wind me up
Scale/perspective shifted 
Just a few patches
Note: when been 'out there' scale 
has shifted. A new normal has been 
created
Development of new perspective 
Current situation/Benefit/focus on 
positive 
Still in pain but it's ok (p.25) (like 
Hanif’s sleep example)
Not getting worse/in pain, but still 
get about
Still quite impaired, but relative 
compared to his experience
Can't put socks/t-shirt on/walk 
around supermarket
Scale/perspective shifted/ Been 
to hell and back (backdrop of 
everything he is experiencing now) 
Note: when been 'out there' scale 
has shifted. A new normal has been 
created
Evaluation: I’m lucky (just a few 
patches)
I'm lucky
I'm lucky to be born now
Life stage (autumn) time to reap 
benefits
Can't do that if haven't got health
Importance of health
Coping and self-efficacy: I can 
deal with it now
Acceptance of condition 
New confidence
I can deal with anything life throws 
at me 
Self-belief in abilities 
Learning new ways of being/
living/coping (counterintuitive): 
Finding a way that works (I have 
a plan, walking can reduce your 
pain, socialising helps, medication 
can't help, painkillers can't help)
Effects of being seen
Positive spin on everything 
Gives me strength to fight it
Feeling better in yourself can only 
help whatever condition you've got
Personal 
Proactive treatment, fill out forms to 
monitor, it's all for me
Biologics is reassuring (something 
battling elements together)
Objectification: you become your 
disease
Nodding, stripping, looked at
Being studied
You feel like the elephant man
Medical voyeurism
Being prodded and poked
The amount of blood taken out of 
me
Invasion
Interrelatedness of physical and 
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psychological 
One affects the other (headache 
makes you want to retreat)
False dichotomy 
Not either/or 
Both have their limitations 
(psychology and medicine)
Psychology can't help when 
physical condition is really bad
Good psychologist worth a lot 
Has to be the right one as 
experience of it not helping
Get to know the problem (his 
solution)
Same situation, different 
perspective, new behaviours  
(habituation/adjustment)
Still pain but don’t care about it
Nothing has changed, but the way I 
think about it has changed 
Learning new behaviours: Not just 
go straight to medicine-cabinet
Relax & stay calm
Deep breathing 
Transformation/altering your 
experience/new perspective on 
pain (related to it differently: the 
pain that was disabling before)
I befriend it, it's a part of me that I 
can’t get rid of 
I understand my pain
I can see my pain
Look pain in the eye
Get to know your pain (advice)
Enlightenment/ Education and 
information about pain can help
Learning to understand the nature 
of pain (l. 359)
 New behaviours/another way; Pill-
taking pacified and teaches you 
that you must get rid of it
Most people think only way to deal 
with pain is to get rid of it by taking 
a pill
Getting to know your pain 
transforms it
More to know about pain
Pain has many faces
Many different types of pain 
(headache vs. arthritis) snow 
(Greenland)
You have power, There is a way/
You can do something/self-
efficacy/ power of mind over 
pain/countering passivity/
Finding what works for you
Your brain is magnificent
Utilising power within you
Small exercises can help you 
manage the pain
Countering helplessness
Control over pain
Example: pain with each breath
Managed it through breathing
I found a way and now I can cope
Hypnotism
Agency, employing the self/
Countering helplessness / Pain-
management programme 
transformative 
Wish it was offered earlier 
Other strategies to manage pain
What I learnt about suffering
There's a psychological component 
to suffering that can be managed 
Note: ACT on pain
Situation with sleep now and then 
(Same but response different)
There is learning and growth in 
suffering
Walking in rain example - this is life
Everyone is different (no hard 
and fast rules)
Medicine works differently on 
different people, but if each 
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individual person learns to utilise 
their mental power, this can help
Amitriptyline no effect on me but 
great for my friend
If you can manage yourself 
mentally - helps 
Variation of impact
We're all different
Variation in response
Everyone is different
Element of choice (you can't 
predict..)
Personality factors to do with 
coping
Benefit finding
I've always seen the positives
Always been able to focus on 
positives rather than negatives
The psychological impact of 
physical conditions (variation)
Personality is a variable
Became short-tempered
Inter-linked 
Not easy to separate components 
(because not separate)
What leads to what?
Vicious cycle of life
Interconnectedness
Bi-directionality
Duality mind/body but 
interconnectedness as can’t do 
one without the other
When mind is willing, body is not
Body lets me down 
Conflicted self  
Deep conflict between what I want 
and need
You should be grateful
Fed up/Can't stand it
I hate what is there to help me
I was worse when I didn't have it
I need what I loathe 
I don't understand as I know it's 
doing me good
Unable to assimilate what I need as 
being good for me
Violation of body
Intrusion
Needle phobia
Constantly prodded and poked
It’s killing me as evidenced by 
hair, mind etc. 
Appearance concerns
I looked a mess (hair)
Self-consciousness 
Poison
Slow death
Poison effect
Tastebuds altered
Impact on self/mind
Affects my head/thoughts
Fuzzy head
Muddled head
Can't understand anything
Can't explain 
I'm more than my condition
My condition is not just my skin or 
joints, it affects me
I'm more than my physical 
symptoms 
Lack of person-centred treatment 
(holistic)
Objectification 
I'm prodded and poked
Constant intrusion
I'm not a person, but an object
At the heart of AH’s conflict is 
the lack of choice, forcing her to 
undertake a treatment which she 
perceives as dangerous and 
unsafe. In order to cope, driven 
towards a need for self-
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protection, she occasionally 
rebels, whereby she is reminded 
that she does not have a choice 
or copes by pretending to 
herself that she is going to rebel 
and not go. 
Helplessness/ I don't have a 
choice. As a result she is in a 
persistent battle mode with high 
anxiety, which her body voices. 
Treatment (biologics) forced on me
No option
I have no choice 
There's no alternative/ Not that 
anything can be done 
No solution 
Battle in my head
Constant worry
Constantly weighing up pros and 
cons
Not rational
Battle 
Emotional impact 
Ambivalence 
I'm worse without it
In a way biologics keep me going
Biologics help me walk a bit further 
The body talks 
Body rejects
Body speaking/voicing what she 
feels (veins sunk)
Couldn't swallow
Hairs fell out, went brittle
Symbol of poison
Conditioner ineffective 
Harm herself - can't do it (needle 
phobia)
Emotional impact 
Worry about reaction
Weekend ruined due to worry
Exhausted
Comparison with other 
conditions/disadvantaged self
Comparison with cancer: at least 
treatment ends
Pamper days
No information pamphlets 
PsA ignored
No help for people with PsA
No leaflets 
Awareness in dep. that it's 
underfunded
Note: She persistently wishes 
herself to be in a different position 
than she is, with a different 
condition, even terminal, as she 
sees this as being understood/
support being offered. 
Impact on life outside hospital /
personal relationship
I've become irrational
Flare up at nothing
Loneliness 
Worry
Anxiety
Process over time
No adjustment
Harder rather than easier
Harder rather than easier
Harm rather than help
Body over mind
Get together 
This is dumb (disjointed care)
This is classic silo working
It’s not rocket science
Come on guys, get together
We wouldn’t be too much of a 
bother
You could probably get through us 
all in a morning
Internal dialogue decisive (what 
the self feels that matters)
Your internal psychological 
dialogue is deciding factor when 
comes to self-image
What other people say doesn’t 
matter
They don’t really mean it
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You know you’re damaged goods
Where is the cut-off point?
When is it classified as more that a 
superficial complaint?
Note: This is what biomedical 
thinking is about – which doesn’t 
really work as everyone is different. 
Yet, has to be incorporated into a 
system and not be arbitrary/
random/at the doctor’s fancy.
Heart of battle is a paradox 
(skips treatment in order to be 
normal)
Aversion
Can't face going
Can't be brought in contact with it
My goal is to be normal / have a 
normal life 
Work, shop, do nice things 
Just a few normal days 
Get up in morning refreshed, get 
dressed, walk around shops
Experience of obstacles/being 
pro-active
Self-referral
Proactive strategy
Asked for help dealing with 
situation
Again can't refer her 
They are treating me (must be 
experts)
Yet can't refer med to specialised 
colleagues
Obstacles again
The system: person is 
embedded in a system (ethics 
and cost-effectiveness in 
medicine )
What justifies being on a 
dangerous medication for years 
that isn’t working
The ethics of medicine and cost-
effectiveness is brutal
Do you experiment first?
Who makes this decision?
Brutal selection process
Brutality in medicine
What justification do you have for 
withholding a medicine that cures, 
even if it’s expensive?
Note: Different people need 
different things, but all need to 
be seen/heard; help them! Find 
different things difficult 
depending on their life stage, 
situation but it seems that 
everyone needs to feel safe in 
regard to their treatment. 
Variability in coping/The 
psychological component of 
illness
Why do some people deal with 
things wonderfully and other people 
fall apart?
Meaning making
Responses vary from depression, 
bitterness, anger to calmness
What is it?
You don’t know how you are going 
to cope
Unpredictable
Social/illness comparison/
Positioning psoriasis on a scale/ 
Psoriasis is a well illness
Comparison and evaluation: 
could be a lot worse
A paralysed lady who is so happy is 
awe inspiring
I could never cope with that
I could never have coped (lupus)
I felt lucky after I saw what people 
deal with
Some people have an ill child
Reframing: I don’t have it so bad
I’m lucky compared with what 
everyone else has got
Evaluation: I'm lucky 
I’m quite happy with my psoriasis
Lucky that it didn't strike before 
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(when children were little, washing, 
cooking
 “Thank goodness I got this”
I’m lucky that this is my life and not 
something else
Lucky that I’m having it now when 
all my kids are gone and I don't 
have much work to do
I was lucky that tablets had side-
effects (methotrexate)
Reminder that I’m lucky just to 
have psoriasis
Thank God, I only have this
Variation in impact of disease/
can't use biomedical marker
You can’t predict how something is 
going to affect you or affects 
different people
No objective cut-off-point
Can’t use a biomedical marker
Everyone reacts differently
Why do people cope so differently?
Variation in response: same 
situation, three coped, one didn’t 
(bereavement)
The way you are born
Set in stone
Why did one of us get terrible teeth 
when we were brought up the 
same
Same conditions, different 
response
Impact depends on life-stage/
culture
The importance of appearance 
varies according to different life-
stages
There can be no hard and fast 
rules for when counselling is 
offered, as everyone is affected 
differently
It’s probably worse for some 
(young women/men)
I can’t imagine how that must feel
Enormously devastating for self-
image
Protected by her culture/life 
stage/ lucky that I'm Jewish
Limited exposure of body
Maybe because we’re Jewish, we 
don’t go around in bikinis.
My life-stage “I was already 
married”
If you are in a bikini and not 
married…it’s probably much 
harder, right?
My culture has made it easier for 
me
It would bother me a lot more if I 
had to wander around in a bikini
We don’t have that kind of pressure 
(change noses/breasts bigger)
It’a harder for non-Jewish
Protected by our culture’s norms 
for covering up
We don’t have to look good
We don’t have to wander around in 
bikinis
Appearance is less important
It’s not like I have to go around in a 
bikini
Less pressure on appearance
No choice (related to life-stage 
as well: for NH it was easier 
when she was busy with 
children)
I have no choice
I can’t go to weddings covered in 
psoriasis
Fed up – defeat seeking help/
medical help
New life stage now 
Now a representative (wedding)
Mind and body (stress)
Everyone reacts to stress in certain 
ways
Stress has an effect on body
Everybody has a different reaction
There is a connection between 
mind and body
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Body/soul split
Society immature about mental 
health as opposed to physical 
health
Many people’s problems are 
psychological in origin
As a society we’re afraid of mental 
as opposed to physical health 
problems
Fearful of what can't be seen
Not a holistic approach to health, 
which is physical as well as mental.
Good example: GP provided 
holistic care (counselling for 
depression
Care is not holistic
The true cost of mental health 
issue to society is never measured
Helping people with 
psychological issues is complex
Helped, but the cost..
Different people need different 
things
Need the equivalent of a hospital 
for mental issues
It's complicated/no simple fix
It’s not like putting on a band aid or 
cast on broken limb?
What would have liked
Would have liked warning about 
potential psychological effects
Normalization of potential 
psychological response? (feels 
shame?)
Empowerment through proactive 
information
Having the ability to act before it’s 
too late
Creeping up on you (snatches you)
Comparison with cancer where 
counselling is offered
You might go through a rough ride 
up there in the head
Psychological impact of disease
Helplessness (no agency) can 
lead to depression/so important to 
activate the self 
There was no help
Isn’t it their job to know something 
about managing pain?
Emotional impact of pain (anger 
and depression)
Depression as divide between how 
things are and how you would like 
them to be
Not having a helpful strategy to 
deal with divide
Inability to cope
Helplessness/despair
Jack interesting as tried two very 
opposing types of care: Current 
perception of care is positive
Joint patient disease care/looked at 
disease together/joining of forces
Perception of care
Positive feelings towards hospital
Gratitude to hospital
Your pain is what matters
Different things are important to 
different people
You can only understand once 
you’ve been through it
No matter what people tell you, it’s 
how you feel that matters
Things can only be understood 
retrospectively (Kierkegaard)
Benefit finding/gratitude
At least I lost weight
Worth having the illness to get thin 
(1523)
Excuse to stay in bed and enjoy 
luxury of DVD
I was lucky that tablets had side-
effects (methotrexate)
I’m still walking, I can still use my 
functions
My old friend has kidney failure
Existential Life Wisdom/trust/
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gratitude/faith
Sometimes you think you are 
unlucky, but you are not
Grass is always greener tendency
You can’t always expect to 
understand why something is 
handed to you
Trust in God
Blaming doesn't help
Gratitude to the NHS
Could never have afforded this 
myself
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Appendix P 
Master Theme Table With Quotes 
!20
9
Master theme : New Lease of Life
Sub-theme 1: Miracle of biologics
Participant Page & line-
number
Quote
Hanif 691 Happiness 
Matthew 1034 -1040 Yes, physical, totally. It was from the pit of my stomach and it 
went upwards and up. I know, this is how I got it, the feeling went 
from the pit of my stomach up, and then I got a tingling on my 
hair like goosebumps, and then I could feel it – look, I’m getting 
it again now a bit.. Because I know, I remember it so vividly. 
What a feeling 
Matthew 419-426 It was... Oh, you see I wouldn’t want to be, I don’t want to sound 
crude, but it was probably, when it went, it wasn’t gradual. A few 
bits went, and then after about a week, my wife turned around and 
said to me, “It’s gone.” Because my back was always the hardest 
part to go, and I could see it going everywhere else, but when the 
back went, yes. It was – I don’t want to sound crude but it was 
like a massive orgasm. The elation, it was like from the pit of my 
stomach up, and I got goosebumps. I could feel it on the top - it 
was so...  
Hanif 671-678 I do remember the time when my skin was clear, one day when I 
brought myself under the shower, I was singing for the first time, 
and I was so happy because I couldn’t take a shower easily, 
because when water brought to my skin, the pain was terrible and 
my skin came, became like a baby, very soft. It took four or five 
weeks 
Rebecca 905-911 but for me, like, biologics are amazing. I really have been, like, so 
much happier and nor- more, you know. Like I said, I just felt 
normal (..)I didn't feel normal before, do you know what I mean? 
Like, why, like why have you got it and no-one else has it, you 
know
Samuel  447-451  But what I couldn’t believe was how quickly, relatively speaking 
because I was told that it might take two, three, four months 
before it kicks in. I think it kicked in within four or five weeks, 
and I was beginning to really feel a distinct difference 
Samuel 141-144 The Methotrexate was a bit more helpful but the Enbrel was 
unbelievable. Almost immediately, within four or five weeks I felt 
a different person. That’s the case up until today  
Jack 172-174 So it’s, so going on to biologics has been a huge success story. 
Erm, for me, it’s enabled to go back to before I ever had any 
manifestations of the, of the, er, symptoms
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Jack 155-163 I mean, from having a situation where I had, I had large areas of 
plaque all over my back, erm, all the joints, hands, erm, er, er, 
scalp, some small ones on the face, it completely cleared up 
within a very short amount of time. And as far as I’m concerned, 
while I have Humira, erm, I, I don’t have, I don’t have any of the 
manifestations. I get some small areas of plaque (…) but virtually 
on the level of dry skin. Erm, and I have no mobility issues at all  
Hanif 610 It helped me a lot, and it was life-changing, for me  
Jack  150-154 that you have to self-inject every two weeks. And, erm, that 
immediately set to work on condition, on the condition very 
quickly. Not only did it put the, erm, psoriasis into remission but I 
gained mobility as well. So it was an enormously successfully, 
successful thing 
Hanif 116-117 fortunately, the biologic medicine helped me a lot. It was like 
magic after a few weeks – gone 
Matthew 291-296 I mean, as with the skin, it has been a miracle. To me, it’s been 
such fantastic results. It’s amazing  
Matthew 1052-1057 How you feel to how – you know, and to me, getting that first 
time when I was clear, I didn’t have a single plaque on my body 
for the first time in so many years. It was, hold on, this is not 
right, you know? It’s so good, and I know, you know, it can only 
be good for me. It can only – if you’re feeling better in yourself, 
surely it’s going to help whatever condition you’ve got “
Matthew 512-515 You don’t imagine you’ll ever get that. You know, I mean I’d 
touch my wife’s skin, and she’s got very, very soft skin and I’d 
touch her and I’d be jealous, you know? I’d be so jealous, and 
then I could feel – and it’s great. It’s great
Matthew 445-447 Yes, it was. I’m back to how I was when I was 18. You know? 
That was a part of my life,,which was hard, but it was behind me 
now. It was, oh, it was so good. It was so good 
Samuel 444 I started giving myself the injections which I found very easy
Rebecca  172-197 But the truth is, having said that about biologics, the tablets, I had 
to go the whole time to hospital. I had to go for a blood test the 
whole time, and I had to be monitored, and I had to... I was like 
much busier with the tablets than with the biologics (…) The 
biologics, you don't need to go the whole time, you just have to 
go for your injection, and that's it, So for me, it was amazing (..) 
amazing, amazing, It was brilliant, 'cause all I had to do was 
inject myself. I didn't have to take four tablets a day..It was like so 
easy..It was ever so good, It was really, really good 
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Treatments 
before 
biologics
Matthew 304-309 They were trying different cures, they gave light treatment and I 
actually burnt. I was in underneath the lamp, and I could see the 
smoke coming off my skin. It actually burnt me (…) So they 
won’t let me have that again, but it was quite severe to look at. So 
many people likened it to I’d been in a fire, you know?
Matthew 487-490 He goes, “You’ve got a bit of an infection in your skin.” I said, 
“Right.” So he gave me penicillin and I’d never been allergic 
before but I just had an allergic reaction and all my legs went 
black and I was in hospital for quite a few weeks with it
Hanif 720-724 I tried to stay at home and moisturise myself two or three times a 
day, and just imagine if you moisturise yourself three or four 
times a day and each time takes ages, because all over your body’
Matthew 476-480 She was there through the real bad time when I the allergic 
reaction to the penicillin. She was through that. I couldn’t be 
touched, physically touched. I couldn’t, the pain was so extreme. 
Oh, it was – I was near enough one big blister 
Matthew 620-625  I’d like to change the fact that I had to keep on trying so many 
different creams that were all steroid-based because I mean, my 
legs are scarred to hell now because of it 
Hanif 216-219 I was admitted in hospital for my psoriasis four times, five times, 
plus in one occasion for the liver failure and even that one was 
related to psoriasis anyway 
Samuel 365-377 You know, one of the things with psoriasis is you’ve got to be 
quite a disciplined person, putting on the creams and the potions 
and lotions (…) making sure you applied the creams sufficiently 
so that you’re not in discomfort became tedious. Also in those 
days, less so today although I think they’re still the better drugs, 
the tar-based ones were the ones that stained your clothing, the 
very strong ones, and the smell was quite –
Matthew 435-443 Because all the years through the treatment, all I kept on getting 
told by the nurses and everything, “It’ll go after 10 years. It’ll go, 
it’ll go.” Then it never went, never went, and they used to say to 
me, a receptionist up at the Willington Hospital, she used to say to 
me, “You’re the longest one here.” You know, because everyone 
else is getting treated and it’s cleared and gone, and you’re still 
coming after like 13, 14 years. You know, I said, “Well I don’t 
know
Jack 169-76  Erm, and the, the, the thing is, erm, er, you know, constantly 
taking a medication which really has no effect is very depressing 
(..)And, and your, and the, and the local use of creams and, and 
things is, is messy and horrible 
Jack 624-627 I, I’d, I’d got to the point where I was at, at, you know, 
Methotrexate, you know, is variable and milligrams on the dosage 
and I got pretty well up to the top in, in quotes, ‘safe dosage’. 
Erm, and it wasn’t having any effect 
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Jack 108-118 It was getting worse. And it got to the point about eight years ago 
when I, I had to buy myself a walking stick. I mean, my, my, the, 
the rheumatoid part of the condition had got very bad. Erm, and I 
could only walk with a stick..Erm, and at that point, I got really 
fed up with it all. I stopped taking any medication and I went to 
the doctor, the doctor and explained the situation and I was lucky 
that that doctor knew, erm, had several contacts here at, erm, the 
Royal Free and suggested that I transfer to the Royal Free 
Hanif 145-162 Even at one point, at one stage I was tired of all these medications 
because I was under lots of them. But you can’t believe it, I tried 
Chinese herb. I saw someone in Harley Street, who specialised in 
Chinese herbs. You know what happened when I used it? After 
three days, my liver failed. Yes, my liver failed and my knees size 
was this much. I couldn’t wear trousers, and I was admitted 
hospital again under, I was given lots of steroids and it took about 
two weeks time for me to go back to normal. Yes. All of my body 
was white spots, liver failed, I couldn’t breathe. Every day in the 
hospital, every day, they took one to one and a half litre of water 
from each knee 
Jack 696-719 But again, the thing is, I was trying to do a, to work for a living…
Then you’ve got the point that, that – you’re gonna have to start 
taking a lot of time off work to come to a hospital repeatedly to 
do – I mean, it, it becomes something which, er, you know, as you 
said earlier, might be regarded as a, erm, minor ailment, starts to 
have major, major, like even more major, life impacts (…)I can’t 
remember what the frequency was..(..)But I remember thinking, 
“Well, I, the condition I’ve got is very severe and what’s the 
photo-, you know, what, what’s that treatment going to be?” And I 
was thinking, well, you know, “Can’t they, can’t give you the 
option of, of getting the right, erm, type of lamp that you could 
have at home?” for instance…But then I understand it’s got to be 
monitored and it’s got to be done. So, I mean, it, it, again, that’s 
an example of where, erm, the cure or maybe the, just the 
maintenance of it becomes something which, ,  you can’t work 
anymore
Sub-theme 2: Being able to do things again
Samuel 177-184 You feel as if you’ve got a new lease of life. I’m probably fitter 
now, with all the pills that I take and all the drugs that I inject and 
so on, at 67 than I was when I was in my mid-40s because in my 
mid-40s I was carrying around 20 stone and I was probably eating 
incorrectly and so on, and working hard and being on the 
treadmill of life. So I’m probably better off now than I was then  
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Rebecca 186-199 I felt normal. You know? I, like, I told you my kids say, erm, that 
our house is the only house in the world were it snows inside 
instead of outside (..) I used to leave trails of, you know, like 
scales the whole time…And always had to have baths, always had 
to put moisturiser on, Even when I went shopping and I tried on a 
skirt, I was so embarrassed, you know, 'cause like all the scales 
used to come off on the skirt, if I didn't buy it. And you know, 
like, it wasn't..It was, you know, it wasn't, it wasn't nice to live 
with it, but I did, so this biologics is brilliant 
Samuel 209-214 You can enjoy your life. If you reach good years and you’ve got 
grandchildren and you’ve got positive things in your life, this is 
probably the only time in your life when you can actually sit back 
and enjoy them. If you haven’t got your health at whatever level, 
that impacts on it. It must impact on it  
Rebecca 241 – 257 It felt normal. I could get up in the morning, I didn't have to start 
having a bath with oil, sit in it for an hour, then put on cream, and 
then... I, I used to have a bath, like sometimes three, four times a 
day, 'cause I couldn't cope with my skin. And everything used to 
be oily, you know? (..) And here, I just felt like a normal person. I 
could get up in the morning, and get dressed, and go out, and you 
know, like-I just, yeah, I felt normal (..)I felt like everyone else 
does, you know. It was really, really – I really felt good, I really, 
really did…Like my whole mood was good, you know, 'cause like 
I didn't have to think about it the whole time
Matthew 827-833 It just is – I mean, I never had a holiday for, as I say the best part 
of, well it would have been about 13, 14 years. I never had a 
holiday. Not a break, you know? But now, I went for a week away 
with my wife down to the coast this year. I went in May. I’m 
going again in September. It’s just these are the little things now 
that I can say, “That’s what I want to do.” You know, if I want to 
go away, I can go away. 
Hanif 693-94 And I started again to see people, and tried to go out and going to 
the gym at the time
Samuel 162-173 My ability to use my body in whichever way I want to is pretty 
good, and much, much better than it was three or four years ago 
where I was walking almost rigid and stiff, and so on. I’m much 
more flexible and so on
Samuel 473-479 Now if you ask me to put myself back into that frame of mind of 
how I was, I was miserable, and I’m not miserable now. So that’s 
the major change. Did the arthritis stop me from doing anything? 
Well yes, it restricted certain things and it restricted therefore as a 
result stamina to do things for a longer period of time. So 
therefore I’ve got more stamina and I’ve got more flexibility, and 
therefore I’m doing more things, and therefore I’m enjoying 
things more
Life with pain, stiffness and immobility 
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Jack 1241 -  1244 But, yes, it was really, er, when I think about it, it was, I was, it 
was really painful. Getting to sleep was really difficult. Waking 
up and then you were incredibly stiff. And try, and getting out of 
bed in the morning and standing up and getting dressed were 
painful processes 
Samuel 106-112 I started getting aches and pains and lacking strength in my upper 
torso and not being able to create any strength. Even if the 
muscular strength was there, the pain level sort of iAvivaibited it, 
and the two things became a vicious circle. The more painful it is 
to do something, the less you do it. Therefore the less you do it, 
the more painful it becomes 
Alice 317-334 My psoriasis was that bad, it was really, really painful..Erm, I 
couldn’t get through the night. I’d have a big tub of the greasiest, 
greasiest emollient…Every ten minutes I’d have to plaster it on 
and as soon as I’d put it on it would be bone dry again…Erm, and 
I couldn’t sleep and it was painful. Erm, and then because I 
literally couldn’t do anything and I couldn’t wash my hands and 
everything was painful. I’d dread getting washed or having a 
bath, everything was painful and once it gets bad like that it’s 
really difficult to……to get it better. Erm, so I, I was just in a 
mess. I couldn’t sleep, I couldn’t get dressed, I couldn’t wash. 
The cream was having no effect at all. Erm, I’d be crying all the 
time. I, I literally wanted to die because I had no quality of life” 
Jack 309 -333 I had the arthritic condition (..)So that was really reducing my 
mobility (..) Where it, er, where it was painful to walk (..) Erm, 
and certain amounts of joint pain in other, other joints as well (..) 
er, again, for, for, er, for me, it was suddenly being confronted 
with, er, I, I guess it would be, erm, I imagine (…) And suddenly, 
erm, it’s something that you think, “Well, I’m old now.” (…) 
Because this is something which, generally speaking in, erm, in, 
the, the body breaking down. It’s something which I associate 
with a, a, with a – – a later stage (…) A, a later or even a sort of 
proto-final phase of life (..) You, you think, “Well, it’s going to 
go, it’s all going to be degenerative from now on. 
Rebecca 1543 I said, I couldn't get out of the bath. I couldn't peel. I couldn't – I 
can't open tins, even now my husband has to open one tin that I 
haven't, doesn't [thing 0:54:40]. I can't, I can't carry, I can't – you 
know, I, it's been impacting me loads (..)I mean, I couldn't even 
walk to the Royal Free. I was like laughing, there was like 80-
year-old ladies walking past me, and they had a stick, and they 
were walking faster than me
Rebecca 151-155 I was itching, It, I was like, I couldn't cope any more. I was like, I 
couldn't sleep at night, I couldn't do anything. I had to sit in the 
bath the whole day, practically. I didn't have time for that
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Rebecca 269-278 My mood, but my mood was only low because of the psoriasis, 
do you now what I mean. I wasn't even low, I just, I couldn't be 
bothered any more. Maybe I'm lazy, I don't know. But you know, 
like the whole time, to have that, and also I was itching and that. 
That I couldn't cope with (..) I can cope with anything else, but 
the itching I couldn't cope with (..)The whole time, the whole 
24/7, the whole time. Itching, itching, itching. I couldn't cope with 
it
Rebecca 1414-1416 I came home and phoned my kids and told them right, this is me, 
you know, this is the old ladies walking faster than me, you know
Rebecca 1422-1440 It had stopped my life, literally. My life stopped for months (..)I 
wasn't able to do anything, I couldn't hardly go up and down the 
stairs, Every time I went to the toilet it was like, nightmare. 
Because I couldn't walk to the toilet, I couldn't, I, I'm so 
embarrassed to say this, but I couldn't even wipe myself after I'd 
been, do you know what I mean? It was, everything was hurting 
me…”And I couldn't itch myself, like that was the worst. That 
was again the worst, the itching. So my psoriasis went really bad, 
and the itching. So if I would have felt okay, if I would have been 
able to itch myself, I would have been okay, but I couldn't even 
itch myself. I couldn't do anything. So it was like, you know- 
Samuel 845-852 I think my body would have started – it does close down on you, 
your body a little bit quicker doesn’t it, because there’s this 
vicious downward cycle of you used to walk two miles a day and 
now you only walk a mile a day, now you only walk half a mile a 
day and so on and everything starts coming in. Well you haven’t 
got any of those restrictions. You do what you want to do, as you 
want to do it, not because you’re being restricted. So you’ve got a 
freedom” 
Samuel 106-112 I started getting aches and pains and lacking strength in my upper 
torso and not being able to create any strength. Even if the 
muscular strength was there, the pain level sort of inhibited it, and 
the two things became a vicious circle. The more painful it is to 
do something, the less you do it. Therefore the less you do it, the 
more painful it becomes”  
Samuel 475-479 Did the arthritis stop me from doing anything? Well yes, it 
restricted certain things and it restricted therefore as a result 
stamina to do things for a longer period of time. So therefore I’ve 
got more stamina and I’ve got more flexibility, and therefore I’m 
doing more things, and therefore I’m enjoying things more
Rebecca 1393-1395 I mean, I couldn't even walk to the Royal Free. I was like 
laughing, there was like 80-year-old 
ladies walking past me, and they had a stick, and they were 
walking faster than me. 
Sub-theme 3: Freedom from stigma and shame
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Matthew 450-461 I mean, straight away I could wear shorts, and t-shirts or a vest, 
you know? I could do that, but I’d have to walk around and all my 
friends might be in shorts and I’m in jeans and I’m sweating. Oh, 
just that. I mean, I still have the joint pain so it’s not like I can go 
back to playing football again or that sort of thing, but as regards, 
I can go out and not feel – I’d be jealous. Friends of mine would 
say, “Oh, we went down to the boating lake. We sat there, we had 
a picnic.” Things like that. I could actually go and do that without 
being self-conscious. It was superb. I could sit in shorts, without 
looking out of place because I’d normally have to wear a long-
sleeved top and jeans, and everyone else is in t-shirts and shorts. 
You feel very, very different then, so that only adds to the self-
consciousness 
Hanif 693-94 And I started again to see people, and tried to go out and going to 
the gym at the time
Matthew 463-468 But it was just little things like that. I could go to a beach. I went 
abroad for the first time, because I didn’t see the point of going 
abroad. All my friends were going to Spain and to Portugal and 
the likes, and why would I go when I’ve got to walk around with 
them? I could go abroad, so I did. It was, you know, it opened the 
door a bit. It was great. It was just a fantastic feeling
Rebecca 199-213 I felt normal. You know? I, like, I told you my kids say, erm, that 
our house is the only house in the world were it snows inside 
instead of outside (..) I used to leave trails of, you know, like 
scales the whole time…And always had to have baths, always had 
to put moisturiser on, Even when I went shopping and I tried on a 
skirt, I was so embarrassed, you know, 'cause like all the scales 
used to come off on the skirt, if I didn't buy it. And you know, 
like, it wasn't..It was, you know, it wasn't, it wasn't nice to live 
with it, but I did, so this biologics is brilliant 
Hanif 251 Yes, I’m very well now and I can love, and I couldn’t love at all. 
No 
Life with stigma and shame
Hanif 715-718 Actually, one of the reasons, yes, because when I was out 
everyone was just showing me to each other, you know?... 
Actually when you feel this way, you don’t feel good when – on 
the other hand, I had pain as well. Then I didn’t go out, because of 
the people first, and the pain as well 
!21
7
Matthew 327-342 Well, I just used to cover myself up all the time and try and avoid 
situations. I didn’t have a girlfriend for 10 years because I was too 
ashamed of how I looked. Yes, it was hard, because getting it at a 
certain time, I’m not sure if I’m right but it probably would have 
been easier to deal with if I was 9 rather than 19, or 29. But latter 
teenage years, yes, it was difficult. In my early 20s it was very 
difficult, because even if I covered up, sometimes I’d move and 
some skin would fall out and land on the floor around me, you 
know? People, they used to comment on it. “You’re 
snowing.” (…) You know? But strangers would comment on it, 
and say, “What’s that? Can I catch it?” Can they catch it off me, 
you know? It wasn’t easy so I tried avoiding a lot of social – the 
social side of anything, I tried to avoid it, you know? 
Rebecca 391-395 I was like more embarrassed, more, you know, like, but – you 
know, people say stupid things, as well. You know what I mean? 
Oh, yes. People like, when I went swimming, I remember I used 
to go swimming. People used to come up to me and say, “Is it 
catching?” You know. People don't know, you know
Samuel 314-320 Well, I didn’t take part in much sport during that period of time. 
Not anywhere where you sort of undress. I mean you know 
psoriasis, I had lumps, an area that big there, an area that big 
there. Both my buttocks would be completely covered. My back 
would be pockmarked. I’d have enormous welts over the arms 
and so on, so you just wouldn’t undress 
Samuel 221-233 At the time that I had the physical side of the psoriasis with the 
encrustation and so on, I was very embarrassed by it, and the 
form of embarrassment is the sort of thing that you wouldn’t go 
swimming. If you went on holiday, you would be covered up. Not 
because you didn’t want to uncover yourself, but you just felt 
self-conscious. So that’s one side of it. The other side of it is the 
physicality of the arthritis where you can’t participate in simple 
things the way other people are. So if you’re going swimming for 
example, I couldn’t do the crawl. I might be able to do the breast 
stroke because it was easier swimming stroke for me, but crawl 
which is what I used to do, I couldn’t do it
Samuel 326-332 One is the ignorance of other people, because when they see that, 
I’m not saying it’s leprosy because it’s not leprosy, it’s nothing 
like leprosy but people who don’t know what it is and don’t know 
psoriasis at all and most people, and why should they, think it 
might be infectious so there was that element of it. So there’s the 
ignorance element of the third party 
Rebecca 399 What's on your face,” or, “Ew, your hands,” you know, like- 
Samuel 333-334 I never felt clean. I never felt clean, and I was always very 
conscious of the flaking skin and so on 
Jack 186-189 Plus the fact that you’re, you know, you’re shedding skin at a, at a 
kind of mega-dandruff level (Laughter) all over your body, it 
makes, it, you know, it, it absolutely destroys your self-image 
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Jack 222-229 It rather goes back to that thing that, you know, that, that the very 
simplest thing that, erm, that dandruff is a, erm, you know, a kind 
of a socially frowned-upon thing. And you can’t wear any dark 
clothes, And it, and, erm, and it, it generally, erm, it seems to be, 
to me, er, one of, an example of one of those things, and it may 
just be me, but it’s one of those things where it kind of shows that 
somebody isn’t looking after themselves well 
Jack 231-236 Because it’s, erm, and, and that may be, that may be very 
harsh..But the fact is it’s an unattractive condition. Erm, and I 
think that, erm, that when you get on to the plaques that form 
from, erm, from psoriasis, erm, it, it just does make you, it, it 
made me feel, you know, ugly and, er, and, er, it’s like having a 
deformation 
Jack 284-295 It’s the fact that you’re shedding skin…and you, you, you, you 
get into habits like, you know, surreptitiously checking a chair 
where you’ve been sitting…Because it, you think, “Well, I 
wouldn’t want to go and sit in a chair that was covered with…
You know, with, er, with skin particles, so, you know, you, you, 
you’re just feeling psychologically, I think, on the back foot all 
the time
Jack 467-479 Because psychologically you’re kind of feeling like a, er, I mean I 
wholly inappropriate comparison. But you’re, erm, you know, 
you’re, you’re feeling like the Elephant Man. (Laughter)
Matthew 540-565 I mean I remember once, alright it worked in my favour but I was 
on a tube on the London Underground and a gypsy came over 
begging with her daughter. She was going through the train 
begging, and she got to me and she was like, she physically 
screamed. She got down and she was grabbing her daughter, “Get 
off, get off. You’ll catch it. Don’t go near him.” In front of the 
whole train, so in one sense she didn’t beg off of me, but she 
made me – and there was nowhere to go. Once you’re on a tube 
train and you’re going through the tunnel, there’s nowhere to go. 
So for the rest of the time to the next stop, everyone was just 
looking at me. It was, you know, people’s perceptions...(..)  But 
you know, some people, I can remember I went to a pub with 
some friends and it was a very, very busy pub and this couple, I 
didn’t know them, and they came in and there was only space to 
get to the bar between me and the next person. The girl walked in 
like that, she’s gone, “Do you mind?” I said, “No, no.” She’s gone 
to the bar and her boyfriend pulled her back and said, “No. Look, 
don’t go near him. Look at the state of him.” (..) Yes, but I was so 
happy when she turned around and she gave him a little smack on 
the face. She goes, “That’s psoriasis.” She knew it. She didn’t 
know me, but she said, “That’s psoriasis. There’s nothing wrong 
with it. Idiot.” She swore at him and I was like, “Thank you.” You 
know? It was brilliant. She was with her boyfriend but she took 
my side on that. You know, that was good 
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Alice 1370-95 When my psoriasis is bad on my hands and people treat you like a 
leper or they step back and they go, “Oh,” or they stare or, you 
know, shops are an awful thing when they slam the change on the 
counter, they won’t put it in my hand, ‘cause I got psoriasis on my 
hand. I’ve come out with many - I, I build all my confidence, I 
pluck up the courage to go shopping and, and again it’s this not 
being believed. Nobody would believe me when I said, “Oh, you 
know, that checkout assistant slammed the change on the 
counter,” they put it in the person before and the person after’s 
hand, and hand them the receipt. It was just me. Then I’ve got my 
friends and family saying, “oh don’t be silly, it wasn’t just you it’s 
just your…” “I was in a wheelchair when I first had my op, my 
partner had to push me into the shop. Psoriasis was bad. He’d 
slammed the change on the counter, wouldn’t put it in my hand, 
threw my receipts at me. We came out the shop, filled up with 
tears and I said, “Was that me or…” to my partner, “Was that 
me?” He said, “No, I’m going back in that shop, if you don’t I’m 
going." So then eventually he believed me. Erm, nobody believed 
me, it was appalling the way I was treated. So erm, so that makes 
it worse (..)It takes a lot to get me to go and then when somebody 
stares or somebody makes a comment it’s, erm…” 
Hanif 417 I was like a person who is in a prison. My office is in my home, 
just upstairs, actually
Hanif 428-437 Before this course, I was in a prison in my home, 24 hours a day, 
just I visited my client, doing the web design, and searching the 
internet and that’s it, and go to sleep, shower, work, eat (…) And 
out? No. Visiting people? No. Going on holiday? No”  
Hanif,  128-133 In one word, I can describe in one word. I coming close to 
suicide. I was suicidal, and it was terrible. It was terrible, and I 
couldn’t sleep. I had pain all the time. I hated people. I didn’t 
want to talk to someone. I didn’t want to see someone. Just a 
terrible situation
Hanif 235-238 At the time, I didn’t know what is love. I hated everyone, as I 
mentioned. I didn’t want to see anyone at all. Just I came to the 
hospital and see the doctor. That’s it
Master-theme: Living with the fear of the unknown 
Participant Page & line-
number
Quote
Sub-theme: It's a firewall not a cure 
Jack 730-744 But going through that self-injecting process is very much a 
reminder, erm, that, you know, I’m, it, I’ve, I’ve got a, I’ve a 
firewall against something which if I stopped doing that would 
probably return with a vengeance very quickly. So (…) well, I’m 
saying an effective treatment that, one, you have to continue for 
ever, because it’s not a cure - is no more than an firewall, is it? I 
mean, you’ve put, you’ve created an effective barrier to the 
manifestation of the condition 
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Alice 19-26 I shouldn’t detest them so much because it’s there to help me but I 
hate it, because it’s every single week. It has been for the last five 
years. I’ve had other biologics previous to that..Erm and very 
often they work for the first sort of three months on me then they 
stop working. 
Alice 508-510 But it, it’s the fact that there’s no end to it and then the fact that 
I’m on this and then my body gets used to it, so then I need 
stronger and stronger stuff 
Alice 1048-1056 My biologics have helped me do that, erm, they help me walk a 
bit further, less pain in my joints…but then I still can’t, I still 
can’t do, it doesn’t cure it. It makes me better, but then I’ve got 
the side effects where I lose virtually two days a week and then 
every six to eight weeks I have my infusion and it’s just……I just 
get tired with it all 
Rebecca 557-559 Because I think your body gets used to it, maybe, or, I don't 
know..They always gave me another one 
Alice 410- 418 Erm, and erm, and then I just start to feel better Thursday and 
Friday and then there’s never a break, and then it’s gosh, you 
know, it’s the weekend (pause) time again. So it’s, you know, if it 
was every month or two months, it wouldn’t be so bad, but I just 
start to feel better and I feel better in my head……and then 
wham, it’s back again 
Alice 1082-1087 “And it just, the weeks come so quickly and then I get over it and 
it’s time to have it again….and I think partly because I’ve got all 
these hospital appointments next week it’s just like, I just want a 
breather. I just want time out” 
Alice 1062-1070 I-if there was an end to it, like if it’s a broken leg, you know 
you’ll be in plaster for however many weeks or months or 
whatever it is but there is no end to this…It, it, it does affect me. 
It’s, I want to, I want it to stop, I want an end to it all. And this, 
and this is why every so often I suddenly stop having my 
treatment ‘cause I have it right, I’m full of it and I’ve had enough 
of it, so I’m…
Alice 144-148 It’s exhausting and I don’t, I feel I never have one day at home to 
myself. Erm, I have my Methotrexate Monday, Tuesday I feel ill 
all day, so I can’t do anything. I’m tired and I feel ill, so I can’t 
really do much.
Alice 200-204 Erm, I feel terribly sick after the tablets…and I’d come back after 
I’d taken them, I’d lie on the settee, blanket over me, and the rest 
of that day or the next day I’d feel sick
Alice 37-45 I was supposed to have had it yesterday, but I didn’t have it ‘cause 
I’ve had it absolutely up to here with it all and every so often I 
just can’t stand it. And yet I know I need it because about two 
years ago, erm, I’d had enough of it, the side effects and, erm, I 
didn’t, I missed four injections and I was bedridden with my 
psoriasis and my arthritis. I was that bad. So I know I need it. So, 
and people say to me, erm, “Well you know you need it. It’s for 
your benefit so you should.” And I still can’t accept it. It’s, there’s 
no end to it 
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Sub-theme: Embodying an experiment 
Jack 377-389 you, you, there was a medication, er, prescribed that was, that had 
dangerous side effects anyway and the fact that, erm, the fact that 
they are, erm, that they are anti-immunes, means potentially, 
because no-, because nobody could say exactly. But that meant 
that, well, if you, if you’re reducing your, of the, erm, efficacy of 
your immune system, what are the other ailments are you leaving 
yourself open to? And that was never really explained (…) But if 
you depress the immune system, or, you know, suppress it, it must 
have, you know, immunosuppressant things must have other 
things. As we – I mean, you know, it, it, it’s all those things that 
you start to worry 
Alice 123-126
I just feel like I’m being prodded and poked. And that can be like 
Monday I have my Methotrexate injection, erm, then Friday I 
have my infusion, then I have to have my bloods done every two 
weeks, and, and I’m just, I hate it 
Jack 747-764 “it’s unknown it’s quite extraordinary that you’ve got these twin 
things about psoria-, about in psoriatic arthropathy, with two very 
different manifestations of what allegedly is the same condition. 
But in was, you can’t imagine anything more difficult, more 
different – than a rheumatoid condition and then a skin – one. It’s 
an extraordinary, erm, an evil combination of opposites…Erm, 
with a treatment that’s not quite known how it works with a 
condition that’s ___[0:41:32] what it is Erm, (Laughter) –So, it, it 
feels quite a strange position 
Samuel 645-654 Also, there wasn’t a great deal of opportunity to discuss anything 
more than the basics, so even something like the Tigason which 
was at experimental stages when I started to take it, there wasn’t a 
long discussion about – yes, “Look, I’ve got this drug. It’s new, 
it’s experimental in the sense that only X number of people are on 
it in the United Kingdom but it’s having great results and so on. 
Would you like to take it?” Well, you’re going to be stupid if 
you’re going to say “No.” You’re going to say “Yes” and that’s 
about as much discussion as there was with it 
Jack 414-417 Erm, none of them were evolved as a treatment for 
psoriasis ..And they happened to work on psoriasis
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Alice 1147-1165 And then one time it wasn’t my normal consultant, it was a 
student doctor and she said, “Let’s have a look at your back.” I 
said, “I haven’t got any psoriasis on my back.” “Oh well we need 
to look because, erm, you do understand the importance of 
checking for skin lesions because you’re prone to skin cancer on 
the treatment you’re on.” This is what a student doctor said to me, 
so that was the reason the consultant wanted to check my back. 
They’re not honest. She wasn’t honest with me and I had the 
shock of my life when the student doctor had said, “Oh well you, 
you do understand the importance of checking for lesions.” No, I 
didn’t know. No, I didn’t know it caused skin cancer.. So I come 
away, have all these shocks and I come away and I’m left to deal 
with it on my own. So then I start looking on the internet, ooh can 
it cause cancer and then I find all this information on the internet. 
I’ve gotta deal with it all on my own. They’re not honest. I’m 
really starting to resent and detest the medical profession 
Jack 423-434 But it’s also worrying that you’re taking something that – I mean, 
to me it’s a, there’s a parallel with the over prescription of 
antibiotics..You find something that’s effective..Erm, you, you 
can end up, erm, you’re, you’re not prescribing a targeted, erm, 
cure. You’re using something which has an effect but you don’t 
understand (Laughter) why it has an effect..It’s just it is effective. 
Well, that’s is, is not best medicine, in my view
Alice 295-304 I had a drug years and years ago, 20 years ago, the PUVA 
treatment and they said it was really safe. They gave me more 
than a lifetimes worth of treatment and now they recognise that 
skin cancer’s very common in people who’ve had that treatment. 
And I know three people who’ve had skin cancer who had PUVA 
at the same time as me. So I, I’m very fearful. Erm, the, the other, 
erm, major health scares I’ve had the blood clot on my lung, the, 
erm, problems with my liver, the problems that I think I’ve got 
with my heart, how do I know it’s not from these drugs
Jack 391-406 I mean, it’s rather like somebody who, erm, erm, who becomes 
HIV..And, you know, a, a, terrible part of that disease, of that 
virus – is that is the depression of the immune system and leaving 
individuals open to other sorts of, of, er, of, er, viruses which they, 
which might not affect [the strong 0:21:12]. But anything else, 
erm, can become a serious condition in its own right. So you’re 
thinking, “Well, they’re giving me a medication, there’s a 
medication…” The state of the thing is not only have you got, 
erm, a condition which is not really, it doesn’t really, it’s not 
going into remission, but you’re doing, you’re, you’re, there are 
quite serious side effects..Erm, and also it’s medication which the 
medical profession doesn’t know why it works  
Alice 543-545 What it’s doing to my body, nobody knows the, the long term side 
effects because they’re relatively new treatments, so what damage 
is it doing
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Matthew 812-819 I don’t have any worries, you know? I don’t. As with any 
medicine, there’s always some sort of side effect, or chance of a 
side effect with anything. A cold remedy, you can get a side 
effect, so I don’t worry about that. You know, there’s just no stress 
whatsoever from – you know? 
Alice 289-293 But it’s, it’s not their body. And then there’s all the long lasting 
side effects.. They don’t know, ‘cause it’s a relatively new 
drug….how do they know how that affects me in ten years’ time? 
Alice 58-62 so you can’t get any independent information. So I look on the 
internet and hear all this worrying, er, all this worrying 
information, you know, this treatment can cause this, this, this. 
And then I suggest it to the hospital, “Oh don’t take any notice of 
that, don’t look on there, oh you’re alright. 
Samuel 667-677 Maybe not. Maybe not, because you don’t want to be told when 
you’re going to die. You know you’re going to die but you don’t 
really want to know when you’re going to die because you’ll 
spend your whole life focused on the wrong thing. But it was 
never mentioned at any stage, “By the way, you should be aware 
that 10%, 20%, 30% of people who have psoriasis will also have 
other problems that are psoriatic arthritis.” It was never 
mentioned, so when I first got my pains and so on, we didn’t 
know what it was so obviously it was diagnosed. So there’s not 
enough information out there
Samuel 559-570 I don’t think enough of that is done in what I call long-term 
conditions. So, okay, you wake up one day and somebody tells 
you you’ve got arthritis, but they don’t really tell you what your 
life’s going to be like with it, or what expectations you’ve got for 
life, or even to say to you, “Look, don’t worry about it. There are 
six million other people in the country that have got these 
problems, or however many, and everyone’s coping with it 
relatively well.” Of course there are some that are better than 
others but there’s no picture painted unless you do the research 
yourself, of what you’ve got to expect going forward. I think 
that...
Samuel 577-589 So there’s very little intercommunication between the medical 
practitioner who knows what they’re doing, and the ability to 
transmit the thought processes that they’re going through that 
would clarify what they’re doing. So in other words, “I think you 
should be on Sulfasalazine. We’ll put you on Sulfasalazine. You’ll 
have X number of these at 2.5 mg” or whatever it is, or two 
tablets a day or whatever it is, and we’ll start off with one tablet 
and so on, but none of that is really explained well. They usually 
give you a leaflet, and I find that the leaflets are over-simplistic in 
some respects, and they don’t do anything about conveying 
emotion. They only just talk about hard facts 
Alice 54-57 you can’t get any independent advice from anyone as to the side 
effects ‘cause the people who give it you if, like I was treated for 
a blood clot on my lung, now I’m having heart problems
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Alice 62-69 I mean for the last, I don’t know how many months, my liver 
count’s been rising and rising which I think is to do with the 
Methotrexate. So they keep their eye on it…but they don’t do 
anything. Finally now I’m going for a liver scan but they don’t, 
they, they don’t willingly do anything. It’s just swept under the 
carpet and they just..
Alice 69-75 It’s not their body, it’s my body and I resent it every week. If I 
have a headache I don’t even like taking a Paracetamol…and I 
resent having a highly toxic drug……into my body. I hate it 
Alice 101-107 And there’s always the scare before I go for my Infliximab. I’ve 
seen one person having it and they, er, had some problem with 
their heart and they were rushed, they went into cardiac arrest, 
they were rushed over to, you know, the, the A&E. And I always 
have a, a fear before I go (…) so I spend all weekend worrying 
about it
Sub-theme 3: The role of information 
Samuel 662-665 Nobody ever mentioned to me that one of the things that you 
might have to face in future years, X percentage of people who 
have psoriasis will also have psoriatic arthritis. It never was 
discussed
Alice 58-62 so you can’t get any independent information. So I look on the 
internet and hear all this worrying, er, all this worrying 
information, you know, this treatment can cause this, this, this. 
And then I suggest it to the hospital, “Oh don’t take any notice of 
that, don’t look on there, oh you’re alright.” 
Hanif 568-582 just one leaflet, one booklet can help to realise about the pain, 
because most people don’t know about the pain. They believe if 
they have headaches, they have to take Paracetamol and the 
headache gone… As I mentioned, you have to know what is the 
pain, and you have to take, even if you want to take one 
painkiller, you need to know each painkiller works for different 
things. You can’t take Gabapentin for headache, or you can’t take 
Paracetamol for your slipped disc. You have to know your pain, 
and you have to know these. You have to educate 
Rebecca 621-629 But you have to do it. I mean, even when you take a panadol, they 
give you a hundred things…And half the time when I was taking 
now, erm, leflunomide, even, yeAlice. The very fact I'm taking it 
was for my skin, and my inflammation. And that's one of the side 
effects that they causes, so I don't understand the whole thing. It 
causes rashes, it causes inflammation, I don't understand, you 
know. So they're just writing everything
Rebecca 640-649 Exactly. So, but I suppose they have to write everything, I don't 
know (..) They have to safeguard themselves (..)Yes, you never, 
you'd never take anything, You'll never take anything” 
Rebecca 656-659 I would take the information home..And I would read it after, 
when it like, when it worked and everything
Rebecca 168-170 So even when they gave me things, leaflets to read and 
everything, I said, “I'm not reading it, because then I'm not gonna 
take the tablets
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Alice 470-478 And, and I’d like them to be more open ‘cause if it is, you 
know……obviously all things have side effects, I can make, I 
could have made the choice in the beginning as to whether…I 
wanted to have it
Alice 1124-1137 You can’t get independent advice. The only people advising you 
are the people who are pushing the drug, who want you to have it 
or the GP who says, “Well yeAlice, the, the hospitals 
recommended it.” But I want some sort of independent advice or 
somebody to say, “Well these are your options..This causes this 
side effect, this this,” and, and give me the information and the 
time for you to go and read and…They, they kept a lot back from 
me on, on the side effects of these things. They, they don’t tell 
you and then it’s only after you’ve been on it for a while that……
things come to light, “Oh yes it does do that, oh yes,” 
Samuel 796-800 But when you’ve got to live with something for a long period of 
time, I think the communication of what to expect, how to treat, 
and how things develop, how things may not develop and so on, I 
think that’s still relatively under-served, that area” 
Samuel 806-811 I mean, if I’m going to spend shall we say 30 or so years of my 
life with problems related to psoriatic arthritis, I shouldn’t 
become an expert at it but I should know what my path might be, 
what the options are in what you do for yourself and what your 
options are if your body goes in a particular direction 
Alice 1180-1194 Well to me the patient has the right to know, I have the right to 
know…I’d rather, it’s my body, it’s not their body…I’d rather, I’d 
like to know everything……and then and then weigh up the pros 
and cons……and then it’s my, I don’t like to have a treatment and 
then, erm, and be told it’s fine and then have it over lifetimes 
worth of treatment of it……and then to be told oh you’d probably 
get skin cancer, that isn’t fair. I’d like to know 
Jack 1260-1306 So I think offering that right package of saying, erm, “We do need 
to, to tell you that,” er, from a, in a proactive way – “We do need 
to tell you about this, that we do not, we are not, erm, oblivious to 
the fact that something like this, that might take a while to cure, 
erm, it might remain in a very mild manifestation that happily 
will clear up and a few months visiting a clinic and medication 
will work and you won’t have it providing you take certain things. 
It might not be troublesome..“But also –“– it is going to, it is 
something that you’re going to find upsetting. And we are not “– 
we’re not oblivious to that side of it.”So I think that that positive 
thing. And it has to handled sensitively because you don’t’ want 
to start a fire where (..) – there isn’t one” 
Jack 1310 – 1312 But personally, I feel like it should probably be proactive..Erm, in 
the information that’s given out 
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Alice 343-350 The very first time I went on a biologic, I was sort of forced into 
it. I wasn’t given lots of information about it. This is a few years 
ago, and I was told it was a different hospital to what I’m at now, 
basically well if you don’t have this treatment, ‘cause I said I’m a 
bit worried about the side effects, well if you don’t have this 
treatment, if, if the treatment doesn’t kill you, the disease will. So 
virtually you got no option but to go on it 
Jack 391-406 I mean, it’s rather like somebody who, erm, erm, who becomes 
HIV..And, you know, a, a, terrible part of that disease, of that 
virus – is that is the depression of the immune system and leaving 
individuals open to other sorts of, of, er, of, er, viruses which they, 
which might not affect [the strong 0:21:12]. But anything else, 
erm, can become a serious condition in its own right. So you’re 
thinking, “Well, they’re giving me a medication, there’s a 
medication…” The state of the thing is not only have you got, 
erm, a condition which is not really, it doesn’t really, it’s not 
going into remission, but you’re doing, you’re, you’re, there are 
quite serious side effects..Erm, and also it’s medication which the 
medical profession doesn’t know why it works 
Alice 455-459 But they’re not honest with me, if they showed me and explained 
everything……then, well I don’t know what choice I have but I, I 
like to be kept in the picture 
Sub-theme 4: Coping with the fear of what tomorrow brings
Matthew 397-405 I really don’t know. I just – my mum is a very strong-willed 
woman and I think I do take after her and she’d say, “You’ve just 
got to get on.” Her dad had it (…)  She used to say to me, “He 
just had to get on with it. Get up, go to work.” She said, “Back 
then when he was a young man, there was nothing.” There was 
nothing. You might get a load of coal tar and that was it. Smother 
yourself in that or put petroleum jelly. That was it. That was the 
basics back when he had it. So she said, “You’ve just got to get on 
with it. You still have to go to work. You can’t not work.” I just 
took it on board and said, “Well, yes.” Obviously she’s seen my 
grandfather doing it, so just get on with it. That was it, I just dealt 
with it  
!22
7
Rebecca 792-811 You see so much in the world now, like so many afflictions, and 
you read so many stories about this person who's not well, and 
that person, or this person has an ill child, or you know. Like for 
me, I was like – 'cause I, I remember once, 'cause Jewish people 
organise things, and one lady brought somebody over, have you 
heard of like healing, like heat, heat healing, or..I don't know, you 
have all those people, dowsing and all that type of thing. Have 
you heard about these things?Yeah,  like alternative medicines. I 
went once, to this like man, he was like – I mean, he didn't touch 
us or anything, 'cause we're not allowed anyway. So I thought, 
you know, you can't lose, you can only lose money. So I went to 
him, and there were loads of people in the waiting room. And if I 
promise you, I came out thinking, “Thank God I have my 
psoriasis.” Because other people had so much worse. Like phys- 
you know, some people had like no, the oxygen in their legs, or 
something. I can't even remember any more. All I can remember 
is coming out thinking, “It was worth going just to know that I'm 
happy with my psoriasis.  
Matthew 647-651 “No, you’re lucky you’ve got some treatment.” You know, she 
said, “And there’s always someone worse off than you.” You 
know, so you can keep on thinking that every day of the week, 
every day of the week. It’s what might get you up. You know, it 
probably got me up out of bed a few times, you know?”  
Matthew 747-753 It’s totally helped me, so – but some days all I want to do is go 
and lie down, curl in a ball and cry. I don’t. I haven’t done it, but 
I’ve wanted to on quite a number of occasions. But just there, 
saying you know, I know people. I know a few people that have 
got terminal cancer. I know three or four people, it’s not great but 
I do know them, and I think to myself, “Well, look at them. 
They’re getting up and going.” You know? 
Rebecca 1111 I read stories, like I read now something, erm, about this lady, 
what was it? I don't know, I think she's practically paralysed or 
something. And, erm, and she's like so positive. Because we have 
like Jewish magazines, and people write in their stories… She's so 
positive, and so, erm, like smiles, and, and, and you know, I think 
to myself, again, “Thank goodness I got this.” I could never cope 
with that, you know (..) Like, it just, there are so much worse 
things around..But I don't know” 
Rebecca 168-170 So even when they gave me things, leaflets to read and 
everything, I said, “I'm not reading it, because then I'm not gonna 
take the tablets
Matthew 409-415 There’s always someone worse. I’ve always focused on that. 
There’s always someone worse, you know?” (…)I’ve had a 
couple of very young cousins die of cancer, when I was younger. 
It was like, there’s always someone worse (…) Yes, stop moaning 
about it and just... So that was basically it 
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Rebecca 114  And you know what? When you see what everyone else has got, I 
was quite happy with, you know, my psoriasis (..) It's a well 
illness, and it, you know, erm (..)Yeah.that's what it's called, It's 
called a well illness, Thank God, you know, like
Rebecca 1464-1474 But you'll laugh at me now, 'cause I'm saying that my sister has 
lupus. Do you know what lupus is? So she had it since she's been 
married. That means she had it with having been pregnant, having 
kids. Having to change their nappies, having to lift them And I 
thought, “Thank God it happened to me now. I could never have 
coped like she did, with the kids. Never. 
Rebecca 1338-1375 You should have seen me six – that was one good thing that came 
out of this illness, I tell everybody, I was like – I lost weight 
because I didn't eat..And I was tired, and I didn't – and I think the 
tablets also made me like a bit nauseous, you know…And, and it 
was – so now I'm keeping it up. I tell you, it was the best thing. I 
was like, I was, I was very overweight before..Really, really 
overweight..Yeah, I'm really happy. So it was worth having the 
illness 
Rebecca 1506-1515 When I got better, I enjoyed the excuse for staying in bed..I 
enjoyed the excuse for staying..I got myself a DVD machine.. 
And I, and I watched DVDs. 
Matthew 812-819 It’s been fantastic so to me, even if I’m on the same dose of 
Humira for the next however long, five months, five years, 
whatever it may be, I know my condition will only get better. I’m 
positive about that so I mean, as regards that, I don’t have any 
worries, you know? I don’t. As with any medicine, there’s always 
some sort of side effect, or chance of a side effect with anything. 
A cold remedy, you can get a side effect, so I don’t worry about 
that. You know, there’s just no stress whatsoever from – you 
know? 
Samuel 710-712 I don’t concern myself about the future. I’ve learnt to live for 
today and not in excess, but to take each day as it comes
Samuel 715-722 No, I think it’s my general philosophy on life. I’ve always had 
this feeling that people spend too much time projecting too far 
forward because there are many things that happen in life that are 
outside of your control, and you need to be resilient enough to 
adapt accordingly. But okay, maybe when you’re in your 20s you 
don’t see that quite so clearly, but I think as you get older you 
realise that there’s nothing forever  
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Samuel 736-748 But I would have been like that if I hadn’t had the illness. I learnt 
very early on when we went to live in Israel, Israel is a troubled 
place at the moment (..)But one of the things we learnt because of 
that stressful type of society that Israel is, because of what goes 
on there, was that you need to live for today because you don’t 
know what tomorrow will bring and I think that most of us in 
England don’t have that attitude, purely and simply because our 
lives are, well, we don’t expect to be living in a warzone 
Hanif 762-789 I try to stop myself to think about these things. It may come back, 
but I don’t want to think about it..If it happens, I’ll think about it 
later. Now, it’s gone. (Laughter) Do you see my point?... Yes, I do 
remember there was a programme in the TV and someone had an 
interview with one guy who suffered from, he try and be positive 
and he was doing something and he said, “You know you are 
suffering from this disease and you don’t live more than three 
years, five years”, I don’t know. I don’t remember how many 
years, and he said, “Is there any guarantee that you live more than 
me?” To the interviewer (…) It may happen. In my case, my 
psoriasis may come back in a few years’ time, but if it comes back 
I want to think about this, in a few years but not now 
Hanif 801-807 A few days ago we had one conversation about the interest rate of 
the mortgage. Oh, it’s going to be blah, blah, blah, in this country, 
the most part of your earning goes for the mortgage and I said to 
myself, “How about now? If it’s going to be in a few years time, 
in six months time, I will think about it then, not now. 
Rebecca 1333 And she realised that, you know, like, you've got to make the best 
out of your life..And not always think you could have done better, 
you could have had this, do you know what I mean? It was such a 
good story, it was like, you know…So she happened to find out 
that what, what life gave her was good, really
Rebecca 1654-1717 It does help, but like let's say, like, 'cause we believe that God 
doesn't send you anything that you can't cope with. But we do, we 
don't believe that anything is coincidence. Everything is pre-
ordained, you know. Everything is Pre-ordained. (so) I'd say that I 
would have to have, I had to have it. And the good Lord made it 
as easy as possible, in a way.  Because whatever you're sent, it's 
how you deal with it. Whatever you're sent-The thing is how 
you're gonna deal with it.Yeah. That's how you stop yourself 
going down, no? Making sense of it. But there's a lot of things 
that don't make sense with it. Because you make sense of some 
things, you have to believe that the things you can't make sense of 
are also good. Yeah, because you don't know it. 
“So sometimes you do see why this is good, and why this had to 
happen to you, but loads of times you don't see it..You can't 
always say, “Oh, thank you God for giving me this,” and, “Thank 
you God for giving me that,” when he doesn't give you 
something..You say, “Oh, why haven't you given me this?” You 
can't thank somebody, and then get annoyed when he doesn't. You 
have to believe that everything he gives you is 
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Matthew 856-85 If I’m out walking, if I have to stop I have to stop, simple. If I 
have to sit down, I sit down or if I have to get up, I get up. I can 
deal with that. I can deal with that because it’s such an 
improvement on what it was, such an improvement 
Matthew 894-896 How I’ve dealt with things in the past, I can deal with stuff, and I 
don’t let it get on top of me. So to me that’s a massive positive 
coming through my own experiences with the –“
Rebecca 848 I know my cousin, that she has, erm, migraines. She literally has 
to stay in bed, and has migraines. It's also stress, you know what I 
mean. Everything's really stressed. I don't know, some people can 
cope, you know (…) IBS, you know, like, everybody's got 
something 
Rebecca 1606-1616 It, it is part of Jewish – a very big part of Jewish culture, that 
everything what happens is for your good (..) You know, it doesn't 
always have to – it's like a, it's like, er, when you give injections 
to a child, you really, the kid's screaming and doesn't want you to 
give it, and really you're cruel, but you're not, because you know 
the bigger picture sort of thing. So that is our culture, but it's not 
rammed down our throats, it's just that we, we, we try and like 
learn it through life, that this happens, it's for the good, you know. 
That's what keeps us going, I suppose 
Master-theme: The importance of seeing the person and the 
disease 
Participant Page & line-
number
Quote
Sub-theme: I am a person not a petri-dish
Matthew 350- 365 “it was very – that was, I mean I saw one doctor there. I won’t 
mention his name but it was terrible because not once, I saw him 
for about four or five years and not once did he look me in the 
eyes in all those times. He was always staring at his paperwork. 
He’d look at my skin, but not once in my eyes, and then say, 
“Right, those tablets and that cream aren’t working. Here’s 
another set” and that’s all I ever got for four or five years from the 
one doctor (..) No, nothing. He never looked me in the eyes once 
(...)And that is, you know, you’d think there’s got to be some sort 
of (..) Between patient and doctor, there’s got to be some sort of 
(…) how do you put it
Matthew 374-377 “Yes. He might as well have been looking in a petri dish..Yes, he 
might as well have just been looking in that, because that’s all he 
saw the skin as. He never... You know?” 
Alice 626-631 And I, I asked where they give me my tablets at my hospital, “Oh 
no, they won’t do that, that’s not something we’ve heard of, oh 
no.” I can phone, nobody would help me. So the medical 
profession are there to help me but then they’re not, because I had 
to go two weeks without the injection, ‘cause nothing could be 
arranged
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Jack 68-80 And it ended up being – I’d have a – so I’d be going regularly for 
blood monitoring and monitoring things for the psoriasis and a 
separate se-, a completely separate series of appointments for 
rheumatology. And it seemed to be they, it was just stuck in a 
ridiculous loop where each department had an idea about what 
Methotrexate dosage there, there should be, Which varied, But 
they didn’t seem to speak to each other, Erm, it, meanwhile, both 
conditions were worsening
Jack 127-130 Erm, which I did…Erm, and what was good about it, and, and, 
and I – did I go back on to the Metho- I, I think I went back on to 
Methotrexate. I don’t recall. Erm, but, erm, (Pause) er, basically I 
then went on, on to this – it was a joint clinic, so they were 
looking at both aspects
Alice 1094-1098 No, and I’m, no, again, the medical profession, no. It’s like no 
one wants to know. They, they ask me when I have my 
Methotrexate, “Oh how are you?” And I’d tell them, but it’s all 
like service. They don’t really take note, they make light of 
everything 
Alice 433-440 But I, I don’t think they really do understand the impact it has and 
how much I actually hate it. Nobody’s got the time, they’re there 
to do something. She’s there to give the injection…so they don’t 
wanna hear when you start or if you say, “Well I’ve got this, I 
think it’s from the Methotrexate.” They tend to poo poo the idea 
and say, “Oh it can’t be from Methotrexate”
Matthew 973-979 You know, when I noticed the two different sides to the treatment, 
it was like, “Wow. All I’ve been doing at the Whittington Hospital 
was as it I was just going through the motions.” Turn up, take 
them, go away. Turn up, take them, go away, and I did that for so 
many years. But here, everything is proactive because I never 
filled out a form like that, nothing like this at the other hospital, 
nothing. There was none of this 
Samuel 577-589 So there’s very little intercommunication between the medical 
practitioner who knows what they’re doing, and the ability to 
transmit the thought processes that they’re going through that 
would clarify what they’re doing. So in other words, “I think you 
should be on Sulfasalazine. We’ll put you on Sulfasalazine. You’ll 
have X number of these at 2.5 mg” or whatever it is, or two 
tablets a day or whatever it is, and we’ll start off with one tablet 
and so on, but none of that is really explained well. They usually 
give you a leaflet, and I find that the leaflets are over-simplistic in 
some respects, and they don’t do anything about conveying 
emotion. They only just talk about hard facts 
Jack 1042-1045 So I think overall we deal with it very badly on every level…Erm, 
and, erm, I, I guess may- maybe because it’s at the heart of it it’s 
something we’re very fearful of. More than physical conditions 
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Jack 986-990 Well, I think it’s one of the big – I think it’s one of the things 
enormously to our demerit as a society that, erm, er, anything 
from, er, form severe mental illness to personality disorders to 
psychological conditions, erm, are – we’re very, I believe, we’re 
very immature about it as a society 
Jack 853-862 There may be a trigger point. Because it’s gonna vary with 
people..Also, people deal with conditions, people. I mean, you 
know, we’ve all seen or experienced cases of different people 
with a similar ailment. Some people deal with it wonderfully. 
Other people can have a much milder form of it and it, they fall 
apart (…) Well, that obviously there’s a psycho-, there’s a 
psychological component to all conditions”  
Jack 865-872 And, you know, we, we all know that, you know, the response to 
it can vary from depression to bitterness and anger, erm, to a, a 
great calmness and, er, and people who are, are suffering from 
bad conditions who, it humbles you to see their response to it (..) 
And, and it’s unpredictable. Whoever you are as an individual, I 
don’t think you can predict, erm, extremis or things that effect 
you, er, physical and psychologically. It’s very difficult to, er, to 
predict
Sub-theme: Not being seen or heard
Alice 644-649 You’re sitting in an uncomfortable chair, erm, there’s absolutely 
no privacy. They come every time before they start your infusion 
to ask if you’ve had any infections. Someone could be there, there 
can be two men and myself and it’s just not private. There’s, 
there’s a pull round curtain, but they can hear everything. There’s 
no privacy 
Alice  652-657 The, the whole what used to be the skin ward, has just been taken 
over. It’s all managers’ offices, and it’s always dermatology and 
rheumatology are just shoved down in the corner and there’s like 
three upright little chairs that you have to sit on to have your 
infusion. It’s not comfortable, it’s not pleasant surroundings 
Alice 695-701 The other thing that gets me when I go to rheumatology, erm, 
every week for my injection there’s all these posters all around 
the, the clinics and the wards, you know, erm, rheumatoid 
arthritis, lupus, osteoarthritis, it’s all these leaflets for arthritis, 
there’s never anything for psoriatic arthritis. There’s, there’s 
nothing. There must be other people with it 
Matthew 21-26 It was frustrating because I mean, by the end of it I saw three or 
four different rheumatologists, and in the end they were very curt 
with me. It was like, “Look, they’re not inflamed. We’ve taken x-
rays. They’re not inflamed. You haven’t got it. You have to get 
over it.” I was like, well, this is strange because I know the pain I 
was feeling
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Alice 724-735 Now I get a lot of arthritis in my chest and again it’s the not being 
believed and being ridiculed by the medical profession. “You 
know, I am very tender anyway, you know I get arthritis there,” 
“You don’t get arthritis there.” And this was a doctor, and the 
nurse laughed at me, “You don’t get arthritis there,” and I was 
saying, “Well actually I do, I get it in my rib cage, I get it here.” 
And they just laugh at me, “You don’t get arthritis there.” Even 
the medical profession aren’t aware of it
Matthew 31-37 Before I came here, there was no link. Even though I was in pain 
and it all coincided at the same time, there was no actual link. 
They said, “You haven’t got rheumatoid arthritis.” I said, “Right, 
fine, but I’ve got pains.” No, that’s it, you haven’t got rheumatoid. 
They didn’t link it with the psoriasis, you know? So obviously 
that was just an oversight but it was very frustrating for quite a 
few years
Samuel 345-350 You see, the trouble is, it’s not life-threatening, and because it’s 
not life-threatening, people turn around to you and say, “Pull 
yourself together. There are much worse things in life than 
psoriasis” and they’re absolutely correct, but when a person has 
got a condition, you focus on your own problems and you become 
self-pitying and so on 
Matthew 48-53 I thought I was maybe losing it, you know? (Laughter) But then 
the relief, the weight off my shoulders when I actually got told, 
“Yes, there is a link” and they put a name on it as psoriatic 
arthritis (…) I was happy. (Laughter) I was happy, even in the 
pain, I was happy, you know?  
Alice 737-739 Erm, I can’t even, I can’t even put it into words. It, it, it just, I, I 
can’t explain it. It affected me that badly I can’t even find words 
to, you know, again it’s not being believed
Alice 744-754 It could be something, over something absolutely minor. so 
between me and my partner, erm, and I’ve got this big thing at the 
moment that I’m not being believed. Now it’s fine, normally, 
under normal circumstances, “Oh I don’t agree with you,” or, or 
joking, “Oh that didn’t happen, “and it, and I just flare up, “You 
don’t believe me,” and it’s like, for years not being believed. And 
it’s so important to me to be believed and so it’s become, erm, I 
can’t think of the word, erm, in a way my behaviour’s become 
irrational because it’s like all blown up out of proportion that I’m 
not being believed 
Alice 768-776 There was something, I can’t even remember what it was about, 
but there was something at the weekend, I ended up having an 
argument with my partner because I said, “You don’t believe me, 
you don’t.” He said, “It’s not that I don’t believe you.” I said, 
“You don’t believe me, do you.” And then he said, “What’s all 
this about,” ‘cause I’d gone over the top and then I just broke 
down and said, erm, “Nobody ever believes me.” And, and I was 
in tears and, you know, nobody ever believes me” 
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Matthew 101-112 I mean it was always there, thinking, “Am I imagining this 
because I’ve got one condition, am I imagining another 
condition?” I was self-doubting. You know, was I feeling it (…) It 
was. It was strange. It’s very hard to explain (…) Well, the 
feelings I was having, because to keep getting told, “You haven’t 
got it.” It’s not easy (..) Not easy, and you know, I even said to 
one of the nurses there, I said, “I’d just like the doctor to live one 
day in my shoes, and then tell me I haven’t got the pain.” You 
know?
Mathew 155-164 Oh, it’s okay. It’s all different now, I mean the relief, the joy you 
feel when someone just says, “Well this is it.” That’s like, I knew 
it all along, you know? It’s like, “Yes.” (Laughter) You know (..) 
Yes, I mean it seems strange to be happy that you’ve got 
something, but just because you’ve been told that it is something 
(..) Yes, and that’s all I got for nearly 20 years. So the frustration 
is... (Laughter) 
Alice 1222-1226 I’ve got this, but I’m having to fight all the time. Why should I 
fight, why isn’t stuff offered to, for treatments for things. So again 
skin rheumatology just wash their hands
Alice 1306-1312 You know, and for, for people receiving chemo or cancer they 
have like, erm, I’ve seen a, a notice up today if you’re on chemo, 
erm, pamper days and things like that. There should be things like 
that…it, it is a serious illness and it just gets you down, makes 
you feel run down. There should be things to help along the way 
Alice 824-839 So you’d think that everybody would be more aware. And I 
remember when this probably started, I’m 48 and it was when I 
was about 20, so it’s 28 years ago, erm, I remember going to my 
GP, feeling ill. And it would be, I’d get up in the morning, I’d 
wake up and I’d feel like my body had gone through a fast spin in 
the washing machine and it ached and it was, I was exhausted. 
And I kept going with these symptoms and, er, he said it was, 
erm, it was probably ME, a mild form of ME. And I think now 
looking back that is when my arthritis first started, because you 
know, and that was so 28 years, but it was, it was the tiredness 
and just feeling generally under the weather. No specific aches 
and pains but just generally and I think now that that’s when it 
first started. So it, it took a long time for it to be diagnosed and 
then it started getting worse and worse. 
Jack 1207-1231 Well, also, no you’ve even go, that practical thing about the fact 
that you’re in a hospital all the time..Because you’ve got two 
parallel sets of thinking…You’re thinking, “This is dumb…This 
is dumb. This is, this is, this is silo, classically silo working. Get – 
“Come on guys, get together (Laughter) Is it really that hard to 
work out? And because, again, you know, I think we mentioned it 
before. I forget the percentage, but I mean, it’s comparatively 
small percentage of people who have, erm, psoriasis ___, 
psoriachical arthropathy. So actually, it’s not like you’ve got to 
majorly disrupt running a joint clinic…You’d probably get 
through your psoriatic arthropathy patients in a morning
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Hanif 175-180 It started with my knees pain, back pain, shoulder pain, my hand 
was terrible and gradually, because I didn’t discuss this with my 
Dermatologist (…) Because I didn’t know it’s related to each 
other
Sub-theme: Mobilising the self to help the body
Alice .
Hanif 329-334 Yes, I think at the time, I suffered a lot. I’m not sure if you 
believe it or not. I think partly I suffered psychologically, not just 
physically. I believe at the time, if I could manage myself 
psychologically, maybe I suffered less, but I’m not sure 
Hanif 815-846 They are related..But in my case, at the time, I couldn’t or I didn’t 
think about it psychologically. I just physically, it helped me 
physically, a lot physically, and but obviously, when you suffer a 
lot, and this medication can help you physically, obviously it 
improves your condition psychologically as well (…) Yes, for 
instance, at the time when psoriasis patches were all over my 
body, I didn’t go out, and partly because of the pain I had, but 
partly because of people. I didn’t want to contact with people in 
my condition but when my psoriasis gone with the help of 
biologic treatment, firstly I didn’t have pain anymore on my skin. 
I’m not talking about the joint pain. I didn’t have any pain on my 
skin and I was happier and even with the small headache, when 
you have a headache – I’m sure you have headache in your life. 
Even with the headache, you don’t want to – when you are on 
headache, you don’t want to go to your friends (…) Or if your 
friends, even if your friend called, you see his or her name, you 
don’t answer your phone. It’s your friend, but you don’t want to 
talk to her. 
Hanif 345-346 And I wish I was in this [pain management] programme in first 
stage. I learned a lot 
Hanif 356-363 Yes, actually I have pain, and I need to take painkiller. When I 
take it, it doesn’t work. In this programme, first of all, I 
understood what is the pain, how pain affects to your brain, to 
your system and I realised even through the meditation, through 
the subconscious I can cope with the pain
Hanif 974-979 It’s very difficult, I don’t know. Just try to convince the patient to 
know the problem, to know the pain, and how to cope with the 
pain. Not just the medication because I believe the effect of 
mental part to – it’s very strong, it’s very powerful 
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Hanif 1024-1052 I don’t know how to explain, it’s nothing changed, but the way I 
think about the pain is totally different (…) If I have pain now, I 
don’t go to my cupboard and take the medication straight away. I 
try to think about the pain first, try to be relaxed, try to be calm 
and breathing helped me a lot, deep breathing. Breathing in and 
exhaling, and going out, even for five or ten minutes of walking. 
Yesterday it was raining. I have a programme in my life now. I 
have a time schedule for myself, waking up, having breakfast, 
having fruit and walking, and going to bed. Yesterday, it was 
raining but I wanted to go out (…) I don’t care about the rain. I 
went out, I was wet but I enjoyed it (…) It was so good. Much 
better than a sunny day (..) I really enjoyed it, and it was a sunny 
day with the rain. I was totally wet but I really, really enjoyed 
it(..)This is life 
Hanif 989-993 Actually, on the other hand, I just went back to 15, 16 years ago, 
at a time when psoriasis was all over my body, even if a good 
Psychologist advised me something, did I listen to him or her, or 
not?  
Matthew 291-296 I mean, as with the skin, it has been a miracle. To me, it’s been 
such fantastic results. It’s amazing, and that makes it, I think 
psychologically the way I’ve looked at it, it’s made me be able to 
bear the pain from the joints that much more, because I’m happier 
with my appearance, you know? 
Matthew 1013-1022 Oh, much more now. Oh, totally, totally. I know everything that 
gets done here is totally proactive and it’s for my own good, you 
know? I know it’s all for me. You know, that’s how I get made to 
feel here. It’s proactive for me. Not to go in a textbook about the 
disease. It’s all for me and to feel like that, it does, I’m sure it 
must have something to do with the fact that your skin is so good 
anyway, now it has to have, you know? Because if you get – the 
feeling that it’s all for you, it puts a positive spin on everything 
because you’re thinking, “Oh yes, it’s because they’re focused on 
me. I’m going to focus on me. I’m going to beat this. 
Matthew 1051-1057 I’m no doctor but I do believe they go hand in hand together, how 
you feel to how – you know, and to me, getting that first time 
when I was clear, I didn’t have a single plaque on my body for the 
first time in so many years. It was, hold on, this is not right, you 
know? It’s so good, and I know, you know, it can only be good for 
me. It can only – if you’re feeling better in yourself, surely it’s 
going to help whatever condition you’ve got 
Rebecca 1736-1746 “Brilliant. I don't know, amazing. I, I wanted to phone somebody 
to thank them, because – thank them, because the truth is, I could 
never have afforded it without the NHS  (..)Do you know what I 
mean? And they were, I don't know, they were like the best thing. 
Like, if I ever complain about the NHS, I don't complain any 
more. (Laughs) 
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Hanif 396-403 Just the best way is knowing the pain. I didn’t know what is the 
pain, this is the most important thing. I had a friend a long time 
ago in Germany, and he, what do you call it? He was Psychologist 
with the hypnotism, and I do remember one day he put one 
cigarette on my hand, and it didn’t burn at all, but he put his 
finger on my hand, and it burnt” (Hanif,) 
Matthew 591-599 It took a long time but it’s there now. I mean, I get it all the time 
now. I have to say, this clinic, everything, even the rheumat- 
Everyone I see, all of it, is based on you as a person, not just you 
as a patient (…) I’ve noticed a massive – it’s fantastic. The 
facilities here in the Royal Free are fantastic for it, absolutely 
superb for it. The difference, because I got treated for so many 
years in a different hospital, the difference is amazing
Matthew 920-922 Yes, I self-referred, and since I’ve done that, which was the best 
decision, other than marrying my wife, it’s probably the best 
decision I’ve ever made in my life (…) Honestly 
Rebecca 646-653 so I just started here, and I've really been happy, and everyone's 
been really nice, and you know (..)They're really, really nice 
(..)Really, really nice. They really care. They really, really care. I 
can't get over it (..) And also, I see the same people the whole 
time. They're so nice, all of them, like really, really nice
Matthew 657-673 But now, psychologically it’s fantastic. I mean, I come here, I 
hear people moaning because they’re waiting an hour for an 
appointment. It doesn’t bother me if my appointment’s at 9 
o’clock and I don’t get seen until 3 o’clock. I don’t care, because 
I’m just so happy with everything, the way the treatment is. I 
don’t know if that answers your question (..) It’s massively 
improved now. You know, no-one likes going to the hospital, no-
one likes that obviously. But I used to dread going to 
appointments before because I knew there would be no outcome. 
It would just be change this, change that, go out and get on with 
it. I dreaded it. I thought, “Why am I wasting my time coming 
here?” But here, I mean I don’t care, as I was saying. My 
appointment could be 9 o’clock. 3 o’clock, if I get seen, I get 
seen. It’s fine. I’ve done it before. I’ve walked away from here. 
They said, “Sorry, no-one’s going to get seen.” “No problem, I’ll 
come back next week.” People are moaning and shouting. “Yes, 
no problem.” 
Matthew 678 – 697 Yes, I’m probably more tolerant of things than I ever used to be 
before (…) But I mean, I’m in pain now a lot of the time. I don’t 
let things wind me up. I don’t. It’s a massive difference on my 
psyche that way (…) I think I’m just feeling better in myself (..) 
The skin has cleared up, the joint – I mean, the joints were getting 
worse steadily anyway, but now it’s like it’s levelled off. They’re 
not getting worse. They’re not great, but they’re not getting as 
bad as they were. If I hadn’t had the biologics, I know I’d 
probably have been walking the way I was before. I’d be 
struggling to walk around at the moment, whereas alright it hurts, 
but I still get about 
!23
8
Matthew 946-956 You know, I can only say how happy I am in myself and I’m not 
saying it just because we’re here in this hospital. I’m not, but the 
treatment I get here is out of this world. After a lot of years of 
frustration, the treatment I get here, and I mean that, I’m not 
saying it just because we’re here (…) It’s superb (…) It’s 
superb..It just makes me feel so much better 
Jack 853-862 There may be a trigger point. Because it’s gonna vary with 
people..Also, people deal with conditions, people. I mean, you 
know, we’ve all seen or experienced cases of different people 
with a similar ailment. Some people deal with it wonderfully. 
Other people can have a much milder form of it and it, they fall 
apart (…) Well, that obviously there’s a psycho-, there’s a 
psychological component to all conditions 
Jack 865-872 And, you know, we, we all know that, you know, the response to 
it can vary from depression to bitterness and anger, erm, to a, a 
great calmness and, er, and people who are, are suffering from 
bad conditions who, it humbles you to see their response to it (..) 
And, and it’s unpredictable. Whoever you are as an individual, I 
don’t think you can predict, erm, extremis or things that effect 
you, er, physical and psychologically. It’s very difficult to, er, to 
predict 
Jack 986-990 Well, I think it’s one of the big – I think it’s one of the things 
enormously to our demerit as a society that, erm, er, anything 
from, er, form severe mental illness to personality disorders to 
psychological conditions, erm, are – we’re very, I believe, we’re 
very immature about it as a society…. 
Rebecca 591-598 The funny thing was, that I didn't get ill so often before. I used to 
get colds, or, or, you know, ear- I don't know, you know, I used to 
get things (…) And since I was on the biologics, I was supposed 
to get even iller because my immune system was so low. And 
thank God, I don't think I was ill once, really, I don't think I had a 
cough or cold or anything. Maybe because my mood was like 
good, or, you know  
Matthew 90-96 It was totally frustrating, and I’m positive because, I’m not saying 
it was mistreatment or anything because my skin, it looks great 
now but for years it’s been very, very bad. I mean, the amount of 
time I’ve gone, I’ve probably gone maybe a whole year at one 
stage where I had about 95% of my skin covered and everything. 
But I’m positive that had something to do with it. The fact that 
they wouldn’t recognise the pain I was in. I’m sure that made the 
skin flare up
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Matthew 155-164 Oh, it’s okay. It’s all different now, I mean the relief, the joy you 
feel when someone just says, “Well this is it.” That’s like, I knew 
it all along, you know? It’s like, “Yes.” (Laughter) You know (..) 
Yes, I mean it seems strange to be happy that you’ve got 
something, but just because you’ve been told that it is something 
(..) Yes, and that’s all I got for nearly 20 years. So the frustration 
is... (Laughter)
Hanif 531-536 It’s for instance, last night, I had pain. I had pain on my ribcage. 
The pain was under the rib and I had this pain with each breath in 
and out, one deep pain in and one deep pain out, in time, and I 
could see it, and with breathing, I could manage to stop the pain
Hanif 543-545 Yes, I’ve found a way, because you know, sometimes you tried 
everything and it doesn’t work. I found a way and now I can cope 
with it
Hanif 480-483 Yes, it may help to some people, but if you could manage yourself 
mentally, definitely it works, but you can’t say medication 100% 
works 
Alice 268-272 Erm, at first I’d get annoyed, I’d get angry and I’d get annoyed 
with them, and, erm, then it has a longer lasting effect that I really 
resent the medical profession. These are people who are supposed 
to be treating me, they should be listening to me and they’re just 
dismissing
Alice 150-158 Oh this isn’t, erm, this isn’t a side effect, it’s probably not from 
your Methotrexate. Have a word with your doctor.” And I knew it 
was because I’d get it every, erm, a few hours after my 
Methotrexate and it would last all day Tuesday and then other 
times for any reason I haven’t had my Methotrexate I don’t get 
those feelings..And I’ve been telling them for years this is what I 
get. Suddenly now they recognise it
Alice 30-32 Now I’ve developed, which I’ve never had before, a needle 
phobia and it’s from all the injections and having my bloods taken 
all the time 
Alice 110-114 I’ve never had a problem with, with having my blood taken or 
cannulas, but I think it’s my, my veins have, have, when they’re 
overused, if they sunk or something or they, they’re scarred so the 
cannula pops out and I dread having that done, ‘cause it’s three or 
four attempts now having that in. Erm, and I hate it
Alice 179-186 Erm, and then I’d put it in my mouth and if I couldn’t swallow it 
straightaway where the tablet had been I’d get blisters in my 
mouth. I could feel it stick all the way down
Hanif 568-582 Just one leaflet, one booklet can help to realise about the pain, 
because most people don’t know about the pain. They believe if 
they have headaches, they have to take Paracetamol and the 
headache gone… As I mentioned, you have to know what is the 
pain, and you have to take, even if you want to take one 
painkiller, you need to know each painkiller works for different 
things. You can’t take Gabapentin for headache, or you can’t take 
Paracetamol for your slipped disc. You have to know your pain, 
and you have to know these. You have to educate 
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Jack 1221-1259 Well, again, it reminds me, which I, I, which, erm, I, erm, which 
I’d forgotten completely actually, was that the rheumatic pain was 
so bad that one of the things that really pissed me off, to use a 
technical term, at the Whittington was that the doctors in there, in 
the rheumatology department seemed to utterly discount the fact 
that rheumatoid, that rheumatoid conditions are very, arthritic 
conditions – are very painful. And at times, I, I was absolutely 
exhausted and worn out by pain. I was on quite strong pain killers 
and there seemed to be, I don’t know, maybe a, maybe a (Pause) 
complete insensitivity that it was because I – maybe if you’re in 
that kind of department, all your patients are going to suffer from 
pain (..)But I remember saying, you know, “I really need some 
help for managing pain.”And getting really nothing (…)But, yes, 
it was really, er, when I think about it, it was, I was, it was really 
painful. Getting to sleep was really difficult. Waking up and then 
you were incredibly stiff. And try, and getting out of bed in the 
morning and standing up and getting dressed were painful 
processes..And there was no help for it… And I was 
thinking, well, I was aware of the concept of pain management 
yet it wasn’t offered…And you think, “Well, this is dumb, this is 
dumb.” Because whatever else that, that the doctors are doing – 
the practical thing of being able to suggest something.That surely 
there must be some things about pain management..And, and it 
was, it was quite acute 
Jack 1252-1278 Well, it makes you angry (..) And then ultimately, I think it does 
make you depressed, Because, because, you know – if you could, 
if you could maybe, or for me, if, if, if one could pinpoint the 
origin of depression, it’s rightly or – well, that’s, it’s not a right or 
wrong thing. It, it originates out of an area of, erm, frustration of 
not being able to be in synch with, er, how maybe you would like 
things to be. Erm, and not having a successful mental stratagem 
for dealing with how they are..And that divergence spirals into 
depression…Because it’s, it, it’s like an inability to cope 
Alice 1207-1211 Look, you know, is there any sort of, erm, erm, help I can get like, 
erm,, cognitive behavioural therapy for me to cope with, with my 
treatment, some and to try and help me accept my condition?” 
“Oh no, there’s nothing like this. You, you could go somewhere 
privately, you could do this, do that.”
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